TOKEN	PREDICTED
(	O
2015	O
).	O

Study	O
has	O
shown	O
that	O
exposing	O
edible	O
mushroom	O
to	O
ultraviolet	O
B	O
light	O
could	O
increase	O
its	O
Vitamin	O
D2	O
content	O
and	O
raise	O
serum	O
25	O
-	O
OH	O
VitD2	O
in	O
healthy	O
adults	O
[	O
2	O
,	O
3	O
].	O

Genotyping	O
,	O
which	O
was	O
not	B
practical	I
in	O
our	O
study	O
setting	O
,	O
might	O
have	O
aided	O
the	O
interpretation	O
of	O
our	O
findings	O
,	O
as	O
shown	O
in	O
a	O
vitamin	O
D	O
supplementation	O
trial	O
for	O
tuberculosis	O
.	O
20	O
We	O
accounted	O
for	O
nutritional	O
factors	O
through	O
a	O
diet	O
questionnaire	O
,	O
weight	O
at	O
recruitment	O
,	O
and	O
growth	O
comparison	O
at	O
the	O
end	O
of	O
our	O
study	O
—	O
any	O
nutritional	O
deficiencies	O
would	O
have	O
been	O
equally	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

Earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
[	O
13	O
]	O
and	O
few	O
data	O
are	O
available	O
linking	O
habitual	O
diet	O
to	O
neonatal	O
anthropometric	O
measurements	O
.	O

However	O
,	O
according	O
to	O
the	O
recent	O
studies	O
,	O
vitamin	O
D	O
deficiency	O
is	O
also	O
common	O
in	O
these	O
countries10	O
,	O
11	O
.	O

Rodent	O
models	O
of	O
leptin	O
deficiency	O
exhibit	O
marked	O
decreases	O
in	O
BAT	O
thermogenic	O
capacity	O
,	O
as	O
well	O
as	O
activity	O
(	O
Ueno	O
et	O
al	O
.,	O
1998	O
).	O

In	O
our	O
study	O
we	O
found	O
that	O
the	O
adjusted	O
relative	O
risk	O
of	O
GDM	O
was	O
highest	O
among	O
overweight	O
mothers	O
who	O
snored	O
during	O
pregnancy	O
(	O
OR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
3	O
)	O
when	O
compared	O
with	O
lean	O
mothers	O
who	O
did	O
not	O
snore	O
.	O

2	O
-	O
D	O
gel	O
electrophoresis	O
-	O
based	O
proteomics	O
and	O
mass	O
spectroscopy	O
were	O
used	O
to	O
investigate	O
differential	O
protein	O
expression	O
.	O

Nonetheless	O
,	O
in	O
our	O
study	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
lower	O
depression	O
scores	O
after	O
intervention	O
.	O

An	O
increase	O
of	O
'	O
mTOR	O
signaling	O
'	O
within	O
developmental	O
period	O
II	O
was	O
observed	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
the	O
LP	O
group	O
.	O

Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
the	O
search	O
terms	O
:	O
pregnant	O
,	O
neurodevelopment	O
,	O
cognition	O
,	O
fish	O
and	O
seafood	O
.	O

[	O
24	O
]	O
found	O
that	O
seafood	O
consumption	O
that	O
excluded	O
fish	O
intake	O
had	O
a	O
detrimental	O
effect	O
on	O
neurodevelopment	O
,	O
while	O
fish	O
intake	O
alone	O
led	O
to	O
improved	O
outcomes	O
.	O

While	O
the	O
GraviD	O
study	O
indicates	O
an	O
association	O
between	O
T3	O
25OHD	O
and	O
consequences	O
of	O
placental	O
insufficiency	O
,	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
might	O
be	O
a	O
stronger	O
predictor	O
of	O
placental	O
dysfunction	O
,	O
as	O
it	O
is	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

Transfer	O
Mechanisms	O
of	O
Allergy	O
(	O
Immunopathogenesis	O
of	O
Atopy	O
)	O
The	O
allergic	O
status	O
of	O
the	O
mother	O
can	O
potentially	O
affect	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
through	O
numerous	O
factors	O
that	O
are	O
transferable	O
via	O
the	O
placenta	O
or	O
breast	O
milk	O
.	O

furthered	O
our	O
understanding	O
of	O
the	O
effects	O
of	O
paternal	O
folate	O
deficiency	O
[	O
6	O
].	O

Medical	O
history	O
of	O
liver	O
disease	O
;	O
3	O
).	O

In	O
Afghanistan	O
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
is	O
low10and	O
exposure	O
of	O
women	O
to	O
sunlight	O
is	O
limited	O
by	O
the	O
widespread	O
use	O
of	O
the	O
burqa	O
.	O

Only	O
lower	O
maternal	O
fat	O
intake	O
(−	O
0	O
.	O
22	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
trend	O
for	O
higher	O
carbohydrate	O
intake	O
(	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
06	O
)	O
early	O
in	O
pregnancy	O
were	O
correlated	O
with	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
6	O
months	O
.	O

Multivariable	O
logistic	O
regression	O
analyses	O
of	O
the	O
outcome	O
variables	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
performed	O
with	O
25OHD	O
at	O
T1	O
,	O
T3	O
and	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
as	O
the	O
independent	O
variables	O
.	O

Their	O
offspring	O
were	O
more	O
likely	O
to	O
have	O
weighed	O
less	O
at	O
birth	O
and	O
to	O
have	O
had	O
a	O
lower	O
BMI	O
at	O
age	O
7	O
years	O
(	O
table	O
1	O
).	O

The	O
mean	O
total	O
number	O
of	O
combined	O
visits	O
was	O
9	O
.	O
58	O
±	O
4	O
.	O
88	O
:	O
18	O
%	O
of	O
participants	O
made	O
≤	O
4	O
visits	O
,	O
28	O
.	O
5	O
%	O
made	O
between	O
5	O
–	O
9	O
visits	O
and	O
53	O
.	O
3	O
%	O
had	O
≥	O
10	O
visits	O
.	O

Both	O
intervention	O
and	O
control	O
treatment	O
arms	O
will	O
receive	O
the	O
usual	O
antenatal	O
and	O
postnatal	O
care	O
services	O
by	O
BRAC	O
.	O

Regarding	O
female	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
a	O
main	O
effect	O
of	O
prenatal	O
diet	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
7	O
.	O
517	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
and	O
an	O
almost	O
significant	O
effect	O
of	O
treatment	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
3	O
.	O
928	O
,	O
P	O
=	O
0	O
.	O
056	O
]	O
on	O
chocolate	O
intake	O
(	O
Figure3G	O
).	O

We	O
did	O
not	O
observe	O
an	O
overall	O
association	O
between	O
any	O
attribute	O
-	O
defined	O
gene	O
-	O
associated	O
class	O
methylation	O
and	O
LINE	O
-	O
1	O
methylation	O
levels	O
.	O

Eight	O
viable	O
fetuses	O
per	O
sow	O
were	O
collected	O
starting	O
at	O
the	O
tip	O
of	O
the	O
left	O
uterus	O
horn	O
and	O
alternating	O
between	O
left	O
and	O
right	O
horn	O
.	O

Study	O
midwifes	O
and	O
/	O
or	O
fieldworkers	O
collect	O
birth	O
data	O
(	O
phase	O
4	O
)	O
within	O
a	O
window	O
of	O
12	O
h	O
.	O
Postnatal	O
data	O
are	O
collected	O
at	O
6	O
weeks	O
(+	O
14	O
days	O
)	O
(	O
phase	O
5	O
);	O
24	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
6	O
);	O
6	O
weeks	O
post	O
measles	O
immunisation	O
(±	O
3	O
days	O
)	O
(	O
phase	O
7	O
)	O
or	O
30	O
weeks	O
(+	O
30	O
days	O
)	O
if	O
measles	O
immunization	O
was	O
not	O
given	O
between	O
24	O
and	O
28	O
weeks	O
;	O
and	O
52	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
8	O
)	O
postnatal	O
age	O
.	O

2	O
.	O

In	O
order	O
to	O
investigate	O
transcriptional	O
features	O
of	O
developmental	O
nutritional	O
programming	O
we	O
conducted	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

They	O
have	O
all	O
demonstrated	O
that	O
the	O
rapid	O
acting	O
analogues	O
are	O
as	O
effective	O
as	O
regular	O
insulin	O
in	O
the	O
treatment	O
of	O
GDM	O
,	O
with	O
comparable	O
,	O
if	O
not	O
favorable	O
,	O
outcomes	O
(	O
Table	O
3	O
).	O

This	O
could	O
support	O
the	O
hypothesis	O
that	O
sex	O
hormones	O
and	O
,	O
therefore	O
,	O
menstrual	O
and	O
reproductive	O
events	O
,	O
may	O
modify	O
thyroid	O
cancer	O
risk	O
in	O
women6	O
,	O
although	O
these	O
associations	O
–	O
which	O
could	O
indicate	O
either	O
a	O
causal	O
link	O
or	O
a	O
surveillance	O
bias	O
–	O
may	O
reflect	O
an	O
aetiology	O
shared	O
by	O
both	O
the	O
above	O
-	O
mentioned	O
factors	O
and	O
by	O
thyroid	O
cancer	O
.	O

(	O
2012	O
)*/†	O
MethylmercuryMouseOral	O
(	O
water	O
)	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
+	O
neonatalAdulthoodBehavioral	O
abnormalitiesHistone	O
modification	O
DNA	O
methylationOnishchenko	O
et	O
al	O
.	O

In	O
particular	O
,	O
the	O
degradation	O
of	O
essential	O
,	O
branch	O
-	O
chained	O
amino	O
acids	O
like	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
was	O
found	O
to	O
be	O
regulated	O
,	O
which	O
may	O
illustrate	O
the	O
LP	O
offspring	O
'	O
s	O
efforts	O
to	O
mimic	O
prenatal	O
experiences	O
in	O
terms	O
of	O
dietary	O
supply	O
during	O
postnatal	O
development	O
in	O
the	O
face	O
of	O
richer	O
conditions	O
.	O

?	O

We	O
did	O
not	O
identify	O
any	O
correlations	O
between	O
baseline	O
variables	O
.	O

American	O
Wagyu	O
steers	O
fed	O
a	O
high	O
-	O
corn	O
diet	O
had	O
greater	O
fat	O
accumulation	O
than	O
did	O
animals	O
fed	O
a	O
hay	O
-	O
based	O
diet	O
[	O
120	O
].	O

Methods	O
The	O
aims	O
of	O
this	O
prospective	O
cohort	O
study	O
are	O
:	O
1	O
)	O
to	O
assess	O
dietary	O
intake	O
and	O
nutritional	O
status	O
of	O
urban	O
pregnant	O
women	O
in	O
Johannesburg	O
,	O
South	O
Africa	O
,	O
and	O
2	O
)	O
to	O
determine	O
associations	O
with	O
birth	O
outcomes	O
,	O
measures	O
of	O
maternal	O
health	O
,	O
as	O
well	O
as	O
measures	O
of	O
offspring	O
health	O
and	O
development	O
.	O

Patients	O
must	O
be	O
monitored	O
closely	O
for	O
potential	O
adverse	O
effects	O
of	O
corticosteroids	O
,	O
especially	O
gestational	O
diabetes	O
,	O
preeclampsia	O
,	O
and	O
intrauterine	O
growth	O
retardation	O
.	O

The	O
MiG	O
Study	O
randomized	O
751	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
or	O
metformin	O
.	O
72The	O
women	O
in	O
the	O
metformin	O
arm	O
were	O
treated	O
with	O
supplemental	O
insulin	O
if	O
the	O
maximal	O
dose	O
of	O
metformin	O
,	O
2500	O
mg	O
daily	O
,	O
failed	O
to	O
meet	O
the	O
glucose	O
targets	O
.	O

PubMed	O
Central	O
:	O

The	O
researchers	O
found	O
that	O
the	O
more	O
vegetables	O
,	O
fruits	O
,	O
and	O
proteins	O
a	O
woman	O
ate	O
,	O
the	O
lower	O
the	O
risk	O
of	O
her	O
child	O
having	O
leukemia	O
.	O

Sample	O
size	O
The	O
available	O
sample	O
size	O
for	O
follow	O
-	O
up	O
assessment	O
at	O
6	O
-	O
months	O
of	O
age	O
was	O
predetermined	O
by	O
the	O
LIMIT	O
trial	O
,	O
which	O
was	O
powered	O
on	O
the	O
primary	O
outcome	O
of	O
large	O
for	O
gestational	O
age	O
,	O
with	O
2212	O
women	O
randomised	O
[	O
22	O
].	O

Data	O
will	O
be	O
analysed	O
prospectively	O
to	O
determine	O
associations	O
between	O
variables	O
at	O
different	O
time	O
points	O
(	O
longitudinally	O
)	O
by	O
using	O
appropriate	O
statistical	O
methods	O
(	O
e	O
.	O
g	O
.	O

(	O
2016	O
),	O
could	O
impair	O
the	O
sympathetic	O
neurotransmission	O
and	O
hormones	O
involved	O
in	O
energy	O
metabolism	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
;	O
Keimpema	O
et	O
al	O
.,	O
2013	O
,	O
2014	O
;	O
Cristino	O
et	O
al	O
.,	O
2014	O
).	O

For	O
instance	O
,	O
the	O
Mediterranean	O
diet	O
during	O
pregnancy	O
has	O
been	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
both	O
persistent	O
and	O
atopic	O
wheeze	O
and	O
atopy	O
in	O
children	O
at	O
6	O
.	O
5	O
years	O
old	O
[	O
1	O
,	O
2	O
].	O

In	O
another	O
study	O
,	O
the	O
cold	O
-	O
induced	O
increase	O
in	O
thermogenesis	O
was	O
accompanied	O
by	O
a	O
decrease	O
in	O
body	O
weight	O
,	O
mainly	O
affecting	O
the	O
fat	O
mass	O
compartment	O
(	O
Yoneshiro	O
et	O
al	O
.,	O
2013	O
).	O

The	O
male	O
pups	O
were	O
weaned	O
on	O
postnatal	O
day	O
21	O
and	O
housed	O
in	O
groups	O
of	O
3	O
–	O
6	O
.	O

This	O
hospital	O
performs	O
approximately	O
85	O
%	O
of	O
all	O
obstetrical	O
deliveries	O
in	O
Providence	O
County	O
(	O
the	O
largest	O
population	O
center	O
in	O
Rhode	O
Island	O
)	O
and	O
approximately	O
74	O
%	O
of	O
all	O
deliveries	O
in	O
Rhode	O
Island	O
.	O

However	O
,	O
the	O
previous	O
study	O
was	O
based	O
on	O
cortical	O
and	O
hippocampal	O
tissue	O
from	O
adult	O
female	O
animals	O
,	O
whereas	O
the	O
current	O
study	O
was	O
based	O
on	O
tissue	O
from	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
male	O
animals	O
.	O

Cocaine	O
has	O
been	O
associated	O
with	O
an	O
increase	O
in	O
the	O
onset	O
of	O
neurodevelopmental	O
abnormalities	O
,	O
but	O
the	O
direct	O
influence	O
on	O
autism	O
development	O
is	O
still	O
lacking	O
.	O

She	O
described	O
the	O
pain	O
as	O
continuous	O
,	O
10	O
/	O
10	O
in	O
severity	O
,	O
worsened	O
with	O
movement	O
and	O
breathing	O
,	O
and	O
relieved	O
by	O
nothing	O
.	O

2009	O
).	O

Finally	O
,	O
136	O
participants	O
completed	O
the	O
EPDS	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Although	O
an	O
assessment	O
was	O
conducted	O
at	O
6	O
months	O
post	O
-	O
partum	O
involving	O
66	O
%	O
of	O
participants	O
[	O
18	O
],	O
there	O
have	O
been	O
no	O
early	O
infant	O
outcomes	O
reported	O
to	O
date	O
.	O

There	O
were	O
significant	O
effect	O
of	O
both	O
diet	O
and	O
time	O
,	O
but	O
no	O
interaction	O
between	O
them	O
on	O
food	O
intake	O
and	O
weight	O
gain	O
,	O
suggesting	O
that	O
vitamin	O
diets	O
strongly	O
alter	O
the	O
phenotype	O
of	O
mature	O
offspring	O
independent	O
of	O
time	O
.	O

Sleep	O
was	O
assessed	O
using	O
the	O
General	O
Sleep	O
Disturbance	O
questionnaire	O
[	O
30	O
].	O

Results	O
Both	O
phases	O
only	O
ran	O
for	O
7	O
months	O
;	O
integration	O
required	O
4	O
months	O
.	O

Phase	O
3	O
data	O
are	O
collected	O
at	O
36	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
).	O

However	O
,	O
until	O
their	O
safety	O
in	O
pregnancy	O
can	O
be	O
clearly	O
established	O
,	O
the	O
initiation	O
of	O
long	O
-	O
acting	O
insulin	O
analog	O
therapy	O
in	O
women	O
with	O
GDM	O
cannot	B
be	I
recommended	O
.	O

SIRTs	O
have	O
an	O
important	O
role	O
in	O
the	O
process	O
of	O
synapse	O
promotion	O
and	O
modulation	O
of	O
their	O
strength	O
,	O
which	O
is	O
important	O
for	O
memory	O
formation	O
.	O

Introduction	O
Obesity	O
,	O
well	O
known	O
to	O
be	O
associated	O
with	O
a	O
number	O
of	O
comorbidities	O
,	O
including	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
,	O
has	O
become	O
a	O
major	O
public	O
health	O
problem	O
in	O
recent	O
decades	O
,	O
and	O
has	O
reached	O
epidemic	O
proportions	O
,	O
not	O
only	O
in	O
high	O
-	O
income	O
countries	O
,	O
but	O
also	O
in	O
most	O
middle	O
-	O
income	O
societies	O
.	O

Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
females	O
presented	O
a	O
significant	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Acaca	O
,	O
Fasn	O
,	O
Cpt1a	O
,	O
Acox1	O
,	O
Insig1	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Scd1	O
in	O
PAT	O
compared	O
to	O
that	O
of	O
CC	O
ones	O
(	O
Figures5A	O
–	O
C	O
).	O

PubMed	O
Central	O
:	O

The	O
classification	O
of	O
women	O
into	O
three	O
groups	O
with	O
different	O
levels	O
of	O
symptoms	O
(	O
low	O
,	O
middle	O
and	O
high	O
)	O
was	O
based	O
on	O
predefined	O
,	O
but	O
arbitrary	O
cut	O
-	O
offs	O
from	O
the	O
self	O
-	O
reported	O
answers	O
to	O
the	O
CAPE	O
questionnaire	O
.	O

Therefore	O
,	O
pregnancy	O
following	O
thyroid	O
cancer	O
is	O
not	O
infrequent	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
the	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

Maternal	O
dietary	O
risk	O
factors	O
in	O
childhood	O
acute	O
lymphoblastic	O
leukemia	O
(	O
United	O
States	O
).	O

For	O
other	O
abbreviations	O
,	O
see	O
text	O
.	O

Undernourishment	O
in	O
utero	O
can	O
stress	O
the	O
foetus	O
in	O
ways	O
that	O
permanently	O
affect	O
physiological	O
growth	O
and	O
development	O
,	O
and	O
can	O
be	O
described	O
as	O
a	O
reprogramming	O
of	O
the	O
foetus	O
’	O
s	O
developing	O
phenotype	O
[	O
4	O
].	O

BMI	O
,	O
defined	O
as	O
weight	O
in	O
kilograms	O
divided	O
by	O
height	O
in	O
meters	O
squared	O
,	O
was	O
calculated	O
.	O

Using	O
a	O
new	O
assessment	O
technique	O
,	O
we	O
investigated	O
Vitamin	O
D	O
nutritional	O
status	O
among	O
outpatients	O
with	O
GDM	O
in	O
our	O
hospital	O
,	O
and	O
analyzed	O
Vitamin	O
D	O
sources	O
and	O
its	O
association	O
with	O
dietary	O
pattern	O
.	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	O
(	O
1	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
global	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
phenotype	O
(	O
s	O
);	O
(	O
2	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
size	O
and	O
nature	O
of	O
cohort	O
,	O
type	O
of	O
sample	O
analyzed	O
,	O
use	O
of	O
case	O
controls	O
,	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
,	O
validation	O
in	O
independent	O
cohorts	O
);	O
or	O
(	O
3	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

In	O
animal	O
models	O
,	O
prenatal	O
exposures	O
to	O
overnutrition	O
,	O
high	O
-	O
fat	O
and	O
high	O
-	O
protein	O
diets	O
,	O
“	O
junk	O
”	O
food	O
,	O
and	O
stress	O
have	O
been	O
linked	O
with	O
greater	O
adiposity	O
in	O
offspring	O
[	O
10	O
–	O
12	O
].	O

Dermatologists	O
should	O
be	O
aware	O
of	O
the	O
distinguishing	O
features	O
of	O
scattered	O
bone	O
formation	O
and	O
diffuse	O
capillary	O
proliferation	O
of	O
AAOC	O
rather	O
than	O
the	O
lobular	O
aggregates	O
in	O
PG	O
.	O

Several	O
studies	O
have	O
shown	O
that	O
fetal	O
nutritional	O
programming	O
affects	O
growth	O
and	O
/	O
or	O
beef	O
quality	O
,	O
including	O
marbling	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
categorised	O
based	O
on	O
standardised	O
quartiles	O
and	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
statusPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Low711	O
(	O
25	O
)	O
328	O
(	O
46	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
07	O
)	O
46	O
(	O
6	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
66	O
,	O
1	O
.	O
57	O
))	O
57	O
(	O
8	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
42	O
)	O
28	O
(	O
4	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
30	O
)	O
36	O
(	O
5	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
29	O
)	O
84	O
(	O
12	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
39	O
)	O
Low	O
-	O
Moderate755	O
(	O
27	O
)	O
318	O
(	O
42	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
12	O
)	O
42	O
(	O
6	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
64	O
)	O
65	O
(	O
9	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
74	O
,	O
1	O
.	O
52	O
)	O
25	O
(	O
3	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
39	O
,	O
1	O
.	O
16	O
)	O
33	O
(	O
4	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
3572	O
(	O
10	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
32	O
)	O
Moderate	O
-	O
High702	O
(	O
25	O
)	O
309	O
(	O
44	O
)	O
1	O
.	O
0	O
†	O
37	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
50	O
(	O
7	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
39	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
81	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
High630	O
(	O
23	O
)	O
258	O
(	O
41	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
06	O
)†	O
35	O
(	O
6	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
78	O
,	O
1	O
.	O
96	O
)	O
40	O
(	O
6	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
30	O
)	O
10	O
(	O
2	O
)	O
0	O
.	O
47	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
)	O
30	O
(	O
5	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
25	O
)	O
60	O
(	O
10	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
11	O
)	O
Vitamin	O
D	O
Status	O
<	O
25	O
nmol	O
/	O
L99	O
(	O
4	O
)	O
51	O
(	O
52	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
)	O
8	O
(	O
8	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
03	O
))	O
6	O
(	O
6	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
32	O
,	O
1	O
.	O
52	O
)	O
5	O
(	O
5	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
38	O
,	O
2	O
.	O
52	O
)	O
7	O
(	O
7	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
04	O
)	O
13	O
(	O
13	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
66	O
,	O
2	O
.	O
01	O
)	O
25	O
-	O
50	O
nmol	O
/	O
L673	O
(	O
24	O
)	O
301	O
(	O
45	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
03	O
)	O
45	O
(	O
7	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
75	O
)	O
59	O
(	O
9	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
34	O
)	O
26	O
(	O
4	O
)	O
0	O
.	O
89	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
47	O
)	O
29	O
(	O
4	O
)	O
0	O
.	O
75	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
16	O
)	O
74	O
(	O
11	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
24	O
)	O
>	O
50	O
-	O
75	O
nmol	O
/	O
L928	O
(	O
33	O
)	O
428	O
(	O
46	O
)	O
1	O
.	O
0	O
†	O
48	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
80	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
52	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
107	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
>	O
75	O
nmol	O
/	O
L1098	O
(	O
39	O
)	O
435	O
(	O
40	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
04	O
)	O
60	O
(	O
5	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
87	O
,	O
1	O
.	O
87	O
)	O
67	O
(	O
6	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
12	O
)†	O
26	O
(	O
2	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
28	O
)	O
51	O
(	O
5	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
26	O
)	O
104	O
(	O
9	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
12	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
pregnancy	O
outcome	O
and	O
fetal	O
sex	O
As	O
there	O
is	O
evidence	O
to	O
suggest	O
that	O
vitamin	O
D	O
metabolism	O
within	O
the	O
placenta	O
may	O
differ	O
with	O
respect	O
to	O
fetal	O
sex	O
[	O
35	O
]	O
thus	O
,	O
we	O
assessed	O
the	O
effect	O
of	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
on	O
pregnancy	O
outcome	O
stratified	O
by	O
fetal	O
sex	O
(	O
Table	O
3	O
).	O

[	O
18	O
],	O
Hibbeln	O
et	O
al	O
.	O

In	O
all	O
cases	O
,	O
multiple	O
comparisons	O
were	O
assessed	O
by	O
Bonferroni	O
post	O
-	O
hoc	O
test	O
.	O

Targeted	O
genotyping	O
of	O
genes	O
of	O
interest	O
in	O
the	O
context	O
of	O
fatty	O
acid	O
,	O
lipid	O
and	O
micronutrient	O
metabolism	O
will	O
also	O
be	O
investigated	O
following	O
the	O
Ion	O
AmpliSeq	O
Targeted	O
Sequencing	O
approach	O
using	O
the	O
Ion	O
Chef	O
™	O
and	O
Ion	O
S5	O
™	O
Systems	O
(	O
ThermoFisher	O
).	O

EPA	O
and	O
DHA	O
are	O
mainly	O
found	O
in	O
fatty	O
fish	O
,	O
with	O
levels	O
that	O
vary	O
by	O
the	O
species	O
of	O
the	O
fish	O
,	O
environmental	O
factors	O
and	O
geographic	O
area	O
[	O
27	O
].	O

;	O
P	O
=	O
.	O
002	O
).	O

Allergic	O
rhinitis	O
commonly	O
coexists	O
with	O
asthma	O
;	O
80	O
%	O
of	O
asthmatic	O
adults	O
also	O
have	O
AR	O
,	O
and	O
20	O
%	O
to	O
50	O
%	O
of	O
patients	O
with	O
AR	O
also	O
have	O
asthma	O
[	O
25	O
].	O

Prevalence	O
of	O
postpartum	O
depression	O
varies	O
throughout	O
the	O
world	O
;	O
however	O
researchers	O
have	O
used	O
different	O
scales	O
and	O
cut	O
off	O
points	O
to	O
describe	O
this	O
psychological	O
disorder	O
.	O

Although	O
the	O
exact	O
mechanisms	O
underlying	O
these	O
associations	O
have	O
yet	O
to	O
be	O
fully	O
elucidated	O
,	O
evidence	O
from	O
experimental	O
studies	O
suggest	O
that	O
insufficient	O
sleep	O
and	O
sleep	O
fragmentation	O
result	O
in	O
metabolic	O
and	O
neuroendocrine	O
alterations	O
,	O
particularly	O
alterations	O
in	O
the	O
hypothalamic	O
-	O
pituitary	O
adrenal	O
(	O
HPA	O
)	O
axis	O
,	O
that	O
may	O
contribute	O
to	O
the	O
development	O
of	O
impaired	O
glucose	O
tolerance	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
mellitus	O
[	O
16	O
-	O
20	O
].	O

We	O
aimed	O
to	O
study	O
the	O
relationship	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
and	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
in	O
a	O
population	O
-	O
based	O
birth	O
cohort	O
,	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
.	O

Randomised	O
clinical	O
trials	O
have	O
been	O
conducted	O
using	O
fish	O
oil	O
supplementation	O
in	O
pregnancy	O
,	O
but	O
not	O
with	O
fish	O
considered	O
as	O
a	O
whole	O
food	O
.	O

wks	O
,	O
weeks	O
;	O
d	O
,	O
days	O
,	O
pp	O
,	O
postpartum	O
Maternal	O
socio	O
-	O
economics	O
and	O
-	O
demographics	O
Socio	O
-	O
economic	O
and	O
-	O
demographic	O
data	O
are	O
collected	O
at	O
phase	O
1	O
by	O
means	O
of	O
a	O
structured	O
interview	O
.	O

The	O
mortality	O
rate	O
in	O
our	O
study	O
cohort	O
was	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
95	O
%	O
CI	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
):	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
;	O
ten	O
cases	O
)	O
in	O
our	O
vitamin	O
D	O
group	O
and	O
3	O
·	O
4	O
per	O
1000	O
child	O
years	O
(	O
1	O
·	O
3	O
–	O
7	O
·	O
1	O
;	O
seven	O
cases	O
)	O
in	O
our	O
placebo	O
group	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
research	O
council	O
(	O
research	O
project	O
number	O
:	O
193053	O
)	O
and	O
ethics	O
committee	O
(	O
research	O
ethics	O
number	O
:	O
IR	O
.	O
MUI	O
.	O
REC193053	O
).	O

Increases	O
in	O
stress	O
were	O
related	O
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	O
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	O
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

Significant	O
correlations	O
were	O
observed	O
in	O
both	O
groups	O
between	O
first	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
002	O
,	O
ra	O
=	O
0	O
.	O
713	O
,	O
pb	O
=	O
0	O
.	O
005	O
,	O
rb	O
=-	O
0	O
.	O
540	O
,	O
in	O
A	O
and	O
B	O
group	O
,	O
respectively	O
)	O
and	O
second	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
009	O
,	O
ra	O
=	O
0	O
.	O
628	O
and	O
pb	O
=	O
0	O
.	O
008	O
,	O
rb	O
=-	O
0	O
.	O
518	O
,	O
in	O
groups	O
A	O
and	O
B	O
,	O
respectively	O
)	O
with	O
infant	O
’	O
s	O
height	O
.	O

Furthermore	O
,	O
many	O
studies	O
found	O
no	O
benefit	O
of	O
a	O
restricted	O
diet	O
avoiding	O
the	O
consumption	O
of	O
allergy	O
-	O
inducing	O
food	O
during	O
pregnancy	O
[	O
82	O
].	O

Although	O
previous	O
cross	O
-	O
sectional	O
studies	O
have	O
reported	O
a	O
positive	O
association	O
between	O
childhood	O
consumption	O
of	O
sugar	O
-	O
containing	O
drinks	O
,	O
including	O
fruit	O
juice	O
,	O
and	O
asthma	O
[	O
5	O
–	O
8	O
],	O
intake	O
of	O
free	O
sugar	O
in	O
early	O
childhood	O
in	O
our	O
study	O
was	O
not	O
associated	O
with	O
any	O
respiratory	O
or	O
atopic	O
outcome	O
.	O

Gestational	O
and	O
neonatal	O
data	O
were	O
retrieved	O
from	O
medical	O
records	O
.	O

Further	O
well	O
designed	O
studies	O
are	O
required	O
to	O
strengthen	O
the	O
evidence	O
base	O
regarding	O
the	O
type	O
and	O
quantity	O
of	O
maternal	O
fish	O
consumption	O
during	O
pregnancy	O
and	O
associated	O
neurodevelopmental	O
outcomes	O
in	O
the	O
offspring	O
,	O
while	O
considering	O
the	O
contribution	O
of	O
mercury	O
from	O
fish	O
-	O
containing	O
diets	O
.	O

Conclusions	O
Findings	O
from	O
the	O
current	O
study	O
indicate	O
that	O
excessive	O
GWG	O
and	O
mothers	O
'	O
eating	O
behaviors	O
during	O
pregnancy	O
,	O
especially	O
intake	O
of	O
sweets	O
in	O
overweight	O
/	O
obese	O
mothers	O
,	O
may	O
influence	O
offspring	O
weight	O
status	O
early	O
in	O
infancy	O
.	O

The	O
appropriate	O
age	O
for	O
,	O
and	O
duration	O
of	O
,	O
vitamin	O
A	O
deple	O
tion	O
or	O
supplementation	O
have	O
been	O
suggested	O
as	O
important	O
factors	O
that	O
affect	O
MS	O
.	O
Oka	O
et	O
al	O
[	O
134	O
]	O
reported	O
that	O
restricting	O
vitamin	O
A	O
in	O
15	O
-	O
month	O
-	O
old	O
cattle	O
until	O
the	O
final	O
finishing	O
phase	O
(	O
29	O
months	O
of	O
age	O
)	O
increased	O
MS	O
,	O
but	O
not	O
in	O
23	O
-	O
month	O
-	O
old	O
cattle	O
prior	O
to	O
finishing	O
.	O

The	O
expression	O
of	O
adipogenic	O
factors	O
(	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
beta	O
,	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
alpha	O
,	O
and	O
PPARG	O
)	O
in	O
the	O
subcutaneous	O
fat	O
and	O
IMF	O
was	O
higher	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
,	O
indicating	O
that	O
the	O
dietary	O
roughage	O
/	O
concentrate	O
ratio	O
affects	O
adipogenic	O
gene	O
expression	O
in	O
fat	O
tissues	O
.	O

Therefore	O
,	O
a	O
better	O
method	O
to	O
achieve	O
high	O
digestibility	O
of	O
starch	O
in	O
the	O
small	O
intestine	O
is	O
required	O
to	O
provide	O
high	O
post	O
-	O
absorptive	O
glucose	O
to	O
the	O
host	O
animal	O
.	O

We	O
didn	O
’	O
t	O
consider	O
placebo	O
because	O
WHO	O
and	O
Government	O
of	O
Bangladesh	O
have	O
a	O
recommendation	O
that	O
pregnant	O
women	O
should	O
receive	O
60	O
mg	O
of	O
iron	O
supplementation	O
.	O

Women	O
in	O
the	O
highest	O
quartile	O
of	O
healthy	O
dietary	O
pattern	O
were	O
more	O
likely	O
to	O
be	O
employed	O
and	O
graduated	O
and	O
have	O
employed	O
husband	O
,	O
history	O
of	O
IUGR	O
,	O
and	O
less	O
history	O
of	O
early	O
delivery	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
.	O

Meaning	O
that	O
over	O
time	O
,	O
depression	O
scores	O
decreased	O
much	O
more	O
in	O
the	O
vitamin	O
D	O
group	O
in	O
comparison	O
to	O
control	O
group	O
and	O
this	O
shows	O
the	O
possible	O
effects	O
of	O
the	O
vitamin	O
D3supplementation	O
.	O

The	O
decision	O
whether	O
to	O
use	O
a	O
first	O
-	O
generation	O
or	O
second	O
-	O
generation	O
antihistamine	O
for	O
a	O
particular	O
patient	O
must	O
be	O
individualized	O
.	O

A	O
seasonal	O
peak	O
evident	O
in	O
the	O
general	O
population	O
may	O
not	O
behave	O
uniformly	O
within	O
certain	O
subpopulations	O
.	O

Regarding	O
male	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
that	O
there	O
was	O
not	O
prenatal	O
diet	O
effect	O
on	O
chocolate	O
intake	O
and	O
total	O
caloric	O
intake	O
in	O
a	O
treatment	O
-	O
independent	O
manner	O
.	O

In	O
addition	O
to	O
this	O
,	O
a	O
special	O
call	O
centre	O
will	O
be	O
set	O
up	O
centrally	O
where	O
trained	O
nutrition	O
counsellors	O
will	O
systematically	O
make	O
bi	O
-	O
weekly	O
calls	O
to	O
monitor	O
compliance	O
with	O
the	O
supplementation	O
regime	O
.	O

Already	O
widely	O
used	O
in	O
the	O
pharmaceutical	O
industry	O
for	O
developmental	O
toxicity	O
screening	O
,	O
zebrafish	O
models	O
appear	O
to	O
be	O
a	O
promising	O
alternative	O
to	O
mice	O
.	O

In	O
other	O
words	O
,	O
ICDS	O
reflects	O
the	O
country	O
’	O
s	O
obligation	O
to	O
enhance	O
the	O
pre	O
-	O
school	O
education	O
rates	O
and	O
an	O
effective	O
strategy	O
to	O
break	O
the	O
vicious	O
cycle	O
of	O
malnutrition	O
,	O
infection	O
and	O
mortality	O
(	O
3	O
).	O

Conclusion	O
About	O
one	O
third	O
of	O
pregnant	O
women	O
in	O
our	O
study	O
population	O
attended	O
an	O
ANC	O
site	O
different	O
from	O
their	O
local	O
catchment	O
area	O
despite	O
the	O
availability	O
of	O
ANC	O
in	O
their	O
residential	O
area	O
.	O

Women	O
with	O
PPBMI	O
<	O
25	O
kg	O
/	O
m2or	O
≥	O
25	O
kg	O
/	O
m2experienced	O
greater	O
weight	O
gain	O
than	O
the	O
obese	O
group	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
(	O
Table1	O
).	O

2	O
.	O
3	O
.	O

Specifically	O
,	O
POU2F1	O
binding	O
sites	O
were	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extent	O
.	O

Nimitphong	O
et	O
al	O
.	O

Use	O
of	O
vitamin	O
supplements	O
was	O
not	O
significantly	O
linked	O
to	O
leukemia	O
risk	O
.	O

Within	O
this	O
window	O
the	O
peak	O
for	O
immune	O
system	O
priming	O
or	O
susceptibility	O
is	O
believed	O
to	O
vary	O
differentially	O
in	O
response	O
to	O
presenting	O
antigens	O
[	O
53	O
,	O
54	O
].	O

They	O
also	O
suggested	O
that	O
animals	O
deposit	O
fat	O
in	O
the	O
winter	O
to	O
provide	O
insulation	O
for	O
the	O
body	O
under	O
cold	O
stress	O
.	O

N	O
—	O
sample	O
size7421	O
mother	O
-	O
child	O
pairs	O
.	O
135	O
mother	O
-	O
child	O
pairs5449	O
children	O
assessed	O
.	O
217	O
mother	O
-	O
child	O
pairs	O
.	O
MethodMeasured	O
fish	O
intake	O
during	O
at	O
32	O
weeks	O
gestation	O
by	O
Food	O
Frequency	O
Questionnaire	O
(	O
FFQ	O
)	O
during	O
.	O

We	O
selected	O
a	O
95	O
%	O
confidence	O
level	O
and	O
an	O
assumed	O
prevalence	O
of	O
supplement	O
use	O
of	O
50	O
%,	O
informed	O
by	O
other	O
studies	O
[	O
15	O
-	O
19	O
,	O
22	O
],	O
due	O
to	O
the	O
lack	O
of	O
prior	O
data	O
in	O
our	O
region	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
a	O
widespread	O
global	O
problem	O
,	O
which	O
even	O
can	O
observe	O
in	O
the	O
countries	O
which	O
get	O
enough	O
sunlight	O
[	O
49	O
,	O
51	O
].	O

However	O
,	O
there	O
is	O
a	O
limitation	O
to	O
the	O
use	O
of	O
some	O
of	O
these	O
biochemical	O
indicators	O
of	O
iron	O
status	O
in	O
certain	O
settings	O
and	O
conditions	O
;	O
thus	O
,	O
necessitating	O
caution	O
in	O
their	O
interpretations	O
.	O

These	O
disparities	O
may	O
have	O
been	O
due	O
to	O
the	O
use	O
of	O
different	O
routes	O
of	O
administration	O
and	O
variations	B
in	O
rat	O
strains	O
/	O
stocks	O
.	O

Finding	O
a	O
molecule	O
with	O
as	O
much	O
efficiency	O
as	O
the	O
β3	O
agonist	O
in	O
rodents	O
,	O
would	O
be	O
of	O
considerable	O
therapeutic	O
relevance	O
for	O
the	O
treatment	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

The	O
lack	O
of	O
differentiation	O
of	O
underlying	O
complications	O
in	O
pregnancy	O
,	O
which	O
lead	O
to	O
eventual	O
use	O
of	O
induction	O
,	O
could	O
be	O
the	O
cause	O
of	O
these	O
conflicting	O
findings	O
[	O
51	O
].	O

The	O
curvilinear	O
relationship	O
remained	O
evident	O
after	O
participants	O
were	O
stratified	O
on	O
the	O
basis	O
of	O
lean	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
and	O
overweight	O
(≥	O
25	O
kg	O
/	O
m2	O
)	O
pre	O
-	O
pregnancy	O
status	O
(	O
Figure2a	O
).	O

Study	O
Design	O
and	O
Participants	O
The	O
current	O
prospective	O
observational	O
study	O
was	O
conducted	O
among	O
pregnant	O
women	O
during	O
the	O
first	O
trimester	O
,	O
who	O
were	O
being	O
attended	O
at	O
health	O
centers	O
across	O
Isfahan	O
city	O
in	O
the	O
central	O
part	O
of	O
Iran	O
during	O
2015	O
-	O
2016	O
.	O

[	O
18	O
]	O
Year2011201120122009201320122013Number	O
of	O
subjects26414469335619901203119Mean	O
age	O
±	O
SD	O
(	O
year	O
)	O
40	O
.	O
3	O
±	O
0	O
.	O
3a	O
(	O
range	O
15	O
–	O
98	O
)	O
67	O
.	O
5	O
±	O
6	O
.	O
0	O
(	O
range	O
60	O
–	O
97	O
)	O
75	O
.	O
2	O
±	O
6	O
.	O
0	O
(	O
range	O
61	O
–	O
97	O
)	O
35	O
.	O
2	O
±	O
0	O
.	O
5a	O
(	O
range	O
20	O
–	O
50	O
)	O
40	O
.	O
1	O
±	O
0	O
.	O
2a	O
(	O
range	O
25	O
–	O
54	O
)	O
29	O
.	O
3	O
±	O
5	O
.	O
7	O
(	O
range	O
18	O
–	O
40	O
)	O
N	O
/	O
A	O
(	O
range	O
3	O
–	O
12	O
.	O
9	O
)	O
SexM	O
50	O
%	O
F	O
50	O
%	O
F	O
100	O
%	O
F	O
100	O
%	O
F	O
100	O
%	O
M	O
72	O
.	O
8	O
%	O
F	O
27	O
.	O
2	O
%	O
F	O
100	O
%	O
N	O
/	O
AMean	O
25	O
(	O
OH	O
)	O
D	O
±	O
SD	O
,	O
ng	O
/	O
mL	O
(	O
nmol	O
/	O
L	O
)	O
31	O
.	O
8	O
±	O
0	O
.	O
3a	O
(	O
79	O
.	O
3	O
±	O
0	O
.	O
8a	O
)	O
27	O
.	O
1	O
±	O
6	O
.	O
3	O
(	O
67	O
.	O
6	O
±	O
15	O
.	O
7	O
)	O
25	O
.	O
8	O
±	O
6	O
.	O
0	O
(	O
64	O
.	O
3	O
±	O
14	O
.	O
9	O
)	O
29	O
.	O
1	O
±	O
0	O
.	O
4	O
(	O
72	O
.	O
6	O
±	O
1	O
.	O
1	O
)	O
M	O
26	O
.	O
0	O
±	O
0	O
.	O
2a	O
(	O
M	O
65	O
.	O
0	O
±	O
0	O
.	O
5a	O
)	O
F	O
21	O
.	O
4	O
±	O
0	O
.	O
2a	O
(	O
F	O
53	O
.	O
5	O
±	O
0	O
.	O
5a	O
)	O
Trimester	O
of	O
pregnancy1st	O
25	O
.	O
7	O
±	O
6	O
.	O
7	O
(	O
1st	O
61	O
.	O
4	O
±	O
16	O
.	O
6	O
)	O
2nd	O
33	O
.	O
8	O
±	O
8	O
.	O
2	O
(	O
2nd	O
84	O
.	O
4	O
±	O
20	O
.	O
4	O
)	O
3rd	O
36	O
.	O
1	O
±	O
8	O
.	O
9	O
(	O
3rd	O
90	O
.	O
0	O
±	O
22	O
.	O
3	O
)	O
N	O
/	O
APercent	O
of	O
subjects	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
30	O
ng	O
/	O
mL	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
45	O
.	O
2	O
%	O
54	O
.	O
0	O
%	O
77	O
.	O
4	O
%	O
77	O
.	O
8	O
%	O
N	O
/	O
ATrimester	O
of	O
pregnancy1st	O
83	O
.	O
3	O
%	O
2nd	O
30	O
.	O
9	O
%	O
3rd	O
27	O
.	O
4	O
%	O
Age	O
3	O
–	O
5	O
.	O
9	O
yearsb	O
Urban	O
31	O
.	O
3	O
%	O
Rural	O
24	O
.	O
5	O
%	O
Age	O
6	O
–	O
12	O
.	O
9	O
yearsb	O
Urban	O
52	O
.	O
2	O
%	O
Rural	O
29	O
.	O
2	O
%	O
Totalb	O
Urban	O
45	O
.	O
6	O
%	O
Rural	O
27	O
.	O
7	O
%	O
Percent	O
of	O
subjects	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
5	O
.	O
7	O
%	O
31	O
.	O
8	O
%	O
21	O
.	O
5	O
%	O
N	O
/	O
AM	O
13	O
.	O
9	O
%	O
F	O
43	O
.	O
1	O
%	O
Trimester	O
of	O
pregnancy1st	O
26	O
.	O
7	O
%	O
2nd	O
1	O
.	O
8	O
%	O
3rd	O
2	O
.	O
3	O
%	O
M	O
,	O
male	O
;	O
F	O
,	O
female	O
;	O
N	O
/	O
A	O
,	O
not	O
available	O
.	O

Pre	O
-	O
pregnancy	O
nutritional	O
status	O
and	O
weight	O
gain	O
were	O
classified	O
according	O
to	O
the	O
Institute	O
of	O
Medicine	O
guidelines	O
.	O

The	O
order	O
of	O
introduction	O
seems	O
to	O
have	O
little	O
effect	O
on	O
AM	O
.	O

Many	O
factors	O
can	O
alter	O
cutaneous	O
vitamin	O
D	O
production	O
such	O
as	O
aging	O
,	O
skin	O
pigmentation	O
,	O
sunscreen	O
usage	O
,	O
time	O
of	O
the	O
day	O
,	O
season	O
and	O
latitude5	O
,	O
7	O
.	O

In	O
this	O
regard	O
,	O
intrauterine	O
growth	O
should	O
be	O
identified	O
on	O
the	O
basis	O
of	O
measures	O
of	O
fetal	O
growth	O
patterns	O
,	O
rather	O
than	O
birth	O
weight	O
[	O
30	O
].	O

Comparing	O
to	O
the	O
control	O
group	O
,	O
depression	O
level	O
decreased	O
in	O
both	O
intervention	O
groups	O
[	O
67	O
].	O

The	O
functional	O
groups	O
are	O
added	O
or	O
removed	O
by	O
a	O
range	O
of	O
enzymes	O
:	O
acetylases	O
,	O
methyltransferases	O
,	O
kinases	O
,	O
ADP	O
ribosyltransferases	O
,	O
ubiquitin	O
ligases	O
,	O
sumo	O
ligases	O
;	O
and	O
deacteylases	O
,	O
demethylases	O
,	O
phosphatases	O
,	O
ADP	O
ribosyl	O
hydrolases	O
,	O
deubiquitinases	O
,	O
sumo	O
deconjugating	O
enzymes	O
,	O
respectively	O
(	O
Wang	O
&	O
Dasso2009	O
;	O
Khare	O
et	O
al	O
.	O
2012	O
).	O

In	O
addition	O
,	O
the	O
Ministry	O
is	O
planning	O
to	O
improve	O
the	O
supplementary	O
nutrition	O
services	O
;	O
creating	O
Anganwadi	O
based	O
crèches	O
centers	O
;	O
intensify	O
monitoring	O
,	O
and	O
training	O
activities	O
;	O
to	O
develop	O
linkages	O
with	O
different	O
stakeholders	O
such	O
as	O
Pan	O
-	O
chayati	O
Raj	O
Institutions	O
and	O
ministry	O
of	O
rural	O
development	O
(	O
1	O
).	O

The	O
main	O
mediators	O
of	O
such	O
beneficial	O
effects	O
seem	O
to	O
include	O
fibroblast	O
growth	O
factor	O
21	O
(	O
FGF21	O
),	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
),	O
bone	O
morphogenic	O
proteins	O
(	O
BMPs	O
)	O
and	O
prostaglandin	O
D2	O
synthase	O
.	O

Identifying	O
and	O
understanding	O
environmentally	O
induced	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
may	O
lead	O
to	O
adverse	O
outcomes	O
is	O
vital	O
for	O
protecting	O
public	O
health	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
was	O
calculated	O
using	O
the	O
area	O
under	O
the	O
curve	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
values	O
from	O
pregnancy	O
visits	O
3	O
–	O
7	O
.	O

If	O
a	O
child	O
was	O
not	O
seen	O
for	O
more	O
than	O
45	O
days	O
,	O
at	O
the	O
two	O
weekly	O
visits	O
,	O
or	O
at	O
the	O
hospital	O
,	O
they	O
were	O
censored	O
for	O
that	O
period	O
of	O
our	O
study	O
.	O

Differences	O
between	O
these	O
markers	O
can	O
most	O
likely	O
be	O
explained	O
by	O
the	O
unequal	O
distributions	O
of	O
these	O
sequences	O
throughout	O
the	O
genome	O
,	O
owing	O
in	O
some	O
part	O
to	O
the	O
evolutionary	O
age	O
of	O
these	O
two	O
retrotransposable	O
elements	O
(	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

Interestingly	O
,	O
epidemiological	O
studies	O
in	O
women	O
showed	O
that	O
maternal	O
malnutrition	O
during	O
pregnancy	O
can	O
result	O
in	O
fetal	O
growth	O
retardation	O
[	O
11	O
,	O
12	O
].	O

However	O
,	O
previous	O
studies	O
suggested	O
that	O
specific	O
CB1	O
receptor	O
deletion	O
in	O
the	O
hypothalamus	O
was	O
able	O
to	O
decrease	O
body	O
weight	O
and	O
increase	O
energy	O
expenditure	O
,	O
but	O
was	O
not	O
accompanied	O
with	O
changes	O
in	O
food	O
intake	O
(	O
Cardinal	O
et	O
al	O
.,	O
2012	O
).	O

Only	O
the	O
HFol	O
pup	O
diet	O
lowered	O
SeroR2A	O
expression	O
compared	O
to	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
RV	O
pup	O
diet	O
(	O
P	O
=	O
0	O
.	O
008	O
)	O
(	O
Figure	O
5b	O
).	O

Recruitment	O
and	O
consent	O
procedures	O
Consecutive	O
sampling	O
is	O
applied	O
,	O
thus	O
,	O
all	O
accessible	O
pregnant	O
women	O
at	O
the	O
recruitment	O
sites	O
may	O
form	O
part	O
of	O
the	O
sample	O
,	O
if	O
they	O
meet	O
the	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
arrive	O
at	O
study	O
site	O
on	O
their	O
booked	O
date	O
and	O
sign	O
informed	O
consent	O
.	O

Conclusion	O
These	O
preliminary	O
findings	O
suggest	O
associations	O
of	O
short	O
sleep	O
duration	O
and	O
snoring	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
.	O

(	O
2015	O
)*/†	O
Takeda	O
et	O
al	O
.	O

Maternal	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
The	O
level	O
of	O
the	O
participating	O
women	O
’	O
s	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
is	O
assessed	O
at	O
phase	O
1	O
in	O
pregnancy	O
and	O
again	O
at	O
phases	O
6	O
and	O
8	O
postnatally	O
.	O

Several	O
studies	O
have	O
reported	O
that	O
early	O
weaning	O
or	O
early	O
weaning	O
combined	O
with	O
a	O
high	O
-	O
grain	O
diet	O
increases	O
IMF	O
deposition	O
in	O
beef	O
cattle	O
.	O

The	O
epidemiological	O
data	O
from	O
the	O
Dutch	O
Famine	O
have	O
showed	O
that	O
people	O
whose	O
mothers	O
were	O
exposed	O
to	O
undernutrition	O
in	O
early	O
gestation	O
developed	O
more	O
metabolic	O
abnormalities	O
than	O
people	O
exposed	O
in	O
other	O
pregnancy	O
stages	O
(	O
Roseboom	O
et	O
al	O
.,	O
2006	O
).	O

Common	O
risk	O
factors	O
for	O
developing	O
aortic	O
dissection	O
include	O
hypertension	O
,	O
collagen	O
disorders	O
including	O
Marfan	O
/	O
Ehlers	O
-	O
Danlos	O
syndromes	O
,	O
bicuspid	O
aortic	O
valve	O
,	O
positive	O
family	O
history	O
,	O
trauma	O
,	O
and	O
cocaine	O
use	O
[	O
3	O
–	O
7	O
].	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
.	O

Similarly	O
,	O
seasonal	O
occurrence	O
has	O
been	O
observed	O
for	O
chicken	O
pox	O
,	O
measles	O
,	O
influenza	O
and	O
many	O
other	O
common	O
childhood	O
infectious	O
diseases	O
[	O
7	O
,	O
142	O
].	O

The	O
expression	O
of	O
1	O
-	O
α	O
hydroxylase	O
is	O
increased	O
in	O
the	O
kidney	O
and	O
placenta	O
and	O
the	O
concentration	O
of	O
serum	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
increases	O
in	O
normal	O
pregnancy	O
from	O
the	O
first	O
to	O
the	O
third	O
trimester	O
.	O

These	O
results	O
combined	O
indicate	O
that	O
IFA	O
supplements	O
in	O
populations	O
of	O
iron	O
-	O
deficient	O
pregnant	O
women	O
could	O
lead	O
to	O
a	O
decrease	O
in	O
the	O
number	O
of	O
neonatal	O
deaths	O
mediated	O
by	O
reduced	O
rates	O
of	O
preterm	O
delivery	O
.	O

These	O
concerns	O
had	O
been	O
attributed	O
to	O
inadequate	O
infrastructure	O
and	O
poor	O
compliance	O
with	O
preventive	O
treatment	O
,	O
among	O
others	O
[	O
34	O
].	O

Our	O
sample	O
testing	O
suggest	O
that	O
the	O
vitamin	O
D	O
group	O
maintained	O
above	O
mean	O
adequate	O
vitamin	O
D	O
concetrations	O
verses	O
consistently	O
low	O
concentrations	O
in	O
the	O
placebo	O
group	O
.	O

Abstract	O
The	O
results	O
are	O
presented	O
of	O
a	O
case	O
-	O
control	O
study	O
conducted	O
in	O
the	O
north	O
of	O
Iran	O
.	O

These	O
expression	O
patterns	O
suggest	O
a	O
dietary	O
effect	O
on	O
cellular	O
turn	O
-	O
over	O
,	O
which	O
might	O
be	O
increased	O
at	O
early	O
stages	O
but	O
decreased	O
at	O
adult	O
stage	O
in	O
LP	O
offspring	O
.	O

Meta	O
-	O
analysis	O
[	O
8	O
]	O
and	O
prospective	O
follow	O
-	O
up	O
studies	O
indicates	O
that	O
up	O
to	O
75	O
-	O
90	O
%	O
of	O
developmental	O
psychotic	O
experiences	O
are	O
transitory	O
.	O

Although	O
there	O
was	O
an	O
initial	O
small	O
uncontrolled	O
report	O
which	O
suggested	O
that	O
Lispro	O
may	O
have	O
teratogenic	O
effects	O
when	O
used	O
in	O
type	O
1	O
diabetic	O
pregnancy	O
,	O
37this	O
has	O
not	O
been	O
borne	O
out	O
in	O
subsequent	O
studies	O
.	O

Secondary	O
prevention	O
addresses	O
individuals	O
with	O
early	O
indicators	O
of	O
atopic	O
disease	O
.	O

2005	O
).	O

The	O
RT2	O
reactions	O
including	O
the	O
entire	O
RT1	O
reactions	O
,	O
mixed	O
with	O
5	O
µl	O
moloney	O
murine	O
leukemia	O
virus	O
reverse	O
transcriptase	O
(	O
M	O
-	O
MLV	O
)	O
5	O
×	O
buffer	O
(	O
250	O
mM	O
,	O
pH	O
=	O
8	O
.	O
3	O
)	O
Tris	O
–	O
HCl	O
,	O
15	O
mM	O
MgCl2	O
,	O
50	O
mM	O
dithiothreitol	O
and	O
375	O
mM	O
KCl	O
,	O
1	O
.	O
25	O
µl	O
of	O
10	O
mM	O
-	O
deoxyribonucleotide	O
tripho	O
-	O
sphate	O
,	O
1	O
µl	O
M	O
-	O
MLV	O
RNase	O
(	O
200	O
U	O
/	O
µl	O
)	O
and	O
0	O
.	O
5	O
µl	O
RNase	O
inhibitor	O
(	O
40	O
U	O
/	O
µl	O
).	O

Furthermore	O
,	O
the	O
placenta	O
responses	O
to	O
maternal	O
diet	O
in	O
a	O
sex	O
-	O
specific	O
manner	O
(	O
Tarrade	O
et	O
al	O
.,	O
2015	O
),	O
suggesting	O
that	O
the	O
sexual	O
dimorphism	O
in	O
adiposity	O
-	O
relevant	O
parameters	O
could	O
be	O
present	O
at	O
very	O
early	O
stages	O
.	O

Thyroid	O
hormone	O
deficiency	O
may	O
cause	O
severe	O
neurologic	O
disorders	O
,	O
resulting	O
from	O
defects	O
in	O
neuronal	O
cell	O
differentiation	O
and	O
migration	O
,	O
axonal	O
and	O
dendritic	O
outgrowth	O
,	O
myelin	O
formation	O
and	O
synaptogenesis7913	O
.	O

Pre	O
-	O
intervention	O
,	O
only	O
one	O
of	O
the	O
91	O
women	O
with	O
GDM	O
seen	O
received	O
≥	O
1	O
dietetic	O
follow	O
-	O
up	O
appointment	O
.	O

Aims	O
of	O
the	O
study	O
The	O
aims	O
of	O
the	O
NuPED	O
study	O
are	O
1	O
)	O
to	O
assess	O
dietary	O
intake	O
and	O
nutritional	O
status	O
of	O
urban	O
pregnant	O
women	O
in	O
Johannesburg	O
,	O
South	O
Africa	O
,	O
and	O
2	O
)	O
to	O
determine	O
associations	O
with	O
birth	O
outcomes	O
,	O
measures	O
of	O
maternal	O
health	O
,	O
as	O
well	O
as	O
measures	O
of	O
offspring	O
health	O
and	O
development	O
.	O

(	O
2009	O
).	O

Increased	O
placental	O
AluYb8	O
methylation	O
was	O
positively	O
associated	O
with	O
average	O
methylation	O
among	O
CpG	O
loci	O
found	O
in	O
polycomb	O
group	O
target	O
genes	O
;	O
developmentally	O
related	O
transcription	O
factor	O
binding	O
sites	O
were	O
overrepresented	O
for	O
differentially	O
methylated	O
loci	O
associated	O
with	O
both	O
elements	O
.	O

Vitamin	O
D	O
status	O
is	O
determined	O
by	O
measuring	O
circulating	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D2	O
+	O
3	O
(	O
25	O
(	O
OH	O
)	O
D	O
).	O

We	O
conducted	O
a	O
literature	O
review	O
to	O
assess	O
evidence	O
suggested	O
in	O
the	O
worldwide	O
literature	O
.	O

The	O
tendency	O
to	O
lower	O
chocolate	O
preference	O
suggests	O
an	O
increased	O
threshold	O
of	O
the	O
palatability	O
.	O

Furthermore	O
,	O
mean	O
LINE	O
-	O
1	O
methylation	O
levels	O
were	O
significantly	O
different	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
;	O
however	O
,	O
limited	O
numbers	O
may	O
affect	O
our	O
precision	O
,	O
so	O
this	O
result	O
should	O
be	O
confirmed	O
in	O
further	O
analyses	O
.	O

However	O
,	O
the	O
tentative	O
nature	O
of	O
these	O
data	O
and	O
the	O
lack	O
of	O
equally	O
effective	O
substitutes	O
justify	O
their	O
use	O
in	O
pregnancy	O
for	O
this	O
life	O
-	O
threatening	O
emergency	O
.	O

A	O
computational	O
analysis	O
of	O
these	O
data	O
revealed	O
that	O
many	O
of	O
the	O
proteins	O
dysregulated	O
in	O
the	O
DVD	O
model	O
have	O
also	O
been	O
shown	O
to	O
be	O
altered	O
in	O
schizophrenia	O
post	O
-	O
mortem	O
brain	O
studies	O
[	O
18	O
].	O

Measurement	O
of	O
adiposity	O
Adiposity	O
was	O
estimated	O
by	O
calculating	O
the	O
percentage	O
of	O
abdominal	O
fat	O
weight	O
over	O
total	O
body	O
weight	O
.	O

Viruses	O
Environmental	O
exposures	O
to	O
viruses	O
,	O
microbes	O
and	O
other	O
pathogens	O
generally	O
tend	O
to	O
occur	O
more	O
often	O
in	O
particular	O
seasons	O
[	O
25	O
,	O
126	O
,	O
127	O
].	O

Steam	O
flaking	O
further	O
increases	O
marbling	O
in	O
cases	O
of	O
maize	O
and	O
sorghum	O
,	O
and	O
is	O
more	O
effective	O
for	O
sorghum	O
.	O

Our	O
model	O
indicates	O
that	O
gestational	O
LP	O
diets	O
affected	O
the	O
hepatic	O
expression	O
profiles	O
in	O
an	O
acute	O
,	O
short	O
-	O
term	O
as	O
well	O
as	O
in	O
a	O
delayed	O
,	O
long	O
-	O
term	O
manner	O
in	O
LP	O
offspring	O
.	O

(	O
13	O
),	O
anthropometric	O
indicators	O
,	O
including	O
weight	O
and	O
height	O
,	O
were	O
measured	O
and	O
plasma	O
lipids	O
,	O
insulin	O
,	O
and	O
adiponectin	O
and	O
visfatin	O
concentrations	O
in	O
the	O
umbilical	O
cord	O
blood	O
of	O
50	O
large	O
-	O
for	O
-	O
gestational	O
age	O
(	O
LGA	O
)	O
and	O
50	O
appropriate	O
-	O
for	O
-	O
gestational	O
age	O
(	O
AGA	O
)	O
infants	O
born	O
following	O
complication	O
-	O
free	O
pregnancies	O
were	O
assessed	O
.	O

Diet	O
There	O
should	O
be	O
no	O
special	O
diet	O
for	O
the	O
mother	O
during	O
pregnancy	O
and	O
lactation	O
,	O
unless	O
the	O
mother	O
or	O
child	O
has	O
a	O
diagnosed	O
food	O
sensitization	O
.	O

Protected	O
dietary	O
fats	O
are	O
bypassed	O
in	O
the	O
rumen	O
without	O
digestion	O
,	O
and	O
they	O
are	O
digested	O
and	O
absorbed	O
in	O
the	O
small	O
intestine	O
.	O

Eligible	O
women	O
initiated	O
prenatal	O
care	O
before	O
20	O
weeks	O
gestation	O
,	O
were	O
18	O
years	O
of	O
age	O
or	O
older	O
,	O
could	O
speak	O
and	O
read	O
English	O
,	O
and	O
planned	O
to	O
carry	O
the	O
pregnancy	O
to	O
term	O
and	O
to	O
deliver	O
at	O
either	O
hospital	O
.	O

Free	O
sugar	O
does	O
not	O
include	O
lactose	O
when	O
naturally	O
present	O
in	O
milk	O
and	O
milk	O
products	O
or	O
the	O
sugars	O
contained	O
within	O
the	O
cellular	O
structure	O
of	O
fruits	O
and	O
vegetables	O
.	O

Adequate	O
vitamin	O
D	O
intake	O
is	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
cancer	O
[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],	O
cardiovascular	O
diseases	O
[	O
12	O
],	O
autoimmune	O
diseases	O
[	O
13	O
],	O
neurological	O
disorders	O
[	O
14	O
]	O
and	O
diabetes	O
[	O
15	O
].	O

In	O
contrast	O
,	O
in	O
the	O
previous	O
studies	O
2000	O
IU	O
vitamin	O
D	O
supplementation	O
was	O
more	O
sufficient	O
to	O
increase	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
up	O
to	O
the	O
adequate	O
amount	O
(≥	O
32	O
ng	O
/	O
mL	O
)	O
[	O
18	O
,	O
57	O
,	O
58	O
].	O

The	O
primary	O
hypothesis	O
is	O
that	O
in	O
a	O
community	O
-	O
based	O
,	O
cluster	O
randomized	O
controlled	O
trial	O
of	O
women	O
from	O
rural	O
Bangladesh	O
,	O
daily	O
supplementation	O
with	O
60	O
mg	O
elemental	O
iron	O
and	O
400	O
μg	O
folic	O
acid	O
starting	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
and	O
sustained	O
for	O
at	O
least	O
180	O
days	O
,	O
will	O
reduce	O
neonatal	O
mortality	O
by	O
25	O
%	O
from	O
33	O
/	O
1000	O
to	O
24	O
.	O
8	O
/	O
1000	O
live	O
births	O
compared	O
to	O
usual	O
iron	O
-	O
folic	O
acid	O
supplementation	O
programs	O
.	O

From	O
a	O
public	O
health	O
perspective	O
,	O
this	O
is	O
crucially	O
important	O
,	O
and	O
should	O
motivate	O
more	O
effective	O
implementation	O
of	O
nutritional	O
educational	O
programmes	O
for	O
women	O
of	O
childbearing	O
age	O
.	O

Excluding	O
infants	O
who	O
may	O
have	O
received	O
antibiotics	O
,	O
or	O
those	O
delivered	O
prematurely	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S10	O
,	O
Figure	O
S7a	O
),	O
did	O
not	O
qualitatively	O
change	O
the	O
results	O
.	O

The	O
FA	O
de	O
novo	O
synthesis	O
occurs	O
mainly	O
in	O
adipose	O
tissue	O
in	O
ruminants	O
[	O
84	O
],	O
whereas	O
it	O
occurs	O
in	O
the	O
liver	O
in	O
humans	O
and	O
rodents	O
.	O

Differences	O
in	O
age	O
,	O
health	O
and	O
initial	O
vitamin	O
D	O
status	O
between	O
cohorts	O
,	O
as	O
well	O
as	O
study	O
design	O
,	O
may	O
explain	O
the	O
conflicting	O
data	O
.	O

Schizophrenia	O
is	O
a	O
multifactorial	B
disorder	O
with	O
strong	O
genetic	O
vulnerability	O
and	O
the	O
vulnerability	O
might	O
include	O
metabolic	O
aberrations	O
.	O

These	O
models	O
demonstrate	O
that	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
9	O
.	O
7	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
),	O
and	O
with	O
a	O
10	O
%	O
increase	O
in	O
AluYb8	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
14	O
.	O
5	O
(	O
95	O
%	O
CI	O
:	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)	O
(	O
Table	O
1	O
).	O

(	O
2014	O
)*	O
Pascual	O
et	O
al	O
.	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

Human	O
variability	O
It	O
is	O
known	O
that	O
different	O
strains	O
of	O
laboratory	O
animals	O
can	O
respond	O
very	O
differently	O
to	O
the	O
same	O
environmental	O
exposure	O
.	O

Evaluations	O
of	O
these	O
programs	O
using	O
maternal	O
anaemia	O
as	O
the	O
outcome	O
report	O
little	O
or	O
no	O
impact	O
because	O
of	O
the	O
multiple	O
causes	O
of	O
maternal	O
anaemia	O
,	O
low	O
compliance	O
,	O
and	O
inadequate	O
distribution	O
programs	O
.	O

The	O
field	O
team	O
consisted	O
of	O
three	O
women	O
and	O
two	O
men	O
trained	O
in	O
anthropology	O
or	O
social	O
sciences	O
,	O
who	O
had	O
experience	O
in	O
collecting	O
qualitative	O
data	O
.	O

While	O
the	O
rodent	O
and	O
human	O
life	O
cycles	O
share	O
many	O
commonalities	O
they	O
do	O
exhibit	O
subtle	O
differences	O
,	O
both	O
with	O
each	O
other	O
and	O
other	O
mammalian	O
species	O
(	O
Kristensen	O
et	O
al	O
.	O
2013	O
;	O
Laird2013	O
;	O
Leitch	O
et	O
al	O
.	O
2013	O
;	O
Surani2015	O
).	O

Out	O
of	O
which	O
,	O
184	O
qualified	O
mothers	O
were	O
selected	O
who	O
completed	O
the	O
baseline	O
depression	O
questionnaire	O
.	O

It	O
was	O
translated	O
to	O
Persian	O
and	O
was	O
used	O
in	O
the	O
study	O
by	O
Mazhari	O
and	O
Nakhaee	O
,	O
with	O
a	O
validity	O
and	O
reliability	O
of	O
0	O
.	O
76	O
and	O
0	O
.	O
83	O
,	O
respectively	O
[	O
42	O
].	O

Supplements	O
were	O
also	O
included	O
to	O
assess	O
total	O
nutrient	O
intake	O
.	O

In	O
the	O
strata	O
,	O
each	O
eligible	O
pregnant	O
woman	O
was	O
assigned	O
in	O
the	O
control	O
or	O
the	O
vitamin	O
D	O
groups	O
using	O
block	O
randomization	O
strategy	O
.	O

Recent	O
data	O
has	O
extended	O
this	O
list	O
to	O
include	O
specific	O
regions	O
not	O
associated	O
with	O
TEs	O
that	O
are	O
preferentially	O
located	O
within	O
CGIs	O
,	O
enhancers	O
,	O
promoters	O
and	O
gene	O
bodies	O
(	O
Seisenberger	O
et	O
al	O
.	O
2012	O
;	O
Hackett	O
et	O
al	O
.	O
2013	O
;	O
Tang	O
et	O
al	O
.	O
2015	O
).	O

Low	O
Utilization	O
of	O
Maternal	O
Health	O
Service	O
in	O
Developing	O
Countries	O
It	O
is	O
well	O
established	O
that	O
antenatal	O
care	O
provides	O
pregnant	O
women	O
with	O
opportunities	O
to	O
receive	O
cost	O
-	O
effective	O
interventions	O
which	O
are	O
beneficial	O
to	O
mother	O
and	O
child	O
;	O
these	O
interventions	O
include	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anemia	O
.	O

For	O
this	O
reason	O
—	O
although	O
we	O
did	O
mention	O
impaired	O
spermatogenesis	O
as	O
one	O
of	O
the	O
end	O
points	O
encompassed	O
by	O
the	O
testicular	O
dysgenesis	O
syndrome	O
—	O
it	O
was	O
necessary	O
to	O
exclude	O
this	O
end	O
point	O
from	O
our	O
analysis	O
.	O

We	O
excluded	O
stillbirths	O
,	O
those	O
who	O
declined	O
to	O
participate	O
,	O
those	O
with	O
obstetric	O
pathology	O
,	O
or	O
psychiatric	O
,	O
cognitive	O
or	O
other	O
disease	O
that	O
might	O
adversely	O
affect	O
understanding	O
of	O
the	O
study	O
objectives	O
or	O
the	O
ability	O
to	O
provide	O
accurate	O
information	O
.	O

Improve	O
adherence	O
and	O
monitor	O
compliance	O
To	O
improve	O
adherence	O
,	O
a	O
local	O
pharmaceutical	O
company	O
(	O
Eskayef	O
Bangladesh	O
Limited	O
)	O
will	O
produce	O
IFA	O
supplements	O
in	O
an	O
attractive	O
capsule	O
shell	O
and	O
special	O
blister	O
package	O
.	O

This	O
effect	O
did	O
not	O
vary	O
by	O
histology	O
and	O
was	O
seen	O
for	O
supplementation	O
during	O
pregnancy	O
rather	O
than	O
during	O
the	O
month	O
before	O
pregnancy	O
or	O
while	O
breast	O
feeding	O
.	O

A	O
report	O
from	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
found	O
that	O
fish	O
consumption	O
during	O
pregnancy	O
of	O
one	O
to	O
three	O
servings	O
per	O
week	O
was	O
shown	O
to	O
provide	O
a	O
modest	O
but	O
significant	O
improvement	O
in	O
developmental	O
scores	O
of	O
the	O
offspring	O
for	O
language	O
and	O
social	O
activity	O
at	O
fifteen	O
to	O
eighteen	O
months	O
of	O
age	O
[	O
18	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
.	O

The	O
fetus	O
seems	O
to	O
be	O
relatively	O
protected	O
from	O
anaphylaxis	O
perhaps	O
because	O
the	O
placenta	O
does	O
not	O
transmit	O
specific	O
IgE	O
antibodies	O
to	O
the	O
fetus	O
[	O
31	O
].	O

The	O
most	O
popular	O
vitamin	O
and	O
mineral	O
supplements	O
contain	O
iron	O
,	O
folic	O
acid	O
and	O
vitamin	O
D	O
[	O
12	O
,	O
28	O
].	O

There	O
are	O
,	O
however	O
,	O
no	O
current	O
established	O
regulatory	O
procedures	O
or	O
guidelines	O
in	O
chemical	O
safety	O
programs	O
for	O
determining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

Both	O
MS	O
and	O
IMF	O
contents	O
increased	O
with	O
increasing	O
slaughter	O
age	O
(	O
2	O
,	O
4	O
,	O
6	O
,	O
12	O
,	O
and	O
24	O
months	O
)	O
in	O
bulls	O
of	O
German	O
Angus	O
,	O
Galloway	O
,	O
and	O
Holstein	O
-	O
Friesian	O
breeds	O
[	O
24	O
].	O

Fetal	O
programming	O
of	O
nutritional	O
restriction	O
with	O
pasture	O
-	O
based	O
systems	O
retarded	O
offspring	O
growth	O
performance	O
(	O
body	O
weight	O
,	O
feed	O
intake	O
,	O
carcass	O
weight	O
)	O
and	O
production	O
parameters	O
including	O
muscle	O
weight	O
,	O
meat	O
yield	O
,	O
and	O
fat	O
and	O
bone	O
weight	O
at	O
any	O
given	O
age	O
.	O

Among	O
the	O
proteins	O
,	O
beef	O
and	O
beans	O
—	O
both	O
sources	O
of	O
the	O
antioxidant	O
glutathione	O
—	O
showed	O
the	O
highest	O
inverse	O
effect	O
.	O

This	O
suggests	O
that	O
baseline	O
DA	O
signaling	O
may	O
be	O
normal	O
in	O
this	O
model	O
and	O
abnormalities	O
only	O
become	O
unmasked	O
in	O
the	O
presence	O
of	O
drugs	O
that	O
alter	O
DA	O
/	O
glutamate	O
balance	O
in	O
the	O
brain	O
.	O

Duration	O
of	O
gestation	O
We	O
will	O
measure	O
the	O
duration	O
of	O
gestation	O
will	O
be	O
measured	O
using	O
the	O
date	O
of	O
last	O
menstrual	O
period	O
with	O
the	O
pregnancy	O
confirmed	O
by	O
urine	O
test	O
in	O
the	O
field	O
.	O

Children	O
with	O
vomiting	O
were	O
excluded	O
temporarily	O
and	O
enrolled	O
2	O
weeks	O
later	O
after	O
recovery	O
.	O

Artificial	O
insemination	O
and	O
fertility	O
medications	O
were	O
largely	O
found	O
to	O
have	O
to	O
link	O
,	O
yet	O
reports	O
are	O
conflicted	O
.	O

However	O
,	O
several	O
limitations	O
merit	O
discussion	O
and	O
consideration	O
.	O

For	O
6	O
women	O
information	O
on	O
the	O
age	O
was	O
missing	O
.	O

For	O
41	O
.	O
7	O
%	O
of	O
the	O
women	O
this	O
was	O
their	O
first	O
pregnancy	O
(	O
unknown	O
for	O
0	O
.	O
4	O
%	O
of	O
the	O
women	O
),	O
while	O
for	O
45	O
.	O
6	O
%	O
of	O
the	O
women	O
this	O
would	O
be	O
their	O
first	O
child	O
(	O
status	O
not	O
known	O
for	O
1	O
.	O
4	O
%	O
of	O
the	O
women	O
).	O

These	O
responses	O
were	O
compared	O
to	O
the	O
socio	O
-	O
demographic	O
characteristics	O
;	O
marital	O
status	O
,	O
age	O
groups	O
,	O
number	O
of	O
pregnancy	O
(	O
primigravidavs	O
?	O
2	O
pregnancies	O
),	O
number	O
of	O
visits	O
and	O
educational	O
level	O
(	O
Table	O
2	O
).	O

To	O
arrive	O
at	O
a	O
final	O
regression	O
model	O
,	O
stepwise	O
analyses	O
were	O
first	O
conducted	O
within	O
predefined	O
categories	O
(	O
i	O
.	O
e	O
.,	O
demographic	O
(	O
age	O
,	O
parity	O
,	O
race	O
,	O
marital	O
status	O
,	O
education	O
,	O
prepregnancy	O
BMI	O
),	O
physical	O
activity	O
(	O
calories	O
expended	O
per	O
week	O
in	O
moderate	O
physical	O
activity	O
TV	O
hours	O
per	O
day	O
),	O
macronutrient	O
(%	O
of	O
calories	O
from	O
fat	O
,	O
carbohydrates	O
,	O
protein	O
,	O
sweets	O
,	O
and	O
total	O
calories	O
),	O
dietary	O
components	O
(	O
fast	O
food	O
and	O
sugar	O
-	O
sweetened	O
soft	O
drinks	O
)	O
psychosocial	O
variables	O
(	O
mood	O
,	O
restraint	O
,	O
disinhibition	O
,	O
and	O
stress	O
),	O
and	O
sleep	O
.	O

The	O
secondary	O
hypotheses	O
are	O
that	O
the	O
early	O
availability	O
and	O
promotion	O
of	O
IFA	O
supplements	O
in	O
intervention	O
clusters	O
will	O
reduce	O
preterm	O
delivery	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
),	O
and	O
low	O
birth	O
weight	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
).	O

no	O
.	O

Women	O
in	O
the	O
highest	O
compared	O
with	O
the	O
lowest	O
quartile	O
of	O
vitamin	O
D	O
consumption	O
experienced	O
a	O
37	O
%	O
(	O
95	O
%	O
CI	O
,	O
22	O
-	O
50	O
%)	O
lower	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

She	O
recently	O
presented	O
findings	O
showing	O
an	O
association	O
between	O
increased	O
levels	O
of	O
activated	O
T	O
cells	O
in	O
DiNEH	O
Project	O
participants	O
and	O
greater	O
residential	O
proximity	O
to	O
mine	O
waste	O
sites	O
.	O
36	O
“	O
If	O
we	O
see	O
any	O
of	O
these	O
activated	O
T	O
cells	O
,	O
we	O
know	O
that	O
the	O
immune	O
system	O
is	O
highly	O
reacting	O
to	O
something	O
,”	O
Erdei	O
says	O
.	O

In	O
a	O
large	O
retrospective	O
study	O
on	O
595	O
pregnancy	O
-	O
associated	O
thyroid	O
cancers	O
,	O
Yasmeen	O
et	O
al	O
.	O

Associated	O
symptoms	O
include	O
nausea	O
,	O
vomiting	O
,	O
diaphoresis	O
,	O
and	O
light	O
-	O
headedness	O
.	O

No	O
reliably	O
effective	O
chemotherapeutic	O
regimen	O
has	O
been	O
identified	O
.	O

Thus	O
,	O
during	O
the	O
late	O
fattening	O
stage	O
of	O
beef	O
cattle	O
,	O
marbling	O
adipocytes	O
may	O
grow	O
continuously	O
even	O
though	O
development	O
of	O
abdominal	O
,	O
intermuscular	O
,	O
and	O
subcutaneous	O
fat	O
may	O
slow	O
or	O
cease	O
.	O

Results	O
from	O
a	O
large	O
Danish	O
national	O
birth	O
cohort	O
(	O
n	O
=	O
25	O
,	O
446	O
)	O
indicated	O
a	O
significant	O
improvement	O
in	O
motor	O
,	O
cognitive	O
and	O
total	O
developmental	O
scores	O
for	O
eighteen	O
month	O
old	O
children	O
who	O
were	O
born	O
to	O
women	O
within	O
the	O
highest	O
three	O
quintiles	O
of	O
fish	O
intake	O
during	O
pregnancy	O
.	O

Tested	O
at	O
42	O
months	O
,	O
7	O
and	O
8	O
years	O
.	O
Two	O
FFQs	O
during	O
pregnancy	O
(	O
at	O
15	O
weeks	O
and	O
32	O
weeks	O
)	O
were	O
used	O
to	O
estimate	O
fish	O
intake	O
in	O
early	O
and	O
late	O
pregnancy	O
.	O
Cognitive	O
&	O
behavioural	O
outcomes	O
in	O
offspring	O
at	O
9	O
years	O
using	O
the	O
Wechsler	O
Abbreviated	O
Scale	O
of	O
Intelligence	O
.	O

Causal	O
biological	O
mechanisms	O
for	O
the	O
observed	O
positive	O
,	O
though	O
statistically	O
in	O
-	O
significant	O
association	O
between	O
long	O
sleep	O
duration	O
and	O
GDM	O
are	O
not	O
clear	O
.	O

At	O
middle	O
or	O
late	O
term	O
of	O
pregnancy	O
;	O
3	O
).	O

A	O
recent	O
2011	O
population	O
-	O
based	O
study	O
of	O
acute	O
type	O
A	O
aortic	O
dissection	O
in	O
pregnancy	O
revealed	O
an	O
overall	O
incidence	O
of	O
0	O
.	O
4	O
cases	O
per	O
100	O
,	O
000	O
person	O
-	O
years	O
and	O
a	O
prehospital	O
mortality	O
rate	O
of	O
53	O
%	O
[	O
2	O
].	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

Limitations	O
This	O
study	O
is	O
based	O
on	O
retrospectively	O
self	O
-	O
reported	O
data	O
,	O
which	O
could	O
have	O
led	O
to	O
an	O
underestimation	O
of	O
the	O
use	O
of	O
supplements	O
,	O
especially	O
folic	O
acid	O
[	O
27	O
].	O

Any	O
medication	O
and	O
supplementation	O
use	O
is	O
also	O
recorded	O
daily	O
.	O

Similarly	O
,	O
a	O
greater	O
proportion	O
of	O
offspring	O
from	O
overweight	O
/	O
obese	O
mothers	O
were	O
classified	O
as	O
macrosomic	O
(>	O
4000	O
grams	O
;	O
17	O
.	O
2	O
%	O
versus	O
4	O
.	O
8	O
%,	O
resp	O
.	O

Current	O
evidence	O
for	O
putative	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
rodent	O
models	O
.	O

Alternatively	O
,	O
an	O
equally	O
effective	O
,	O
safe	O
,	O
and	O
affordable	O
iron	O
compound	O
with	O
little	O
or	O
no	O
side	O
effect	O
can	O
be	O
developed	O
for	O
use	O
especially	O
in	O
public	O
health	O
antenatal	O
supplementation	O
programmes	O
.	O

Virtually	O
any	O
person	O
treated	O
with	O
any	O
dosage	O
of	O
I	O
-	O
131	O
is	O
at	O
potential	O
risk	O
,	O
but	O
experimental	O
evidence	O
in	O
animals	O
and	O
follow	O
-	O
up	O
studies	O
in	O
humans	O
has	O
failed	O
to	O
reveal	O
any	O
statistically	O
significant	O
effects	O
of	O
I	O
-	O
131	O
on	O
chromosomal	O
abnormalities	O
,	O
congenital	O
malformation	O
or	O
childhood	O
cancers	O
.	O

The	O
cut	O
-	O
off	O
points	O
of	O
<	O
9	O
and	O
9	O
–	O
13	O
were	O
used	O
as	O
low	O
and	O
moderate	O
risk	O
for	O
depression	O
.	O

SPSS	O
16	O
.	O
0	O
(	O
SPSS	O
,	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

They	O
represent	O
the	O
most	O
common	O
malignant	O
brain	O
tumors	O
[	O
1	O
].	O

All	O
clinical	O
investigation	O
was	O
conducted	O
according	O
to	O
the	O
Declaration	O
of	O
Helsinki	O
.	O

Discussion	O
Normal	O
Vitamin	O
D	O
level	O
is	O
one	O
of	O
the	O
nutritional	O
management	O
goals	O
for	O
women	O
with	O
GDM	O
.	O

Furthermore	O
,	O
it	O
is	O
perhaps	O
unsurprising	O
that	O
women	O
with	O
higher	O
educational	O
achievement	O
and	O
also	O
those	O
with	O
greater	O
engagement	O
with	O
prenatal	O
care	O
had	O
better	O
nutritional	O
knowledge	O
and	O
used	O
supplements	O
more	O
.	O

This	O
may	O
be	O
explained	O
,	O
in	O
part	O
,	O
by	O
inadequate	O
control	O
of	O
related	O
risk	O
factors	O
and	O
confounders	O
in	O
statistical	O
analyses	O
,	O
variations	B
between	O
assays	O
that	O
measure	O
vitamin	O
D	O
and	O
significant	O
heterogeneity	B
between	O
studied	O
populations	O
[	O
6	O
].	O

The	O
uncertainty	O
concerning	O
the	O
optimal	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
is	O
even	O
higher	O
.	O

For	O
example	O
,	O
research	O
has	O
suggested	O
that	O
Alu	O
sequences	O
often	O
flank	O
CGIs	O
(	O
Graff	O
et	O
al	O
.	O

Therefore	O
meconium	O
aspiration	O
syndrome	O
cannot	B
be	I
the	O
cause	O
of	O
autistic	O
disorder	O
in	O
children	O
,	O
but	O
it	O
can	O
be	O
a	O
contributing	O
factor	O
[	O
57	O
].	O

The	O
key	O
factor	O
which	O
results	O
in	O
the	O
development	O
of	O
gestational	O
diabetes	O
appears	O
to	O
be	O
a	O
failure	O
to	O
compensate	O
with	O
increased	O
insulin	O
secretion	O
.	O
3As	O
the	O
increase	O
in	O
insulin	O
resistance	O
is	O
greatest	O
in	O
the	O
third	O
trimester	O
,	O
GDM	O
usually	O
develops	O
going	O
into	O
this	O
period	O
.	O

In	O
one	O
study	O
,	O
aspart	O
was	O
detected	O
in	O
the	O
cord	O
blood	O
for	O
one	O
subject	O
.	O
45However	O
,	O
as	O
it	O
was	O
not	O
detected	O
in	O
other	O
subjects	O
,	O
the	O
authors	O
postulated	O
that	O
this	O
was	O
due	O
to	O
the	O
disruption	O
of	O
the	O
uterine	O
-	O
placental	O
barrier	O
during	O
delivery	O
,	O
when	O
the	O
mother	O
had	O
been	O
receiving	O
an	O
aspart	O
infusion	O
.	O

The	O
dosage	O
is	O
based	O
on	O
dietary	O
intake	O
recommendations	O
[	O
10	O
,	O
11	O
].	O

The	O
effect	O
of	O
each	O
gene	O
is	O
further	O
diluted	O
by	O
variable	B
penetrance	O
[	O
61	O
].	O

Bioinformatics	O
was	O
employed	O
as	O
secondary	O
analyses	O
.	O

Discussion	O
This	O
study	O
demonstrates	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
moderate	O
(	O
20	O
%)	O
caloric	O
restriction	O
(	O
undernutrition	O
)	O
during	O
preconceptional	O
(	O
2	O
weeks	O
)	O
and	O
gestational	O
(	O
up	O
2	O
days	O
before	O
birth	O
)	O
periods	O
produced	O
long	O
-	O
term	O
effects	O
on	O
body	O
weight	O
,	O
feeding	O
behavior	O
and	O
gene	O
expression	O
of	O
key	O
components	O
of	O
the	O
ECS	O
(	O
receptors	O
and	O
enzymes	O
)	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

In	O
spite	O
of	O
the	O
theoretical	O
proliferative	O
stimulation	O
caused	O
by	O
HCG	O
and	O
placental	O
growth	O
factors	O
,	O
published	O
data	O
indicate	O
that	O
there	O
is	O
no	O
evidence	O
that	O
thyroid	O
cancer	O
can	O
be	O
influenced	O
by	O
pregnancy	O
.	O

In	O
such	O
instances	O
,	O
the	O
avoidance	O
of	O
peanuts	O
,	O
nuts	O
,	O
fish	O
,	O
eggs	O
,	O
and	O
sesame	O
during	O
the	O
last	O
3	O
months	O
of	O
pregnancy	O
may	O
have	O
a	O
protective	O
effect	O
[	O
106	O
].	O

Data	O
analysis	O
The	O
bioinformatic	O
analysis	O
was	O
done	O
in	O
R	O
[	O
65	O
].	O

Fear	O
of	O
labor	O
pain	O
is	O
another	O
concern	O
of	O
the	O
modern	O
-	O
day	O
mothers	O
[	O
78	O
].	O

The	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
was	O
acceptable	O
for	O
all	O
sections	O
(	O
general	O
recommendations	O
,	O
0	O
.	O
66	O
;	O
sources	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
;	O
the	O
role	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
),	O
except	O
for	O
breastfeeding	O
(	O
0	O
.	O
60	O
),	O
which	O
was	O
therefore	O
eliminated	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
.	O

Therefore	O
,	O
the	O
protective	O
role	O
of	O
high	O
25	O
(	O
OH	O
)	O
D	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
against	O
GDM	O
,	O
as	O
seen	O
with	O
a	O
decreased	O
risk	O
of	O
GDM	O
in	O
women	O
within	O
the	O
‘	O
high	O
’	O
quartile	O
of	O
standardised	O
vitamin	O
D	O
compared	O
to	O
moderate	O
-	O
high	O
,	O
is	O
consistent	O
with	O
knowledge	O
about	O
vitamin	O
D	O
and	O
diabetes	O
.	O

If	O
so	O
,	O
then	O
in	O
terms	O
of	O
policy	O
and	O
guidelines	O
,	O
it	O
is	O
hard	O
to	O
know	O
what	O
regimen	O
to	O
recommend	O
for	O
future	O
trials	O
,	O
given	O
that	O
clinical	O
practice	O
and	O
evidence	O
suggests	O
that	O
daily	O
or	O
weekly	O
supplementations	O
though	O
ideal	O
are	O
not	O
complied	O
with13	O
,	O
14and	O
are	O
impractical	B
for	O
families	O
,	O
especially	O
in	O
developing	O
countries	O
,	O
and	O
food	O
fortification	O
at	O
the	O
population	O
level	O
will	O
not	O
be	O
an	O
option	O
during	O
exclusive	O
breastfeeding	O
periods	O
(	O
aged	O
<	O
6	O
months	O
),	O
nor	O
is	O
it	O
likely	O
to	O
be	O
adequate	O
in	O
highly	O
deficient	O
populations	O
.	O

2002	O
;	O
Jaenisch	O
1997	O
;	O
Rougier	O
et	O
al	O
.	O

47	O
859	O
women	O
were	O
invited	O
to	O
complete	O
a	O
web	O
-	O
based	O
questionnaire	O
,	O
and	O
non	O
-	O
responders	O
received	O
a	O
paper	O
questionnaire	O
.	O

This	O
is	O
despite	O
our	O
previously	O
published	O
findings	O
of	O
significant	O
but	O
modest	O
improvements	O
in	O
maternal	O
diet	O
and	O
physical	O
activity	O
during	O
pregnancy	O
[	O
21	O
],	O
and	O
an	O
18	O
and	O
41	O
%	O
relative	O
reduction	O
in	O
risk	O
of	O
infant	O
birth	O
weight	O
above	O
4	O
[	O
22	O
]	O
and	O
4	O
.	O
5	O
kg	O
,	O
respectively	O
[	O
23	O
].	O

Unfortunately	O
,	O
we	O
do	O
not	O
have	O
any	O
information	O
about	O
the	O
use	O
of	O
such	O
supplements	O
during	O
follow	O
-	O
up	O
.	O

Acute	O
aortic	O
dissection	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
has	O
been	O
attributed	O
to	O
hemodynamic	O
alterations	O
that	O
occur	O
in	O
late	O
pregnancy	O
.	O

An	O
above	O
average	O
level	O
of	O
nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
use	O
of	O
supplements	O
,	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
consultations	O
,	O
age	O
,	O
area	O
of	O
residence	O
or	O
formal	O
education	O
(	O
Table	O
5	O
),	O
but	O
also	O
when	O
the	O
interaction	O
effect	O
of	O
prenatal	O
care	O
and	O
formal	O
education	O
together	O
was	O
taken	O
into	O
consideration	O
(	O
Table	O
4	O
).	O

On	O
the	O
other	O
hand	O
,	O
increased	O
risk	O
for	O
childhood	O
brain	O
tumors	O
has	O
been	O
associated	O
in	O
some	O
studies	O
with	O
a	O
history	O
of	O
chicken	O
pox	O
[	O
137	O
],	O
influenza	O
[	O
138	O
,	O
139	O
],	O
measles	O
[	O
138	O
],	O
general	O
viral	O
infections	O
[	O
140	O
,	O
141	O
],	O
and	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

Supplementing	O
rumen	O
-	O
protected	O
vitamin	O
C	O
in	O
a	O
high	O
sulfur	O
diet	O
increased	O
the	O
MS	O
and	O
the	O
percentage	O
of	O
Choice	O
grade	O
beef	O
in	O
Angus	O
cross	O
steers	O
[	O
151	O
].	O

The	O
medical	O
doctor	O
diagnoses	O
and	O
determines	O
the	O
duration	O
of	O
each	O
morbidity	O
event	O
using	O
the	O
structured	O
questionnaire	O
with	O
reference	O
to	O
the	O
morbidity	O
calendar	O
.	O

Nowadays	O
,	O
we	O
know	O
that	O
brain	O
cells	O
such	O
as	O
microglia	O
and	O
astrocytes	O
,	O
can	O
secrete	O
cytokines	O
.	O

IUFD	O
was	O
defined	O
as	O
pregnancy	O
loss	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

Similarly	O
,	O
the	O
first	O
animal	O
study	O
to	O
demonstrate	O
that	O
an	O
in	O
utero	O
exposure	O
could	O
induce	O
adverse	O
phenotypes	O
in	O
subsequent	O
generations	O
administered	O
the	O
environmental	O
chemical	O
vinclozolin	O
via	O
the	O
intraperitoneal	O
route	O
(	O
Anway	O
et	O
al	O
.	O
2005	O
).	O

Current	O
evidence	O
for	O
putative	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
Human	O
cohorts	O
For	O
many	O
decades	O
,	O
there	O
have	O
been	O
epidemiological	O
studies	O
linking	O
the	O
risks	O
of	O
adverse	O
phenotypes	O
to	O
a	O
wide	O
range	O
of	O
environmental	O
factors	O
.	O

However	O
,	O
in	O
Cameroon	O
,	O
MMR	O
has	O
risen	O
by	O
8	O
%	O
from	O
680	O
to	O
872	O
deaths	O
per	O
100	O
000	O
in	O
the	O
past	O
9	O
years	O
after	O
the	O
initial	O
decrease	O
[	O
3	O
].	O

Defective	O
Spermatogenesis	O
:	O
Martin	O
et	O
al	O
.	O

Hence	O
,	O
not	O
surprisingly	O
,	O
31	O
%	O
and	O
13	O
%	O
of	O
South	O
African	O
women	O
of	O
reproductive	O
age	O
are	O
anaemic	O
[	O
22	O
]	O
and	O
vitamin	O
A	O
deficient	O
[	O
18	O
],	O
respectively	O
,	O
while	O
68	O
%	O
of	O
women	O
are	O
overweight	O
or	O
obese	O
,	O
and	O
46	O
%	O
hypertensive	O
[	O
22	O
].	O

[	O
3	O
].	O

Disruptions	O
in	O
pathways	O
related	O
to	O
calcium	O
-	O
binding	O
proteins	O
and	O
mitochondrial	O
function	O
may	O
underlie	O
some	O
of	O
the	O
behavioural	O
features	O
associated	O
with	O
animal	O
models	O
of	O
developmental	O
vitamin	O
D	O
deficiency	O
Introduction	O
Based	O
on	O
clues	O
from	O
epidemiology	O
,	O
we	O
have	O
proposed	O
that	O
low	O
prenatal	O
vitamin	O
D	O
may	O
be	O
a	O
risk	O
factor	O
for	O
later	O
development	O
of	O
schizophrenia	O
[	O
1	O
].	O

If	O
so	O
,	O
it	O
would	O
be	O
predicted	O
that	O
it	O
is	O
this	O
mismatch	O
between	O
the	O
HV	O
diet	O
fed	O
to	O
the	O
dams	O
and	O
the	O
vitamin	O
content	O
of	O
diets	O
fed	O
to	O
the	O
offspring	O
that	O
leads	O
to	O
an	O
obesogenic	O
phenotype	O
.	O

Additionally	O
,	O
CC	O
and	O
RC	O
adolescent	O
females	O
showed	O
an	O
increase	O
in	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adolescent	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
;	O
Figure3A	O
).	O

Priority	O
was	O
given	O
to	O
papers	O
that	O
presented	O
original	O
data	O
rather	O
than	O
reviews	O
or	O
meta	O
-	O
analyses	O
.	O

Continuous	O
variables	O
were	O
evaluated	O
across	O
quintile	O
categories	O
of	O
dietary	O
pattern	O
scores	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
.	O

multiple	O
linear	O
regression	O
analysis	O
,	O
ANCOVA	O
,	O
logistic	O
regression	O
analysis	O
),	O
adjusting	O
for	O
potential	O
covariates	O
.	O

Specifically	O
,	O
a	O
test	O
statistic	O
was	O
constructed	O
as	O
the	O
maximum	O
absolute	O
t	O
-	O
statistic	O
for	O
the	O
appropriate	O
coefficient	O
from	O
the	O
regression	O
model	O
,	O
where	O
the	O
maximum	O
was	O
computed	O
over	O
the	O
16	O
or	O
41	O
individual	O
regression	O
models	O
.	O

The	O
individual	O
scores	O
for	O
the	O
3	O
patterns	O
show	O
the	O
values	O
estimated	O
for	O
each	O
individual	O
based	O
on	O
their	O
consumption	O
of	O
foods	O
and	O
the	O
factor	O
loadings	O
of	O
the	O
foods	O
.	O

Furthermore	O
,	O
the	O
common	O
practice	O
of	O
swaddling	O
infants	O
might	O
reduce	O
exposure	O
to	O
sunlight	O
.	O
2Thus	O
young	O
children	O
are	O
at	O
a	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

As	O
this	O
is	O
an	O
observational	O
study	O
,	O
we	O
cannot	B
conclude	O
that	O
the	O
information	O
about	O
the	O
roles	O
or	O
sources	O
of	O
nutrients	O
or	O
general	O
recommendations	O
about	O
diet	O
during	O
pregnancy	O
directly	O
influence	O
the	O
frequency	O
with	O
which	O
supplements	O
are	O
used	O
,	O
despite	O
the	O
fact	O
that	O
nutritional	O
knowledge	O
appears	O
to	O
be	O
an	O
important	O
determinant	O
.	O

Over	O
half	O
the	O
children	O
aged	O
6	O
–	O
12	O
.	O
9	O
years	O
residing	O
in	O
urban	O
areas	O
had	O
serum	O
25	O
(	O
OH	O
)	O
D	O
less	O
then	O
20	O
ng	O
/	O
mL	O
(	O
50	O
nmol	O
/	O
L	O
).	O

Furthermore	O
,	O
during	O
pregnancy	O
,	O
nasal	O
congestion	O
can	O
worsen	O
,	O
although	O
the	O
exact	O
mechanism	O
for	O
this	O
is	O
not	O
defined	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Frequency	O
of	O
sequence	O
features	O
associated	O
with	O
RPMM	O
class	O
CpG	O
loci	O
:	O
percentage	O
of	O
CpG	O
loci	O
found	O
in	O
LINE	O
-	O
1	O
(	O
A	O
),	O
LINE	O
-	O
2	O
(	O
B	O
),	O
Alu	O
(	O
C	O
),	O
and	O
MIR	O
(	O
D	O
),	O
within	O
a	O
CGI	O
(	O
E	O
),	O
or	O
having	O
the	O
associated	O
gene	O
considered	O
a	O
PcG	O
protein	O
target	O
gene	O
(	O
F	O
).	O

At	O
this	O
time	O
point	O
the	O
fetuses	O
were	O
subjected	O
to	O
a	O
serious	O
nutritional	O
deficiency	O
that	O
requires	O
an	O
acute	O
transcriptomic	O
response	O
.	O

The	O
delivery	O
mode	O
was	O
drawn	O
from	O
maternal	O
delivery	O
records	O
,	O
and	O
maternal	O
pre	O
-	O
pregnancy	O
height	O
,	O
weight	O
,	O
and	O
parity	O
were	O
determined	O
via	O
a	O
self	O
-	O
administered	O
questionnaire	O
upon	O
study	O
entry	O
and	O
used	O
to	O
compute	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

In	O
a	O
term	O
fetus	O
,	O
amnion	O
and	O
decida	O
have	O
higher	O
levels	O
of	O
mRNA	O
of	O
the	O
visfatin	O
gene	O
(	O
4	O
).	O

Information	O
on	O
medical	O
and	O
reproductive	O
histories	O
and	O
sociodemographic	O
and	O
lifestyle	O
characteristics	O
including	O
average	O
number	O
of	O
hours	O
of	O
sleep	O
before	O
and	O
during	O
early	O
pregnancy	O
was	O
collected	O
.	O

),	O
overweight	O
or	O
obesity	O
,	O
excessive	O
gestational	O
weight	O
gain	O
,	O
excessive	O
central	O
body	O
fat	O
deposition	O
,	O
family	O
history	O
of	O
diabetes	O
,	O
short	O
stature	O
(<	O
1	O
.	O
50	O
m	O
),	O
excessive	O
fetal	O
growth	O
,	O
polyhydramnios	O
,	O
hypertension	O
or	O
preeclampsia	O
in	O
the	O
current	O
pregnancy	O
,	O
history	O
of	O
recurrent	O
miscarriage	O
,	O
offspring	O
malformation	O
,	O
fetal	O
or	O
neonatal	O
death	O
,	O
macrosomia	O
,	O
GDM	O
during	O
prior	O
pregnancies	O
and	O
polycystic	O
ovary	O
syndrome	O
.	O

The	O
increase	O
in	O
blood	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3levels	O
in	O
response	O
to	O
decreased	O
calcium	O
intake	O
may	O
downregulate	O
preadipocyte	O
differentiation	O
,	O
thus	O
decreasing	O
beef	O
marbling	O
.	O

Maternal	O
anthropometric	O
measurements	O
Maternal	O
weight	O
and	O
mid	O
-	O
upperarm	O
circumference	O
(	O
MUAC	O
)	O
are	O
obtained	O
at	O
each	O
phase	O
(	O
1	O
to	O
8	O
),	O
and	O
height	O
only	O
at	O
phase	O
1	O
and	O
5	O
.	O

They	O
were	O
more	O
likely	O
to	O
have	O
experienced	O
fetal	O
distress	O
,	O
been	O
delivered	O
by	O
an	O
elective	O
or	O
emergency	O
cesarean	O
section	O
,	O
and	O
had	O
an	O
Apgar	O
score	O
of	O
less	O
than	O
6	O
at	O
one	O
minute	O
.	O

Within	O
the	O
14	O
h	O
after	O
birth	O
,	O
pups	O
were	O
weighed	O
,	O
sexed	O
,	O
and	O
culled	O
to	O
comprise	O
up	O
to	O
8	O
pups	O
per	O
mother	O
(	O
4	O
males	O
and	O
4	O
females	O
where	O
possible	O
).	O

Priority	O
question	O
:	O
How	O
can	O
we	O
identify	O
particularly	O
susceptible	O
individuals	O
or	O
populations	O
?	O

On	O
the	O
third	O
day	O
postpartum	O
,	O
the	O
diagnosis	O
of	O
gestational	O
diabetes	O
insipidus	O
was	O
suspected	O
and	O
the	O
patient	O
was	O
started	O
on	O
intranasal	O
DDAVP	O
spray	O
5	O
mcg	O
twice	O
a	O
day	O
,	O
after	O
an	O
initial	O
dose	O
of	O
10	O
mcg	O
.	O

Fat	O
supplementation	O
for	O
extra	O
energy	O
supply	O
has	O
been	O
recommended	O
during	O
cold	O
or	O
heat	O
stress	O
to	O
prevent	O
fat	O
degradation	O
.	O

White	O
children	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
35	O
.	O
1	O
ng	O
/	O
mL	O
(	O
87	O
.	O
8	O
nmol	O
/	O
L	O
)	O
at	O
the	O
follow	O
-	O
up	O
visit	O
,	O
which	O
was	O
also	O
found	O
to	O
be	O
significantly	O
higher	O
than	O
both	O
Black	O
and	O
Hispanic	O
children	O
with	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
22	O
.	O
5	O
ng	O
/	O
mL	O
(	O
56	O
.	O
3	O
nmol	O
/	O
L	O
)	O
and	O
25	O
.	O
4	O
ng	O
/	O
mL	O
(	O
63	O
.	O
5	O
nmol	O
/	O
L	O
),	O
respectively	O
(	O
p	O
≤	O
0	O
.	O
0001	O
and	O
≤	O
0	O
.	O
0001	O
,	O
respectively	O
).	O

The	O
risk	O
was	O
also	O
lower	O
for	O
women	O
with	O
a	O
high	O
intake	O
of	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
compared	O
to	O
women	O
with	O
a	O
lower	O
intake	O
of	O
these	O
fatty	O
acids	O
.	O

For	O
example	O
,	O
the	O
increased	O
prevalence	O
of	O
the	O
use	O
of	O
anticonvulsant	O
medications	O
during	O
pregnancy	O
is	O
correlated	O
with	O
an	O
increased	O
risk	O
of	O
autism	O
.	O

Smoking	O
has	O
been	O
found	O
to	O
be	O
an	O
environmental	O
hazard	O
.	O

Data	O
will	O
also	O
be	O
analysed	O
retrospectively	O
in	O
matched	O
-	O
control	O
sub	O
-	O
studies	O
by	O
determining	O
associations	O
between	O
observed	O
outcomes	O
and	O
variables	O
collected	O
at	O
previous	O
time	O
points	O
.	O

We	O
conducted	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
and	O
highlighted	O
their	O
constraints	O
as	O
well	O
as	O
interventions	O
required	O
to	O
strengthen	O
the	O
health	O
services	O
.	O

New	O
drugs	O
with	O
anti	O
-	O
angiogenetic	O
,	O
anti	O
-	O
tyrosine	O
kinase	O
and	O
anti	O
-	O
VEGF	O
effects	O
are	O
currently	O
under	O
observation	O
.	O

While	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
greater	O
reduction	O
in	O
depression	O
scores	O
than	O
the	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Du	O
et	O
al	O
[	O
17	O
]	O
suggested	O
that	O
the	O
order	O
of	O
effectiveness	O
of	O
nutritional	O
management	O
for	O
manipulating	O
IMF	O
deposition	O
is	O
fetal	O
stage	O
>	O
neonatal	O
stage	O
>	O
weaning	O
stage	O
>	O
older	O
stages	O
.	O

Disordered	O
regulation	O
of	O
feeding	O
pathways	O
can	O
affect	O
growth	O
and	O
metabolism	O
,	O
consequently	O
driving	O
the	O
appearance	O
of	O
metabolic	O
syndrome	O
later	O
in	O
life	O
.	O
7	O
,	O
8	O
An	O
extension	O
of	O
the	O
concept	O
that	O
early	O
life	O
factors	O
contribute	O
to	O
chronic	O
diseases	O
is	O
described	O
by	O
the	O
predictive	O
adaptive	O
response	O
(	O
PAR	O
)	O
hypothesis	O
,	O
which	O
suggests	O
that	O
a	O
mismatch	O
between	O
in	O
utero	O
and	O
postnatal	O
environment	O
increases	O
the	O
risk	O
of	O
developing	O
disease	O
in	O
adulthood	O
.	O
9	O
,	O
10It	O
has	O
been	O
proposed	O
that	O
the	O
offspring	O
modify	O
their	O
phenotype	O
based	O
on	O
their	O
in	O
utero	O
environment	O
in	O
order	O
to	O
adapt	O
to	O
the	O
predicted	O
postnatal	O
setting	O
.	O

CT	O
:	O
cholera	O
toxin	O
;	O
ih	O
:	O
intrahippocampal	O
;	O
im	O
:	O
intramuscular	O
;	O
ip	O
:	O
intraperitoneal	O
;	O
sc	O
:	O
subcutaneous	O
.	O

A	O
major	O
issue	O
in	O
sex	O
differences	O
is	O
the	O
need	O
for	O
control	O
the	O
estrous	O
phase	O
on	O
which	O
the	O
evaluations	O
were	O
performed	O
in	O
order	O
to	O
clarify	O
the	O
impact	O
of	O
sex	O
hormones	O
variations	B
in	O
the	O
female	O
.	O

None	O
of	O
the	O
women	O
were	O
anemic	O
at	O
that	O
point	O
,	O
but	O
66	O
%	O
had	O
low	O
levels	O
of	O
ferritin	O
(	O
the	O
principal	O
form	O
of	O
stored	O
iron	O
),	O
suggesting	O
low	O
iron	O
nutritional	O
status	O
.	O

Continuous	O
variables	O
Serum	O
total	O
IgE	O
(	O
kU	O
·	O
L	O
−	O
1	O
)	O
was	O
measured	O
by	O
fluoroimmunoassay	O
using	O
the	O
Pharmacia	O
UNICAP	O
system	O
(	O
Pharmacia	O
and	O
Upjohn	O
Diagnostics	O
,	O
Uppsala	O
,	O
Sweden	O
).	O

Data	O
inTable	O
7represent	O
the	O
crude	O
and	O
adjusted	O
odds	O
ratio	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
for	O
ORs	O
from	O
the	O
multivariate	O
analysis	O
,	O
where	O
neonatal	O
anthropometric	O
measurements	O
are	O
the	O
dependent	O
variables	O
and	O
major	O
maternal	O
dietary	O
patterns	O
the	O
independent	O
variables	O
.	O

The	O
literature	O
also	O
contains	O
many	O
in	O
vitro	O
studies	O
investigating	O
the	O
role	O
of	O
specific	O
epigenetic	O
mechanisms	O
in	O
adverse	O
outcomes	O
induced	O
by	O
environmental	O
exposures	O
.	O

All	O
analyses	O
were	O
analogously	O
performed	O
in	O
the	O
Cesarean	O
section	O
group	O
to	O
assess	O
if	O
an	O
effect	O
of	O
maternal	O
diet	O
on	O
the	O
infant	O
gut	O
microbiome	O
exists	O
in	O
the	O
case	O
of	O
surgical	O
delivery	O
.	O

Dietary	O
habits	O
during	O
the	O
6	O
months	O
preceding	O
the	O
woman	O
'	O
s	O
enrolment	O
in	O
the	O
study	O
were	O
ascertained	O
through	O
a	O
validated	O
FFQ	O
that	O
covered	O
the	O
frequency	O
of	O
consumption	O
and	O
quantity	O
of	O
about	O
eighty	O
food	O
items	O
and	O
beverages	O
[	O
26	O
].	O

There	O
will	O
be	O
one	O
FI	O
for	O
each	O
cluster	O
.	O

To	O
examine	O
similarities	O
in	O
the	O
genomic	O
context	O
of	O
the	O
CpGs	O
making	O
up	O
these	O
data	O
-	O
driven	O
RPMM	O
classes	O
,	O
we	O
examined	O
the	O
proportion	O
of	O
CpG	O
loci	O
associated	O
with	O
specific	O
DNA	O
sequence	O
features	O
within	O
each	O
class	O
,	O
including	O
location	O
within	O
a	O
repetitive	O
element	O
(	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
Alu	O
,	O
or	O
MIR	O
),	O
within	O
a	O
CGI	O
,	O
or	O
having	O
the	O
associated	O
gene	O
considered	O
a	O
PcG	O
protein	O
target	O
gene	O
(	O
Figure	O
2	O
).	O

Further	O
,	O
prenatal	O
vitamin	O
D3	O
depletion	O
has	O
been	O
associated	O
with	O
altered	O
brain	O
development	O
in	O
rodent	O
studies	O
[	O
151	O
].	O

At	O
least	O
two	O
physicians	O
will	O
independently	O
review	O
the	O
data	O
,	O
and	O
they	O
will	O
base	O
their	O
decision	O
on	O
an	O
agreement	O
.	O

We	O
collected	O
self	O
-	O
reported	O
data	O
regarding	O
socio	O
-	O
demographic	O
characteristics	O
,	O
number	O
of	O
prenatal	O
check	O
-	O
ups	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
.	O

They	O
are	O
listed	O
in	O
the	O
table	O
footnotes	O
.	O

Castrating	O
bulls	O
gener	O
ally	O
increases	O
IMF	O
content	O
in	O
several	O
breeds	O
,	O
including	O
Korean	O
cattle	O
and	O
Holstein	O
[	O
9	O
,	O
38	O
–	O
40	O
].	O

Stimulation	O
of	O
BAT	O
activity	O
and	O
/	O
or	O
recruitment	O
of	O
UCP1	O
-	O
positive	O
cells	O
are	O
therefore	O
relevant	O
targets	O
for	O
the	O
treatment	O
of	O
obesity	O
/	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

Of	O
all	O
women	O
included	O
,	O
76	O
.	O
2	O
%	O
reported	O
taking	O
at	O
least	O
1	O
multivitamin	O
during	O
pregnancy	O
.	O

Results	O
:	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
found	O
to	O
be	O
significantly	O
positively	O
associated	O
with	O
birth	O
weight	O
percentile	O
(	O
p	O
=	O
0	O
.	O
01	O
and	O
p	O
<	O
0	O
.	O
0001	O
,	O
respectively	O
)	O
and	O
were	O
found	O
to	O
differ	O
significantly	O
among	O
infants	O
exposed	O
to	O
tobacco	O
smoke	O
and	O
alcohol	O
.	O

Nonetheless	O
,	O
analyses	O
using	O
the	O
2009	O
criteria	O
confirmed	O
the	O
current	O
study	O
'	O
s	O
findings	O
(	O
data	O
not	O
shown	O
).	O

Autism	O
and	O
autism	O
spectrum	O
disorders	O
(	O
ASDs	O
),	O
including	O
Asperger	O
'	O
s	O
syndrome	O
and	O
pervasive	O
developmental	O
disorder	O
,	O
have	O
become	O
increasingly	O
diagnosed	O
over	O
the	O
past	O
decade	O
.	O

‡	O
Studies	O
demonstrating	O
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
animal	O
model	O
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

Postnatal	O
data	O
are	O
collected	O
at	O
the	O
Empilweni	O
Services	O
and	O
Research	O
Unit	O
(	O
ESRU	O
)	O
at	O
RMMCH	O
.	O

Vitamin	O
C	O
increased	O
preadipocyte	O
growth	O
of	O
3T3	O
L1	O
cells	O
[	O
148	O
]	O
and	O
also	O
had	O
a	O
positive	O
effect	O
on	O
differentiation	O
of	O
sheep	O
preadipocytes	O
in	O
primary	O
culture	O
[	O
149	O
].	O

This	O
may	O
therefore	O
be	O
affecting	O
the	O
number	O
of	O
these	O
elements	O
in	O
the	O
genome	O
and	O
the	O
functional	O
relevance	O
of	O
their	O
methylation	O
,	O
particularly	O
in	O
the	O
placenta	O
.	O

Guidelines	O
from	O
Australia	O
,	O
Europe	O
and	O
the	O
USA	O
encourage	O
fish	O
consumption	O
during	O
pregnancy	O
.	O

Given	O
that	O
73	O
%	O
of	O
children	O
had	O
vitamin	O
D	O
deficiency	O
in	O
the	O
study	O
region	O
in	O
2005	O
,	O
12and	O
that	O
the	O
incidence	O
of	O
pneumonia	O
was	O
ten	O
-	O
times	O
higher	O
in	O
vitamin	O
D	O
deficient	O
children	O
than	O
in	O
children	O
without	O
a	O
deficiency	O
in	O
case	O
-	O
control	O
studies1	O
,	O
2we	O
postulated	O
that	O
there	O
would	O
be	O
at	O
least	O
a	O
35	O
%	O
reduction	O
in	O
pneumonia	O
incidence	O
in	O
the	O
vitamin	O
D	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Furthermore	O
,	O
farmers	O
usually	O
are	O
non	O
-	O
smokers	O
and	O
healthier	O
than	O
the	O
population	O
-	O
at	O
-	O
large	O
[	O
43	O
,	O
116	O
,	O
118	O
–	O
120	O
].	O

However	O
,	O
environmental	O
exposures	O
during	O
critical	O
windows	O
of	O
human	O
development	O
and	O
subsequent	O
non	O
-	O
genotoxic	O
/	O
epigenetic	O
changes	O
that	O
may	O
lead	O
to	O
later	O
life	O
adverse	O
health	O
outcomes	O
(	O
such	O
as	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
)	O
across	O
multiple	O
generations	O
continues	O
to	O
be	O
of	O
high	O
concern	O
for	O
all	O
the	O
Organization	O
for	O
Economic	O
Co	O
-	O
operation	O
and	O
Development	O
(	O
OECD	O
)	O
member	O
countries	O
,	O
the	O
International	O
Agency	O
on	O
Research	O
for	O
Cancer	O
(	O
IARC	O
)	O
and	O
the	O
European	O
Commission	O
(	O
EFSA2013	O
;	O
Greally	O
&	O
Jacobs2013	O
;	O
Herceg	O
et	O
al	O
.	O
2013	O
;	O
OECD2014	O
).	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

Therefore	O
,	O
consumption	O
of	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
is	O
associated	O
with	O
higher	O
Vitamin	O
D2	O
detection	O
rate	O
among	O
pregnant	O
women	O
.	O

The	O
potential	O
for	O
such	O
adaptations	O
is	O
already	O
acknowledged	O
at	O
the	O
OECD	O
,	O
but	O
more	O
applied	O
development	O
of	O
key	O
markers	O
and	O
subsequent	O
validation	O
work	O
is	O
needed	O
to	O
formally	O
incorporate	O
epigenetic	O
endpoints	O
into	O
TGs	O
.	O

Hence	O
,	O
thyroid	O
cancer	O
ranks	O
among	O
the	O
most	O
common	O
cancers	O
during	O
pregnancy	O
,	O
with	O
a	O
prevalence	O
of	O
3	O
.	O
6	O
-	O
14	O
per	O
100	O
,	O
000	O
live	O
births	O
,	O
mirroring	O
the	O
its	O
incidence1	O
-	O
4	O
.	O

Discussion	O
The	O
study	O
aimed	O
at	O
exploring	O
the	O
perceptions	O
of	O
pregnant	O
women	O
attending	O
antenatal	O
clinic	O
in	O
the	O
public	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
regarding	O
antenatal	O
care	O
in	O
terms	O
of	O
their	O
knowledge	O
and	O
satisfaction	O
with	O
service	O
delivery	O
.	O

Averaging	O
parameters	O
were	O
set	O
at	O
70	O
%,	O
therefore	O
for	O
a	O
protein	O
spot	O
to	O
appear	O
in	O
the	O
averaged	O
gel	O
it	O
must	O
be	O
present	O
in	O
70	O
%	O
of	O
all	O
gels	O
within	O
a	O
group	O
.	O

We	O
only	O
found	O
a	O
difference	O
between	O
RC	O
and	O
CC	O
female	O
offspring	O
at	O
PND	O
20	O
.	O

Paradoxically	O
,	O
central	O
IL	O
-	O
6	O
delivery	O
was	O
shown	O
to	O
suppress	O
weight	O
gain	O
and	O
visceral	O
obesity	O
,	O
without	O
affecting	O
food	O
intake	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

MTRL	O
has	O
been	O
funded	O
by	O
a	O
FPU	O
predoctoral	O
fellowship	O
of	O
the	O
Spanish	O
Ministerio	O
de	O
Educación	O
,	O
Cultura	O
y	O
Deporte	O
(	O
AP	O
-	O
2009	O
-	O
0225	O
);	O
JS	O
holds	O
a	O
“	O
Miguel	O
Servet	O
”	O
research	O
contract	O
from	O
the	O
National	O
System	O
of	O
Health	O
,	O
ISCIII	O
(	O
grant	O
number	O
CP12	O
/	O
03109	O
).	O

However	O
,	O
the	O
reality	O
is	O
that	O
medications	O
must	O
be	O
considered	O
for	O
pregnant	O
patients	O
with	O
medical	O
disorders	O
,	O
based	O
on	O
a	O
thorough	O
appreciation	O
of	O
the	O
potential	O
deleterious	O
effects	O
of	O
untreated	O
disease	O
.	O

Critical	O
monthly	O
adjustment	O
of	O
levothyroxine	O
therapy	O
:	O
maintain	O
fT4	O
in	O
the	O
upper	O
third	O
of	O
reference	O
range	O
.	O

Obesity	O
was	O
defined	O
as	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
,	O
overweight	O
as	O
BMI	O
≥	O
25	O
and	O
<	O
30	O
kg	O
/	O
m2	O
,	O
normal	O
weight	O
as	O
BMI	O
>	O
20	O
and	O
<	O
25	O
kg	O
/	O
m2and	O
underweight	O
as	O
BMI	O
≤	O
20	O
kg	O
/	O
m2	O
.	O

Women	O
(	O
n	O
=	O
32	O
)	O
who	O
developed	O
gestational	O
diabetes	O
(	O
GDM	O
)	O
were	O
excluded	O
from	O
analysis	O
a	O
priori	O
,	O
given	O
potential	O
impact	O
of	O
GDM	O
on	O
both	O
offspring	O
and	O
maternal	O
weight	O
gain	O
[	O
18	O
].	O

In	O
order	O
to	O
contribute	O
to	O
a	O
comprehensive	O
inventory	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
targets	O
of	O
nutritional	O
programming	O
initiated	O
during	O
fetal	O
life	O
,	O
we	O
applied	O
whole	O
-	O
genome	O
microarrays	O
for	O
expression	O
profiling	O
in	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

We	O
selected	O
potential	O
confounders	O
from	O
a	O
list	O
of	O
variables	O
that	O
were	O
associated	O
with	O
sleep	O
duration	O
and	O
snoring	O
(	O
from	O
prior	O
studies	O
conducted	O
among	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
)	O
and	O
that	O
met	O
criteria	O
for	O
confounding	O
based	O
on	O
a	O
review	O
of	O
the	O
literature	O
and	O
assessment	O
of	O
potential	O
causal	O
relationships	O
based	O
on	O
prior	O
knowledge	O
.	O

They	O
concluded	O
that	O
the	O
TT	O
genotype	O
of	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
is	O
related	O
to	O
greater	O
IMF	O
than	O
the	O
CC	O
genotype	O
when	O
vitamin	O
A	O
is	O
restricted	O
,	O
and	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
could	O
be	O
a	O
genetic	O
marker	O
for	O
enhancing	O
marbling	O
in	O
feedlot	O
steers	O
.	O

The	O
selection	O
of	O
covariates	O
included	O
in	O
the	O
final	O
multivariate	O
models	O
was	O
based	O
on	O
proportional	O
(≥	O
10	O
%)	O
change	O
in	O
β	O
-	O
coefficients	O
and	O
previous	O
subject	O
matter	O
knowledge	O
.	O

As	O
a	O
part	O
of	O
the	O
capacity	O
building	O
efforts	O
,	O
the	O
Ministry	O
of	O
Women	O
&	O
Child	O
Development	O
has	O
recommended	O
policy	O
related	O
and	O
institutional	O
transformations	O
.	O

If	O
1	O
parent	O
is	O
allergic	O
,	O
the	O
risk	O
increases	O
to	O
30	O
%,	O
and	O
if	O
both	O
are	O
allergic	O
,	O
the	O
risk	O
is	O
greater	O
than	O
60	O
%,	O
especially	O
for	O
developing	O
the	O
same	O
organ	O
-	O
specific	O
symptoms	O
[	O
54	O
].	O

This	O
rule	O
,	O
the	O
first	O
of	O
its	O
kind	O
in	O
the	O
world	O
,	O
will	O
apply	O
mainly	O
to	O
personal	O
care	O
products	O
but	O
also	O
could	O
apply	O
to	O
other	O
categories	O
such	O
as	O
food	O
and	O
textiles	O
.	O

We	O
also	O
detected	O
interaction	O
between	O
time	O
and	O
diet	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
3	O
.	O
64	O
;	O
P	O
<	O
0	O
.	O
05	O
],	O
and	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
2	O
.	O
954	O
,	O
P	O
<	O
0	O
.	O
05	O
].	O

However	O
,	O
the	O
exact	O
prevalence	O
of	O
allergic	O
forms	O
of	O
dermatitis	O
in	O
the	O
pregnant	O
population	O
is	O
not	O
known	O
.	O

The	O
differential	O
response	O
to	O
the	O
maternal	O
undernutrition	O
in	O
energy	O
balance	O
is	O
sexual	O
dimorphism	O
dependent	O
during	O
the	O
post	O
-	O
weaning	O
periods	O
.	O

Primary	O
outcome	O
The	O
primary	O
outcome	O
was	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infant	O
age	O
and	O
sex	O
at	O
follow	O
-	O
up	O
[	O
27	O
].	O

NcDNA	O
is	O
transcribed	O
into	O
ncRNAs	O
,	O
which	O
play	O
major	O
roles	O
in	O
regulating	O
gene	O
expression	O
.	O

Engagement	O
with	O
prenatal	O
care	O
appeared	O
to	O
increase	O
the	O
likelihood	O
that	O
less	O
well	O
-	O
educated	O
women	O
would	O
take	O
supplements	O
during	O
pregnancy	O
,	O
suggesting	O
that	O
the	O
prenatal	O
nutritional	O
advice	O
may	O
be	O
a	O
useful	O
intervention	O
.	O

Moreover	O
,	O
the	O
expression	O
of	O
the	O
catalytic	O
subunits	O
of	O
AMPK	O
,	O
PRKAA1	O
and	O
PRKAA2	O
was	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
offspring	O
compared	O
to	O
AP	O
offspring	O
at	O
stage	O
188	O
dpn	O
,	O
which	O
may	O
contribute	O
to	O
an	O
imbalanced	O
cellular	O
metabolism	O
.	O

We	O
suggest	O
further	O
clinical	O
trial	O
in	O
pregnant	O
mothers	O
who	O
are	O
at	O
risk	O
for	O
postnatal	O
depression	O
.	O

The	O
spill	O
dumped	O
94	O
million	O
gallons	O
of	O
mill	O
process	O
effluent	O
and	O
1	O
,	O
100	O
tons	O
of	O
tailings	O
—	O
an	O
acidic	O
,	O
radioactive	O
sludge	O
—	O
into	O
a	O
large	O
arroyo	O
that	O
emptied	O
into	O
the	O
Puerco	O
River	O
.	O
4	O
The	O
Church	O
Rock	O
spill	O
occurred	O
less	O
than	O
four	O
months	O
after	O
the	O
partial	O
meltdown	O
of	O
the	O
Three	O
Mile	O
Island	O
nuclear	O
reactor	O
,	O
and	O
it	O
released	O
three	O
times	O
as	O
much	O
radiation	O
,	O
making	O
it	O
the	O
biggest	O
nuclear	O
spill	O
in	O
U	O
.	O
S	O
.	O
history	O
,	O
yet	O
it	O
received	O
only	O
a	O
tiny	O
fraction	O
of	O
the	O
news	O
coverage	O
.	O
5Declared	O
a	O
Superfund	O
site	O
in	O
1983	O
,	O
the	O
heaps	O
of	O
waste	O
around	O
the	O
mill	O
still	O
cause	O
radiation	O
survey	O
instruments	O
to	O
squeal	O
from	O
the	O
invisible	O
uranium	O
atoms	O
that	O
remain	O
active	O
30	O
years	O
later	O
.	O
6	O
“	O
This	O
area	O
used	O
to	O
be	O
my	O
playground	O
,”	O
Bell	O
-	O
Jefferson	O
says	O
.	O

This	O
review	O
concludes	O
with	O
a	O
discussion	O
highlighting	O
some	O
of	O
the	O
methodological	O
issues	O
in	O
researching	O
associations	O
between	O
diet	O
and	O
infant	O
neurodevelopment	O
.	O

Guidelines	O
emphasising	O
the	O
health	O
risks	O
of	O
methyl	O
-	O
mercury	O
,	O
with	O
little	O
mention	O
of	O
important	O
nutrients	O
found	O
in	O
fish	O
,	O
may	O
be	O
contributing	O
to	O
women	O
consuming	O
less	O
than	O
the	O
recommended	O
fish	O
servings	O
during	O
pregnancy	O
[	O
10	O
].	O

In	O
order	O
to	O
further	O
investigate	O
the	O
effect	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
we	O
performed	O
a	O
compulsive	O
feeding	O
test	O
in	O
the	O
adult	O
offspring	O
.	O

Income	O
was	O
categorized	O
as	O
>$	O
25	O
,	O
000	O
per	O
year	O
versus	O
≤$	O
25	O
,	O
000	O
.	O

An	O
increased	O
daily	O
dose	O
of	O
120	O
mg	O
of	O
iron	O
is	O
further	O
suggested	O
if	O
the	O
duration	O
of	O
supplementation	O
in	O
pregnant	O
nonanaemic	O
women	O
is	O
shorter	O
or	O
where	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
in	O
women	O
is	O
high	O
or	O
in	O
settings	O
where	O
pregnant	O
women	O
are	O
generally	O
anaemic	O
[	O
27	O
].	O

LBW	O
was	O
defined	O
as	O
weight	O
at	O
birth	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
before	O
gestational	O
week	O
+	O
days	O
37	O
+	O
0	O
,	O
including	O
both	O
induced	O
and	O
spontaneous	O
preterm	O
delivery	O
.	O

Furthermore	O
,	O
individuals	O
with	O
sleep	O
disorders	O
may	O
be	O
predisposed	O
to	O
insulin	O
resistance	O
and	O
glucose	O
intolerance	O
due	O
to	O
sleep	O
-	O
related	O
dysregulation	O
of	O
the	O
HPA	O
axis	O
with	O
consequent	O
elevations	O
in	O
serum	O
cortisol	O
[	O
16	O
,	O
45	O
].	O

We	O
calculated	O
person	O
-	O
time	O
at	O
risk	O
for	O
each	O
child	O
up	O
to	O
the	O
date	O
a	O
child	O
reached	O
our	O
primary	O
endpoint	O
,	O
was	O
last	O
seen	O
at	O
the	O
end	O
of	O
our	O
study	O
,	O
or	O
when	O
censored	O
because	O
they	O
were	O
lost	O
to	O
follow	O
-	O
up	O
.	O

Also	O
we	O
exclude	O
twin	O
pregnancies	O
.	O

Feeding	O
medium	O
-	O
chain	O
TGs	O
,	O
such	O
as	O
coconut	O
oil	O
increased	O
the	O
lipid	O
content	O
in	O
the	O
liver	O
and	O
carcasses	O
of	O
Holstein	O
calves	O
under	O
cold	O
stress	O
[	O
104	O
].	O

In	O
Cameroon	O
,	O
there	O
are	O
few	O
reported	O
studies	O
on	O
the	O
quality	O
of	O
ANC	O
services	O
rendered	O
;	O
meanwhile	O
the	O
study	O
of	O
consumer	O
perceptions	O
in	O
relation	O
to	O
behavioral	O
outcomes	O
has	O
been	O
on	O
the	O
rise	O
in	O
other	O
countries	O
[	O
8	O
].	O

If	O
breastfeeding	O
is	O
not	O
possible	O
,	O
hydrolyzed	O
formulas	O
seem	O
to	O
confer	O
a	O
greater	O
protective	O
effect	O
than	O
traditional	O
formulas	O
.	O

Conclusions	O
Folic	O
acid	O
allergy	O
appears	O
to	O
be	O
rare	O
and	O
would	O
not	O
be	O
expected	O
to	O
be	O
well	O
known	O
among	O
health	O
providers	O
or	O
consumers	O
.	O

Vitamin	O
D	O
or	O
placebo	O
was	O
given	O
by	O
fieldworkers	O
once	O
every	O
3	O
months	O
for	O
18	O
months	O
.	O

RNA	O
was	O
polyadenylated	O
by	O
poly	O
(	O
A	O
)	O
polymerase	O
and	O
then	O
dissolved	O
and	O
reverse	O
transcribed	O
using	O
poly	O
(	O
T	O
)	O
adapter	O
.	O

In	O
this	O
study	O
,	O
BMI	O
and	O
percent	O
fat	O
were	O
analyzed	O
with	O
cathelicidin	O
concentrations	O
.	O

Our	O
findings	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
impact	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
for	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
on	O
early	O
infant	O
neurodevelopment	O
.	O

Investigation	O
of	O
the	O
vitamin	O
D	O
nutritional	O
status	O
in	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
in	O
Beijing	O
Abstract	O
Background	O
Vitamin	O
D	O
deficiency	O
is	O
a	O
common	O
issue	O
,	O
which	O
has	O
relation	O
with	O
GDM	O
,	O
during	O
the	O
pregnant	O
period	O
.	O

Recurrent	O
acral	O
angioosteoma	O
cutis	O
in	O
a	O
pregnant	O
patient	O
Introduction	O
Googe	O
et	O
al	O
in	O
2006	O
first	O
described	O
11	O
cases	O
of	O
acral	O
angioosteoma	O
cutis	O
(	O
AAOC	O
),	O
characterized	O
by	O
benign	O
vascular	O
and	O
osseous	O
lesions	O
on	O
acral	O
skin	O
.	O
1Since	O
then	O
,	O
there	O
have	O
been	O
only	O
3	O
additional	O
cases	O
reported	O
.	O
2	O
,	O
3	O
,	O
4This	O
friable	O
erythematous	O
exophytic	O
papule	O
has	O
clinical	O
resemblance	O
to	O
pyogenic	O
granuloma	O
(	O
PG	O
)	O
but	O
has	O
distinct	O
histologic	O
features	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
with	O
an	O
online	O
miRNA	O
prediction	O
tool	O
[	O
4	O
].	O

Returning	O
to	O
our	O
data	O
,	O
weight	O
recovery	O
in	O
offspring	O
may	O
occur	O
as	O
a	O
result	O
of	O
an	O
accelerated	O
catch	O
-	O
up	O
growth	O
before	O
birth	O
caused	O
by	O
an	O
ad	O
libitum	O
maternal	O
feeding	O
.	O

Optimal	O
management	O
of	O
these	O
disorders	O
during	O
pregnancy	O
is	O
vital	O
to	O
ensure	O
the	O
welfare	O
of	O
the	O
mother	O
and	O
the	O
baby	O
.	O

1	O
.	O

Upon	O
the	O
glucose	O
gavage	O
,	O
blood	O
glucose	O
concentrations	O
were	O
determined	O
15	O
and	O
60	O
min	O
later	O
and	O
the	O
incremental	O
area	O
under	O
the	O
curve	O
(	O
iAUC	O
)	O
was	O
calculated	O
.	O

Radioactive	O
iodine	O
is	O
ineffective	O
because	O
I	O
-	O
131	O
uptake	O
by	O
MTC	O
cells	O
is	O
negligible	O
.	O

linear	O
mixed	O
effects	O
models	O
),	O
adjusting	O
for	O
potential	O
time	O
-	O
dependent	O
and	O
static	O
covariates	O
.	O

Iron	O
deficiency	O
anaemia	O
accounts	O
for	O
75	O
–	O
95	O
%	O
of	O
cases	O
of	O
anaemia	O
in	O
pregnancy	O
[	O
9	O
].	O

showing	O
a	O
negative	O
correlation	O
between	O
dietary	O
PUFA	O
intake	O
and	O
the	O
severity	O
of	O
psychotic	O
symptoms	O
[	O
15	O
],	O
as	O
well	O
as	O
studies	O
showing	O
that	O
patients	O
with	O
schizophrenia	O
or	O
depression	O
have	O
lower	O
levels	O
of	O
PUFAs	O
in	O
brain	O
tissue	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblasts	O
and	O
with	O
a	O
low	O
intake	O
of	O
fish	O
and	O
PUFAs	O
[	O
16	O
,	O
29	O
-	O
31	O
].	O

Short	O
Communication	O
Congenital	O
abnormalities	O
are	O
the	O
leading	O
cause	O
of	O
infant	O
mortalities	O
in	O
the	O
United	O
States	O
(	O
25	O
%)	O
and	O
across	O
the	O
world	O
[	O
1	O
].	O

They	O
did	O
not	O
differ	O
concerning	O
the	O
two	O
above	O
-	O
mentioned	O
variables	O
,	O
P	O
=	O
0	O
.	O
09	O
and	O
p	O
=	O
0	O
.	O
13	O
,	O
respectively	O
.	O

Thus	O
the	O
experimental	O
data	O
will	O
complement	O
previous	O
findings	O
from	O
rodent	O
models	O
and	O
epidemiological	O
human	O
data	O
.	O

Any	O
misclassification	O
of	O
other	O
causes	O
of	O
raised	O
respiratory	O
rate	O
as	O
pneumonia	O
,	O
under	O
-	O
reporting	O
,	O
or	O
over	O
-	O
reporting	O
would	O
be	O
distributed	O
equally	O
between	O
the	O
two	O
groups	O
since	O
the	O
families	O
,	O
doctors	O
,	O
radiographers	O
,	O
radiologists	O
,	O
and	O
data	O
entry	O
staff	O
were	O
masked	O
to	O
the	O
randomisation	O
groupings	O
and	O
the	O
randomisation	O
was	O
successful	O
since	O
the	O
characteristics	O
were	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

But	O
neither	O
body	O
weight	O
at	O
weaning	O
nor	O
body	O
weight	O
at	O
188	O
dpn	O
differed	O
significantly	O
among	O
offspring	O
of	O
the	O
LP	O
and	O
the	O
AP	O
group	O
,	O
whereas	O
visceral	O
and	O
subcutaneous	O
fat	O
content	O
remained	O
higher	O
in	O
LP	O
than	O
in	O
AP	O
during	O
postnatal	O
life	O
[	O
15	O
-	O
17	O
].	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

It	O
is	O
known	O
that	O
down	O
-	O
regulation	O
of	O
calcium	O
binding	O
proteins	O
shift	O
essential	O
calcium	O
buffering	O
requirements	O
to	O
the	O
mitochondrial	O
compartment	O
,	O
which	O
,	O
in	O
turn	O
,	O
leads	O
to	O
compromised	O
mitochondrial	O
energy	O
production	O
[	O
34	O
].	O

Attributes	O
of	O
the	O
delivery	O
room	O
and	O
birthing	O
experience	O
also	O
may	O
have	O
a	O
role	O
in	O
autism	O
.	O

Research	O
assistants	O
used	O
Harpenden	O
skin	O
-	O
fold	O
callipers	O
to	O
obtain	O
skinfold	O
thickness	O
measurements	O
,	O
and	O
received	O
ongoing	O
standardised	O
training	O
[	O
29	O
].	O

Previous	O
findings	O
from	O
the	O
GraviD	O
study	O
show	O
lower	O
odds	O
of	O
preeclampsia	O
among	O
women	O
with	O
a	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
in	O
25OHD	O
[	O
3	O
].	O

Consequently	O
,	O
the	O
recommendations	O
for	O
primary	O
and	O
secondary	O
preventive	O
measures	O
are	O
also	O
very	O
limited	O
in	O
number	O
and	O
verification	O
.	O

Suzuki	O
et	O
al	O
.	O

But	O
she	O
will	O
need	O
to	O
consume	O
much	O
more	O
to	O
obtain	O
this	O
daily	O
requirement	O
(	O
i	O
.	O
e	O
.,	O
between	O
20	O
and	O
48	O
mg	O
of	O
dietary	O
iron	O
)	O
[	O
18	O
].	O

Data	O
include	O
date	O
and	O
country	O
of	O
birth	O
,	O
marital	O
status	O
,	O
educational	O
level	O
,	O
home	O
language	O
,	O
employment	O
status	O
,	O
household	O
income	O
,	O
number	O
of	O
members	O
in	O
the	O
household	O
,	O
and	O
beneficiaries	O
of	O
social	O
grants	O
.	O

2	O
.	O
2	O
.	O

Exclusion	O
criteria	O
were	O
avoiding	O
of	O
follow	O
-	O
up	O
during	O
the	O
study	O
and	O
current	O
-	O
smoker	O
women	O
.	O

Several	O
of	O
the	O
components	O
of	O
the	O
network	O
converge	O
on	O
MAPK1	O
,	O
a	O
MAP	O
kinase	O
that	O
serves	O
to	O
integrate	O
multiple	O
biochemical	O
signals	O
(	O
previously	O
known	O
as	O
ERK2	O
),	O
that	O
was	O
found	O
to	O
be	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
proteomics	O
study	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Network	O
analysis	O
of	O
the	O
proteins	O
assembled	O
by	O
Ingenuity	O
Pathway	O
Analysis	O
.	O

Therefore	O
,	O
fetal	O
nutritional	O
programming	O
via	O
nutrition	O
of	O
dams	O
during	O
gestation	O
may	O
be	O
one	O
way	O
to	O
increase	O
marbling	O
in	O
offspring	O
later	O
in	O
life	O
.	O

Further	O
study	O
is	O
needed	O
to	O
confirm	O
this	O
.	O

This	O
correlation	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

Secondly	O
,	O
the	O
possible	O
presence	O
of	O
associated	O
conditions	O
,	O
such	O
as	O
pheochromocytoma	O
,	O
should	O
be	O
recognized	O
before	O
submitting	O
patients	O
to	O
thyroidectomy	O
.	O

In	O
the	O
1980s	O
,	O
with	O
routine	O
treatment	O
for	O
women	O
with	O
mild	O
GDM	O
,	O
their	O
outcomes	O
were	O
not	O
different	O
to	O
women	O
with	O
normal	O
glucose	O
tolerance	O
.	O

In	O
this	O
issue	O
of	O
Journal	O
of	O
Clinical	O
and	O
Translational	O
Endocrinology	O
,	O
Alissa	O
et	O
al	O
.	O

Some	O
sires	O
may	O
have	O
high	O
breeding	O
value	O
for	O
both	O
IMF	O
and	O
YG	O
,	O
and	O
selection	O
of	O
such	O
sires	O
is	O
likely	O
to	O
be	O
beneficial	O
for	O
increasing	O
IMF	O
deposition	O
without	O
decreasing	O
YG	O
.	O

The	O
percentage	O
of	O
women	O
with	O
vitamin	O
D	O
insufficiency	O
and	O
deficiency	O
was	O
higher	O
in	O
the	O
first	O
than	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
but	O
the	O
prevalence	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
higher	O
in	O
the	O
third	O
trimester	O
(	O
Table	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
(	O
Belgian	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
,	O
2010	O
–	O
2011	O
).	O
All	O
womenWalloniaFlanders1sttrimester3rdtrimesterN1300453633633665Age28	O
.	O
5	O
±	O
5	O
.	O
127	O
.	O
9	O
±	O
5	O
.	O
528	O
.	O
8	O
±	O
4	O
.	O
728	O
.	O
3	O
±	O
5	O
.	O
128	O
.	O
8	O
±	O
5	O
.	O
1Gestational	O
weeks22	O
.	O
2	O
±	O
12	O
.	O
522	O
.	O
1	O
±	O
12	O
.	O
822	O
.	O
4	O
±	O
12	O
.	O
39	O
.	O
9	O
±	O
2	O
.	O
834	O
.	O
1	O
±	O
3	O
.	O
625	O
-(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
ml	O
)	O
Median21	O
.	O
220	O
.	O
922	O
.	O
320	O
.	O
422	O
.	O
7	O
*	O
IQR13	O
.	O
8	O
–	O
30	O
.	O
013	O
.	O
5	O
–	O
29	O
.	O
114	O
.	O
6	O
–	O
30	O
.	O
613	O
.	O
6	O
–	O
26	O
.	O
714	O
.	O
3	O
–	O
34	O
.	O
195	O
%	O
CI20	O
.	O
5	O
–	O
22	O
.	O
219	O
.	O
8	O
–	O
22	O
.	O
321	O
.	O
2	O
–	O
23	O
.	O
219	O
.	O
3	O
–	O
21	O
.	O
121	O
.	O
6	O
–	O
24	O
.	O
4	O
%	O
<	O
10	O
ng	O
/	O
ml12	O
.	O
112	O
.	O
310	O
.	O
911	O
.	O
612	O
.	O
6	O
%	O
<	O
20	O
ng	O
/	O
ml44	O
.	O
645	O
.	O
742	O
.	O
347	O
.	O
042	O
.	O
3	O
%	O
<	O
30	O
ng	O
/	O
ml74	O
.	O
176	O
.	O
372	O
.	O
582	O
.	O
266	O
.	O
7	O
Different	O
from	O
first	O
trimester	O
pregnant	O
women	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

Multiple	O
linear	O
regression	O
,	O
model	O
-	O
based	O
clustering	O
methods	O
,	O
and	O
gene	O
set	O
enrichment	O
analysis	O
examined	O
the	O
association	O
between	O
birth	O
weight	O
percentile	O
,	O
demographic	O
variables	O
,	O
and	O
repetitive	O
element	O
methylation	O
and	O
gene	O
-	O
associated	O
CpG	O
locus	O
methylation	O
.	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
University	O
of	O
Toronto	O
Animal	O
Care	O
Committee	O
.	O

A	O
putative	O
decrease	O
in	O
hypothalamic	O
sensitivity	O
to	O
leptin	O
may	O
result	O
in	O
an	O
inability	O
to	O
detect	O
satiety	O
despite	O
the	O
fat	O
stores	O
,	O
which	O
finally	O
develop	O
to	O
obesity	O
(	O
Sasaki	O
,	O
2015	O
).	O

However	O
,	O
we	O
detected	O
a	O
main	O
effect	O
of	O
treatment	O
on	O
chocolate	O
intake	O
[	O
F	O
(	O
3	O
,	O
30	O
)=	O
9	O
.	O
917	O
,	O
P	O
<	O
0	O
.	O
01	O
]	O
and	O
total	O
caloric	O
intake	O
[	O
F	O
(	O
3	O
,	O
30	O
)=	O
11	O
.	O
189	O
,	O
P	O
<	O
0	O
.	O
01	O
].	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
calorict	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
transcription	O
factors	O
(	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
)	O
regulating	O
the	O
expression	O
of	O
genes	O
implicated	O
in	O
lipid	O
and	O
carbohydrate	O
metabolism	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure6	O
).	O

We	O
also	O
report	O
unadjusted	O
estimates	O
for	O
analyses	O
and	O
analyses	O
further	O
adjusted	O
for	O
infant	O
age	O
at	O
sample	O
collection	O
in	O
the	O
supplemental	O
information	O
.	O

The	O
total	O
mean	O
was	O
19	O
.	O
4	O
±	O
3	O
.	O
9	O
ng	O
/	O
mL	O
[	O
56	O
].	O

Such	O
benefits	O
are	O
not	O
just	O
limited	O
to	O
nutrition	O
;	O
advantageous	O
chemically	O
induced	O
epigenetic	O
changes	O
have	O
also	O
been	O
reported	O
.	O

One	O
study	O
observed	O
that	O
maternal	O
high	O
-	O
fat	O
diet	O
during	O
pregnancy	O
was	O
associated	O
with	O
meconium	O
microbial	O
composition	O
but	O
had	O
limited	O
maternal	O
diet	O
data	O
[	O
6	O
].	O

In	O
their	O
study	O
,	O
genotype	O
differences	O
were	O
generally	O
observed	O
in	O
IMF	O
contents	O
of	O
4	O
muscles	O
(	O
biceps	O
femoris	O
,	O
supraspinatus	O
,	O
semitendinosus	O
,	O
longissimus	O
lumborum	O
,	O
and	O
infraspinatus	O
),	O
although	O
semitendinosus	O
muscle	O
IMF	O
did	O
not	O
differ	O
among	O
genotypes	O
.	O

On	O
the	O
basis	O
of	O
these	O
criteria	O
,	O
we	O
controlled	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

Priority	O
questions	O
:	O
What	O
are	O
the	O
detailed	O
mechanism	O
(	O
s	O
)	O
that	O
link	O
a	O
particular	O
exposure	O
to	O
a	O
specific	O
adverse	O
effect	O
?	O

Of	O
these	O
,	O
423	O
probe	O
-	O
sets	O
showed	O
an	O
increased	O
mRNA	O
expression	O
.	O

In	O
addition	O
,	O
regarding	O
the	O
distribution	O
of	O
the	O
women	O
across	O
categories	O
of	O
western	O
dietary	O
pattern	O
,	O
it	O
was	O
found	O
that	O
those	O
with	O
the	O
highest	O
adherence	O
had	O
significantly	O
higher	O
social	O
-	O
economic	O
level	O
,	O
employed	O
husband	O
,	O
history	O
of	O
cesarean	O
,	O
and	O
less	O
IUGR	O
and	O
stillbirth	O
history	O
.	O

In	O
inherited	O
forms	O
,	O
the	O
initial	O
germline	O
mutation	O
produces	O
multiple	O
foci	O
of	O
cells	O
–	O
the	O
so	O
-	O
called	O
C	O
-	O
cell	O
hyperplasia	O
–	O
that	O
are	O
susceptible	O
to	O
tumour	O
formation	O
,	O
and	O
each	O
MTC	O
is	O
the	O
result	O
of	O
a	O
second	O
cell	O
transformation	O
in	O
one	O
of	O
these	O
susceptible	O
clones	O
.	O

Gels	O
were	O
scanned	O
using	O
a	O
transmissive	O
,	O
flatbed	O
scanner	O
(	O
UMAX	O
)	O
and	O
analyzed	O
using	O
Phoretix	O
2D	O
Expression	O
software	O
(	O
Nonlinear	O
Dynamics	O
,	O
Newcastle	O
-	O
upon	O
-	O
Tyne	O
,	O
UK	O
).	O

This	O
was	O
further	O
substantiated	O
in	O
our	O
bioinformatically	O
informed	O
classification	O
analysis	O
,	O
because	O
we	O
identified	O
a	O
significant	O
association	O
between	O
AluYb8	O
methylation	O
and	O
methylation	O
of	O
a	O
group	O
of	O
loci	O
defined	O
by	O
their	O
position	O
in	O
a	O
CGI	O
,	O
PcG	O
target	O
gene	O
,	O
and	O
a	O
TFBS	O
,	O
as	O
well	O
CpGs	O
defined	O
by	O
association	O
with	O
a	O
PcG	O
target	O
gene	O
and	O
LINE	O
-	O
2	O
element	O
and	O
proximal	O
to	O
a	O
TFBS	O
.	O

The	O
effect	O
of	O
maternal	O
diet	O
on	O
child	O
leukemia	O
risk	O
has	O
not	O
been	O
rigorously	O
studied	O
;	O
the	O
few	O
studies	O
that	O
have	O
been	O
done	O
have	O
focused	O
on	O
specific	O
dietary	O
factors	O
,	O
and	O
the	O
results	O
have	O
been	O
mixed	O
.	O

At	O
weaning	O
,	O
10	O
male	O
offspring	O
(	O
one	O
per	O
dam	O
)	O
per	O
gestational	O
diet	O
group	O
were	O
terminated	O
.	O

Maternal	O
iron	O
deficiency	O
and	O
anemia	O
early	O
in	O
gestation	O
can	O
result	O
in	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

Here	O
the	O
focus	O
is	O
on	O
the	O
hepatic	O
transcriptomic	O
response	O
.	O

When	O
dividing	O
the	O
cohort	O
by	O
vitamin	O
D	O
sufficiency	O
status	O
for	O
additional	O
analyses	O
,	O
vitamin	O
D	O
deficiency	O
was	O
defined	O
as	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)).	O

Pollutants	O
,	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
,	O
artificial	O
insemination	O
,	O
and	O
fertility	O
medications	O
may	O
have	O
a	O
link	O
,	O
but	O
results	O
are	O
often	O
conflicted	O
.	O

The	O
study	O
was	O
able	O
to	O
adjust	O
for	O
several	O
important	O
confounds	O
,	O
including	O
length	O
of	O
gestation	O
and	O
infant	O
sex	O
;	O
however	O
,	O
the	O
sample	O
size	O
was	O
moderate	O
,	O
and	O
only	O
69	O
%	O
of	O
the	O
offspring	O
(	O
mostly	O
non	O
-	O
Hispanic	O
White	O
)	O
had	O
data	O
available	O
at	O
6	O
months	O
.	O

Again	O
,	O
the	O
resources	O
and	O
intensive	O
psychology	O
training	O
required	O
to	O
administer	O
,	O
for	O
example	O
,	O
the	O
more	O
complex	B
Bayley	O
Scale	O
,	O
while	O
generating	O
more	O
detailed	O
information	O
,	O
was	O
not	O
considered	O
feasible	O
in	O
our	O
study	O
population	O
.	O

'	O
AMPK	O
signaling	O
'	O
is	O
a	O
metabolic	O
pathway	O
which	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
lipid	O
and	O
energy	O
metabolism	O
in	O
mammalian	O
cells	O
[	O
51	O
-	O
56	O
].	O

The	O
RNA	O
samples	O
were	O
visualised	O
on	O
1	O
%	O
agarose	O
gels	O
containing	O
ethidium	O
bromide	O
to	O
check	O
RNA	O
integrity	O
.	O

The	O
inclusion	O
and	O
exclusion	O
criteria	O
for	O
participants	O
were	O
designed	O
as	O
such	O
to	O
obtain	O
a	O
sample	O
of	O
generally	O
healthy	O
women	O
,	O
who	O
are	O
able	O
to	O
speak	O
the	O
local	O
language	O
and	O
who	O
could	O
be	O
followed	O
-	O
up	O
from	O
early	O
pregnancy	O
until	O
the	O
infants	O
are	O
12	O
months	O
old	O
.	O

Much	O
like	O
anticonvulsants	O
and	O
other	O
drug	O
exposures	O
,	O
the	O
use	O
of	O
SSRIs	O
in	O
pregnant	O
women	O
and	O
its	O
association	O
to	O
autism	O
have	O
been	O
explored	O
.	O

Guidelines	O
could	O
be	O
developed	O
for	O
improved	O
molecular	O
(	O
in	O
vivo	O
,	O
in	O
vitro	O
and	O
epidemiological	O
)	O
and	O
bioinformatic	O
study	O
designs	O
that	O
incorporate	O
suitable	O
new	O
technologies	O
(	O
such	O
as	O
omics	O
platforms	O
)	O
and	O
appropriate	O
inhibitors	O
/	O
treatments	O
/	O
cessations	O
(	O
for	O
exposure	O
/	O
change	O
/	O
effect	O
validation	O
)	O
to	O
definitively	O
identify	O
detailed	O
epigenetic	O
mechanisms	O
that	O
link	O
,	O
or	O
act	O
as	O
markers	O
of	O
,	O
environmental	O
exposures	O
and	O
adverse	O
health	O
outcomes	O
.	O

Expression	O
of	O
other	O
genes	O
was	O
unaffected	O
.	O

We	O
will	O
train	O
the	O
evaluation	O
team	O
over	O
a	O
four	O
-	O
week	O
period	O
,	O
and	O
standardize	O
measurement	O
methods	O
and	O
retrain	O
as	O
needed	O
every	O
six	O
months	O
.	O

2010	O
).	O

In	O
rodents	O
,	O
many	O
studies	O
reported	O
an	O
impact	O
of	O
maternal	O
low	O
protein	O
diets	O
on	O
expression	O
and	O
affinity	O
of	O
the	O
glucocorticoid	O
receptor	O
and	O
its	O
signaling	O
molecules	O
[	O
8	O
,	O
48	O
,	O
59	O
-	O
61	O
].	O

Authors	O
’	O
contributions	O
All	O
authors	O
listed	O
have	O
contributed	O
sufficiently	O
to	O
the	O
project	O
to	O
be	O
included	O
as	O
authors	O
,	O
and	O
all	O
those	O
who	O
are	O
qualified	O
to	O
be	O
authors	O
are	O
listed	O
in	O
the	O
author	O
byline	O
.	O

A	O
negative	O
correlation	O
was	O
observed	O
between	O
serum	O
retinol	O
concentrations	O
and	O
carcass	O
MS	O
values	O
in	O
Japanese	O
Black	O
cattle	O
[	O
130	O
,	O
131	O
].	O

Randomisation	O
was	O
by	O
use	O
of	O
a	O
computer	O
-	O
generated	O
list	O
.	O

A	O
population	O
-	O
based	O
study	O
in	O
Utah	O
(	O
US	O
)	O
looked	O
at	O
prenatal	O
variables	O
of	O
autistic	O
children	O
and	O
focused	O
on	O
gestational	O
weight	O
.	O

Chi	O
-	O
square	O
test	O
was	O
used	O
to	O
examine	O
significant	O
differences	O
in	O
the	O
distribution	O
of	O
study	O
participants	O
in	O
terms	O
of	O
categorical	O
variables	O
across	O
different	O
quintile	O
categories	O
of	O
dietary	O
pattern	O
scores	O
.	O

Overall	O
,	O
the	O
Ministry	O
of	O
Women	O
and	O
Child	O
Development	O
has	O
been	O
given	O
the	O
responsibility	O
to	O
coordinate	O
monitoring	O
at	O
different	O
levels	O
(	O
5	O
).	O

A	O
possible	O
increase	O
in	O
the	O
rate	O
of	O
miscarriages	O
has	O
been	O
reported	O
to	O
occur	O
in	O
the	O
early	O
period	O
after	O
therapy	O
,	O
but	O
it	O
remains	O
uncertain	O
whether	O
abortion	O
can	O
be	O
caused	O
either	O
by	O
I	O
-	O
131	O
itself	O
,	O
by	O
the	O
thyroid	O
autoimmunity	O
often	O
associated	O
with	O
disease	O
or	O
by	O
the	O
hypothyroid	O
-	O
hyperprolactinaemic	O
status	O
accompanying	O
I	O
-	O
131	O
therapy	O
.	O

At	O
the	O
end	O
of	O
each	O
interview	O
,	O
the	O
data	O
collector	O
will	O
store	O
the	O
data	O
on	O
the	O
local	O
device	O
and	O
then	O
upload	O
the	O
data	O
to	O
the	O
central	O
server	O
after	O
the	O
end	O
of	O
a	O
day	O
’	O
s	O
work	O
.	O

Additionally	O
,	O
these	O
women	O
may	O
choose	O
to	O
eat	O
traditional	O
foods	O
[	O
82	O
]	O
that	O
do	O
not	O
form	O
part	O
of	O
the	O
South	O
African	O
Food	O
Database	O
for	O
nutritional	O
analysis	O
;	O
and	O
may	O
not	O
be	O
able	O
to	O
speak	O
a	O
local	O
language	O
[	O
83	O
]	O
hampering	B
detailed	O
reporting	O
during	O
dietary	O
assessments	O
.	O

There	O
were	O
post	O
-	O
natal	O
lectures	O
on	O
the	O
immediate	O
care	O
of	O
the	O
newborn	O
and	O
breastfeeding	O
.	O

Nevertheless	O
,	O
they	O
do	O
set	O
a	O
precedent	O
for	O
the	O
existence	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
,	O
and	O
provide	O
tools	O
for	O
linking	O
environmental	O
exposures	O
to	O
adverse	O
health	O
outcomes	O
.	O

A	O
smaller	O
sample	O
size	O
of	O
570	O
women	O
/	O
arm	O
or	O
40	O
pregnant	O
women	O
from	O
28	O
clusters	O
is	O
needed	O
to	O
detect	O
a	O
30	O
%	O
reduction	O
in	O
LBW	O
with	O
the	O
same	O
assumptions	O
.	O

Thus	O
,	O
these	O
neuropeptides	O
are	O
of	O
interest	O
as	O
potential	O
targets	O
for	O
novel	O
antipsychotic	O
agents	O
[	O
39	O
],[	O
40	O
].	O

The	O
children	O
of	O
mothers	O
participating	O
in	O
the	O
NICHD	O
trial	O
were	O
then	O
seen	O
at	O
yearly	O
follow	O
-	O
up	O
visits	O
for	O
three	O
years	O
between	O
the	O
ages	O
of	O
2	O
and	O
7	O
as	O
part	O
of	O
an	O
IRB	O
-	O
approved	O
follow	O
-	O
up	O
study	O
funded	O
by	O
the	O
Thrasher	O
Research	O
Fund	O
(	O
HR	O
#	O
19641	O
,	O
CTRC	O
protocol	O
870	O
).	O

A	O
large	O
literature	O
primarily	O
focused	O
on	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
suggest	O
that	O
sleep	O
loss	O
adversely	O
affects	O
glucose	O
metabolism	O
and	O
increases	O
the	O
risk	O
of	O
type	O
2	O
diabetes	O
[	O
4	O
,	O
11	O
,	O
16	O
,	O
32	O
-	O
35	O
].	O

Only	O
4	O
%	O
of	O
women	O
treated	O
with	O
glyburide	O
achieved	O
inadequate	O
control	O
and	O
required	O
a	O
switch	O
to	O
insulin	O
.	O

The	O
use	O
of	O
forward	O
primers	O
containing	O
one	O
of	O
eight	O
five	O
-	O
nucleotide	O
barcodes	O
between	O
the	O
Illumina	O
-	O
specific	O
bridge	O
and	O
sequencing	O
primer	O
regions	O
and	O
the	O
16S	O
-	O
specific	O
region	O
and	O
a	O
single	O
reverse	O
primer	O
containing	O
1	O
of	O
12	O
Illumina	O
indices	O
enables	O
96	O
samples	O
per	O
lane	O
multiplexing	O
.	O

With	O
good	O
medical	O
and	O
obstetric	O
care	O
,	O
the	O
risks	O
to	O
the	O
pregnancy	O
should	O
be	O
minimal	O
.	O

Differences	O
of	O
longitudinal	O
ontogenetic	O
regulation	O
among	O
LP	O
and	O
AP	O
offspring	O
Considering	O
two	O
adjacent	O
ontogenetic	O
stages	O
within	O
one	O
treatment	O
group	O
,	O
significantly	O
regulated	O
transcripts	O
were	O
determined	O
.	O

HELLP	O
syndrome	O
is	O
considered	O
a	O
spectrum	O
of	O
preeclampsia	O
.	O

Maternal	O
characteristics	O
which	O
differed	O
across	O
quintiles	O
of	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
included	O
age	O
,	O
parity	O
,	O
pregnancy	O
size	O
,	O
season	O
of	O
birth	O
,	O
breastfeeding	O
duration	O
,	O
educational	O
level	O
,	O
ethnicity	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
anxiety	O
level	O
,	O
tobacco	O
exposure	O
and	O
infection	O
during	O
pregnancy	O
.	O

Briefly	O
,	O
high	O
-	O
quality	O
forage	O
is	O
fed	O
ad	O
libitum	O
to	O
develop	O
the	O
rumen	O
during	O
the	O
growing	O
stage	O
(	O
7	O
to	O
12	O
months	O
of	O
age	O
),	O
and	O
the	O
concentrate	O
(	O
CP	O
15	O
%	O
to	O
16	O
%,	O
TDN	O
69	O
%	O
to	O
70	O
%)	O
is	O
restricted	O
to	O
1	O
.	O
5	O
%	O
to	O
1	O
.	O
6	O
%	O
of	O
body	O
weight	O
at	O
this	O
time	O
.	O

The	O
drop	O
-	O
outs	O
had	O
a	O
slightly	O
higher	O
BMI	O
,	O
lower	O
education	O
and	O
were	O
more	O
often	O
smokers	O
and	O
born	O
outside	O
of	O
the	O
Nordic	O
countries	O
.	O

To	O
study	O
the	O
Vitamin	O
D	O
nutritional	O
status	O
of	O
pregnant	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
and	O
analyze	O
the	O
different	O
sources	O
of	O
Vitamin	O
D	O
intake	O
.	O

For	O
a	O
description	O
of	O
placental	O
tissue	O
use	O
,	O
DNA	O
extraction	O
,	O
and	O
DNA	O
purification	O
procedures	O
,	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
).	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
feeding	O
response	O
to	O
AM251	O
in	O
adult	O
offspring	O
The	O
feeding	O
behavior	O
to	O
AM251	O
(	O
chocolate	O
and	O
total	O
caloric	O
intake	O
)	O
was	O
evaluated	O
for	O
4	O
h	O
in	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
13	O
–	O
14	O
(	O
Figures3E	O
–	O
H	O
).	O

Epigenetic	O
regulation	O
of	O
gene	O
expression	O
.	O

The	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
the	O
same	O
as	O
for	O
nonpregnant	O
patients	O
.	O

These	O
effects	O
extended	O
to	O
lipid	O
and	O
cholesterol	O
metabolic	O
pathways	O
,	O
suggesting	O
the	O
existence	O
of	O
a	O
complex	B
pattern	O
alterations	O
derived	O
of	O
adaptation	O
to	O
maternal	O
malnutrition	O
.	O

It	O
is	O
noteworthy	O
that	O
there	O
are	O
few	O
studies	O
assessing	O
the	O
birth	O
anthropometric	O
measurements	O
along	O
the	O
maternal	O
dietary	O
patterns	O
[	O
16	O
].	O

The	O
effect	O
of	O
breastfeeding	O
on	O
the	O
prevention	O
AM	O
is	O
unresolved	O
.	O

We	O
will	O
conduct	O
analyses	O
to	O
identify	O
the	O
subgroups	O
(	O
based	O
on	O
household	O
wealth	O
,	O
sex	O
of	O
infant	O
and	O
maternal	O
education	O
)	O
that	O
modify	O
the	O
response	O
to	O
the	O
intervention	O
.	O

Tissue	O
-	O
specific	O
FGF21	O
regulation	O
was	O
shown	O
to	O
occur	O
in	O
response	O
to	O
chronic	O
cold	O
exposure	O
in	O
mice	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

These	O
changes	O
include	O
increased	O
total	O
circulatory	O
volume	O
,	O
increased	O
systemic	O
blood	O
pressure	O
,	O
and	O
structural	O
changes	O
in	O
the	O
aortic	O
wall	O
secondary	O
to	O
the	O
hormonal	O
effects	O
of	O
estrogen	O
and	O
progesterone	O
[	O
4	O
].	O

The	O
HDL	O
was	O
10	O
-	O
fold	O
reduced	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
indicates	O
a	O
significant	O
reduction	O
of	O
the	O
outlet	O
rate	O
of	O
fat	O
molecules	O
(	O
cholesterol	O
,	O
phospholipids	O
and	O
triglycerides	O
)	O
from	O
cells	O
.	O

We	O
used	O
the	O
elbow	O
method	O
to	O
determine	O
the	O
optimal	O
number	O
of	O
clusters	O
,	O
which	O
is	O
based	O
on	O
the	O
within	O
-	O
cluster	O
sum	O
of	O
squares	O
.	O

Specifically	O
they	O
were	O
asked	O
"	O
Since	O
becoming	O
pregnant	O
,	O
when	O
you	O
are	O
asleep	O
,	O
to	O
the	O
best	O
of	O
your	O
knowledge	O
,	O
have	O
you	O
snored	O
?"	O

To	O
investigate	O
the	O
association	O
between	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
,	O
we	O
used	O
multivariable	O
logistic	O
regression	O
models	O
controlled	O
for	O
energy	O
intake	O
,	O
age	O
,	O
and	O
BMI	O
.	O

Another	O
point	O
that	O
needs	O
to	O
be	O
considered	O
is	O
the	O
measurements	O
error	O
in	O
nutritional	O
assessment	O
;	O
this	O
may	O
increase	O
the	O
likelihood	O
of	O
misclassification	O
,	O
contributing	O
to	O
the	O
discrepancy	O
among	O
our	O
results	O
.	O

In	O
fact	O
,	O
newborns	O
from	O
sows	O
that	O
received	O
a	O
low	O
protein	O
supply	O
during	O
gestation	O
had	O
a	O
significantly	O
lower	O
birth	O
weight	O
,	O
a	O
lower	O
body	O
fat	O
content	O
,	O
reduced	O
size	O
and	O
number	O
of	O
adipocytes	O
and	O
muscle	O
fibres	O
than	O
newborns	O
of	O
the	O
control	O
group	O
.	O

A	O
recent	O
cohort	O
study	O
of	O
live	O
births	O
in	O
Denmark	O
from	O
1996	O
to	O
2005	O
involving	O
3	O
,	O
892	O
cases	O
of	O
ASD	O
found	O
no	O
significant	O
association	O
,	O
as	O
only	O
52	O
cases	O
of	O
SSRI	O
use	O
were	O
found	O
[	O
39	O
].	O

Its	O
pathophysiology	O
is	O
thought	O
to	O
result	O
from	O
increased	O
degradation	O
of	O
arginine	O
vasopressin	O
(	O
AVP	O
)	O
by	O
a	O
placental	O
enzyme	O
called	O
vasopressinase	O
.	O

Here	O
,	O
no	O
confounders	O
were	O
included	O
due	O
to	O
the	O
small	O
number	O
of	O
cases	O
(	O
N	O
=	O
9	O
).	O

The	O
average	O
intake	O
of	O
food	O
items	O
from	O
the	O
FFQ	O
were	O
converted	O
into	O
average	O
intake	O
of	O
energy	O
and	O
nutrients	O
by	O
linkage	O
to	O
the	O
database	O
of	O
nutrients	O
created	O
by	O
the	O
Swedish	O
National	O
Food	O
Administration	O
[	O
27	O
].	O

In	O
addition	O
,	O
not	O
all	O
of	O
the	O
spermatozoal	O
histones	O
are	O
replaced	O
with	O
protamines	O
during	O
spermiogenesis	O
,	O
up	O
to	O
15	O
%	O
of	O
histones	O
within	O
human	O
spermatozoa	O
and	O
1	O
%	O
in	O
mouse	O
spermatozoa	O
are	O
retained	O
(	O
Miller	O
et	O
al	O
.	O
2010	O
;	O
Carrell2012	O
).	O

The	O
normal	O
BMI	O
range	O
is	O
18	O
.	O
5	O
–	O
25	O
kg	O
/	O
m2	O
,	O
although	O
the	O
range	O
may	O
vary	O
for	O
different	O
countries	O
.	O

The	O
research	O
team	O
took	O
written	O
approval	O
for	O
the	O
study	O
from	O
Directorate	O
General	O
of	O
Health	O
Service	O
(	O
DGHS	O
)	O
under	O
Ministry	O
of	O
Health	O
&	O
Family	O
Welfare	O
before	O
allocating	O
the	O
clusters	O
to	O
a	O
treatment	O
group	O
or	O
the	O
trial	O
interventions	O
begin	O
.	O

Women	O
of	O
high	O
educational	O
level	O
were	O
the	O
most	O
interested	O
in	O
the	O
health	O
talk	O
recommendation	O
(	O
76	O
%	O
of	O
all	O
recommendations	O
were	O
made	O
by	O
this	O
class	O
of	O
respondents	O
),	O
arguing	O
that	O
the	O
“	O
lectures	O
”	O
should	O
be	O
more	O
detailed	O
than	O
what	O
they	O
were	O
at	O
the	O
moment	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Comparison	O
of	O
socio	O
-	O
demographic	O
characteristics	O
with	O
respondent	O
'	O
s	O
knowledge	O
about	O
when	O
to	O
start	O
ANC	O
visits	O
and	O
the	O
number	O
of	O
visitsSocio	O
-	O
demographic	O
characteristicFisher	O
'	O
s	O
exact	O
test	O
(	O
N	O
=	O
385	O
)	O
=	O
x	O
p	O
-	O
valueWhen	O
to	O
start	O
ANCMarital	O
status2	O
.	O
220	O
.	O
55Age	O
group16	O
.	O
560	O
.	O
09Pregnancy	O
number10	O
.	O
230	O
.	O
46Number	O
of	O
visit8	O
.	O
130	O
.	O
039	O
+	O
Educational	O
level7	O
.	O
690	O
.	O
27How	O
many	O
visits	O
to	O
attendMarital	O
status7	O
.	O
80	O
.	O
049	O
+	O
Age	O
group36	O
.	O
040	O
.	O
000	O
+	O
Pregnancy	O
number18	O
.	O
970	O
.	O
000	O
+	O
Number	O
of	O
visit1	O
.	O
0750	O
.	O
81Educational	O
level11	O
.	O
320	O
.	O
065	O
statistically	O
significant	O
Primigravida	O
,	O
younger	O
and	O
single	O
women	O
were	O
less	O
likely	O
to	O
know	O
how	O
many	O
ANC	O
visits	O
they	O
were	O
expected	O
to	O
attend	O
during	O
their	O
gestational	O
period	O
when	O
compared	O
to	O
older	O
and	O
multiparous	O
womenPTable	O
2	O
).	O

In	O
a	O
population	O
-	O
based	O
prospective	O
study	O
,	O
it	O
has	O
been	O
shown	O
that	O
women	O
in	O
the	O
“	O
wheat	O
products	O
”	O
pattern	O
had	O
higher	O
odds	O
of	O
having	O
infants	O
with	O
the	O
low	O
birth	O
weight	O
and	O
head	O
circumference	O
compared	O
with	O
women	O
in	O
the	O
“	O
rice	O
,	O
fish	O
,	O
and	O
vegetables	O
”	O
pattern	O
[	O
24	O
].	O

(	O
2015	O
)	O
described	O
a	O
protective	O
effect	O
of	O
early	O
(	O
in	O
utero	O
through	O
lactation	O
)	O
exposure	O
to	O
dietary	O
omega	O
-	O
3	O
fatty	O
acids	O
on	O
neuroplasticity	O
in	O
rats	O
that	O
involved	O
specific	O
changes	O
in	O
DNA	O
methylation	O
.	O

In	O
a	O
study	O
by	O
Mozaffari	O
-	O
Khosravi	O
et	O
al	O
.,	O
high	O
doses	O
of	O
vitamin	O
D	O
have	O
been	O
effective	O
in	O
men	O
and	O
women	O
who	O
were	O
depressed	O
[	O
30	O
].	O

For	O
a	O
second	O
filtering	O
step	O
standard	O
deviations	O
were	O
calculated	O
for	O
each	O
probe	O
-	O
set	O
over	O
all	O
subsets	O
of	O
arrays	O
of	O
the	O
particular	O
comparisons	O
.	O

PubMed	O
Central	O
:	O

The	O
main	O
positive	O
findings	O
of	O
our	O
study	O
are	O
summarised	O
infigure	O
1	O
.	O

Further	O
studies	O
are	O
required	O
to	O
confirm	O
these	O
findings	O
.	O

Women	O
who	O
stated	O
that	O
they	O
had	O
received	O
dietary	O
or	O
breastfeeding	O
advice	O
had	O
a	O
higher	O
probability	O
of	O
using	O
folic	O
acid	O
or	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

This	O
association	O
was	O
not	O
significant	O
for	O
fish	O
consumption	O
in	O
early	O
pregnancy	O
(	O
15	O
weeks	O
gestation	O
)	O
suggesting	O
that	O
fish	O
consumption	O
may	O
be	O
of	O
more	O
benefit	O
during	O
the	O
third	O
trimester	O
[	O
21	O
].	O

Being	O
synthesized	O
from	O
the	O
placenta	O
,	O
higher	O
enzyme	O
concentrations	O
were	O
observed	O
in	O
twin	O
and	O
triple	O
pregnancies	O
.	O

Characterizing	O
normal	O
variation	B
within	O
the	O
epigenome	O
between	O
non	O
-	O
disease	O
states	O
would	O
provide	O
valuable	O
data	O
to	O
begin	O
establishing	O
limits	O
of	O
epignetic	O
change	O
above	O
which	O
cellular	O
homeostasis	O
fails	O
and	O
epigenetic	O
toxicity	O
is	O
induced	O
.	O

Methods	O
The	O
GraviD	O
study	O
is	O
a	O
prospective	O
cohort	O
study	O
,	O
conducted	O
in	O
parts	O
of	O
the	O
Västra	O
Götaland	O
region	O
in	O
the	O
southwest	O
of	O
Sweden	O
,	O
at	O
latitude	O
57	O
–	O
58	O
°	O
N	O
[	O
3	O
].	O

[	O
20	O
]	O
also	O
adjusted	O
for	O
maternal	O
diet	O
,	O
while	O
Mendez	O
et	O
al	O
.	O

Therefore	O
,	O
the	O
participants	O
’	O
honesty	O
was	O
one	O
of	O
this	O
research	O
limits	O
.	O

For	O
example	O
,	O
researchers	O
have	O
reported	O
a	O
common	O
occurrence	O
of	O
unbooked	O
pregnancies	O
[	O
49	O
,	O
50	O
]	O
and	O
a	O
wide	O
range	O
(	O
60	O
%	O
to	O
90	O
%)	O
of	O
antenatal	O
care	O
utilization	O
rates	O
(	O
i	O
.	O
e	O
.,	O
antenatal	O
care	O
clinic	O
attendance	O
of	O
at	O
least	O
once	O
during	O
most	O
recent	O
pregnancy	O
)	O
[	O
51	O
–	O
53	O
].	O

Current	O
OECD	O
human	O
health	O
related	O
TGs	O
that	O
have	O
the	O
potential	O
for	O
adaptation	O
to	O
include	O
epigenetic	O
endpoints	O
.	O
Type	O
of	O
studyTGsDescriptionGeneral	O
exposure	O
studiesTG	O
451Carcinogenicity	O
studies	O
TG	O
452Chronic	O
toxicity	O
studies	O
TG	O
453Combined	O
chronic	O
toxicity	O
/	O
carcinogenicity	O
studiesPost	O
-	O
mitotic	O
cell	O
studiesTG	O
424Neurotoxicity	O
study	O
in	O
rodentsPrenatal	O
effectsTG	O
414Prenatal	O
development	O
toxicity	O
study	O
TG	O
426Developmental	O
neurotoxicity	O
studyReproductive	O
effectsTGs	O
415	O
,	O
416One	O
-	O
and	O
two	O
-	O
generation	O
reproduction	O
toxicity	O
TG	O
421	O
(	O
Revised	O
)	O
Reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
422	O
(	O
Revised	O
)	O
Combined	O
repeated	O
dose	O
toxicity	O
study	O
with	O
the	O
reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
443Extended	O
one	O
-	O
generation	O
reproductive	O
toxicity	O
studyGenotoxicity	O
testsTG	O
483	O
(	O
Revised	O
2015	O
)	O
Mammalian	O
spermatogonial	O
chromosome	O
aberration	O
testAlternative	O
models	O
integrating	O
multiple	O
mechanisms	O
of	O
toxicityTG	O
236	O
-	O
Zebrafish	O
embryo	O
epigenetic	O
toxicity	O
assay	O
Xenopus	O
Embryo	O
Thyroid	O
Assay	O
(	O
XETA	O
Assay	O
)	O
(	O
in	O
validation	O
)	O
Updated	O
from	O
Greally	O
and	O
Jacobs	O
(	O
2013	O
).	O

Significant	O
differences	O
were	O
reported	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Importantly	O
,	O
when	O
performing	O
in	O
vivo	O
testing	O
such	O
as	O
skin	O
tests	O
or	O
provocation	O
test	O
,	O
the	O
exceptional	O
immunologic	O
status	O
accompanying	O
pregnancy	O
should	O
be	O
considered	O
when	O
interpreting	O
test	O
results	O
.	O

All	O
other	O
offspring	O
from	O
dams	O
fed	O
the	O
HV	O
diet	O
were	O
weaned	O
to	O
RV	O
,	O
HV	O
or	O
HFol	O
diets	O
.	O

The	O
study	O
protocol	O
has	O
been	O
described	O
previously	O
[	O
11	O
,	O
12	O
]	O
and	O
further	O
information	O
can	O
be	O
found	O
atwww	O
.	O
alspac	O
.	O
bris	O
.	O
ac	O
.	O
uk	O
,	O
which	O
contains	O
details	O
of	O
all	O
the	O
data	O
that	O
are	O
available	O
(	O
www	O
.	O
bris	O
.	O
ac	O
.	O
uk	O
/	O
alspac	O
/	O
researchers	O
/	O
data	O
-	O
access	O
/	O
data	O
-	O
dictionary	O
/).	O

Quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
First	O
-	O
strand	O
cDNA	O
was	O
synthesized	O
from	O
2	O
μg	O
of	O
total	O
RNA	O
(	O
n	O
=	O
14	O
per	O
diet	O
and	O
stage	O
)	O
using	O
random	O
primers	O
and	O
oligo	O
d	O
(	O
T	O
)	O
13VN	O
in	O
the	O
presence	O
of	O
Superscript	O
III	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
,	O
Karlsruhe	O
,	O
Germany	O
).	O

Weight	O
,	O
blood	O
pressure	O
,	O
and	O
heart	O
rate	O
of	O
the	O
fetus	O
were	O
measured	O
by	O
the	O
same	O
person	O
using	O
a	O
digital	O
scale	O
,	O
digital	O
barometer	O
,	O
and	O
fetal	O
heart	O
detector	O
(	O
sonicaid	O
).	O

Recently	O
,	O
LC	O
-	O
MS	O
/	O
MS	O
became	O
the	O
gold	O
standard	O
of	O
measuring	O
Vitamin	O
D	O
level	O
due	O
to	O
its	O
ability	O
to	O
differentiate	O
and	O
accurately	O
quantify	O
the	O
two	O
subgroups	O
of	O
25	O
-	O
OH	O
Vitamin	O
D	O
(	O
25	O
-	O
OH	O
Vitamin	O
D2	O
and	O
25	O
-	O
OH	O
Vitamin	O
D3	O
);	O
(	O
2	O
)	O
high	O
specificity	O
,	O
which	O
allows	O
differentiation	O
of	O
the	O
target	O
molecule	O
from	O
other	O
metabolic	O
intermediates	O
,	O
as	O
well	O
as	O
avoiding	O
interference	O
as	O
seen	O
in	O
immunological	O
methods	O
;	O
(	O
3	O
)	O
high	O
sensitivity	O
,	O
which	O
allows	O
detection	O
at	O
ng	O
/	O
mL	O
level	O
.	O

Bodnar	O
et	O
al	O
.	O

Insulin	O
resistance	O
is	O
present	O
even	O
in	O
simple	O
obesity	O
,	O
without	O
hyperglycemia	O
,	O
indicating	O
a	O
fundamental	O
abnormality	O
of	O
insulin	O
signaling	O
in	O
states	O
of	O
excess	O
adipose	O
tissue	O
mass	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Summary	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
peopleStudyChailurkit	O
et	O
al	O
.	O

The	O
results	O
from	O
infant	O
gut	O
microbiome	O
cluster	O
analyses	O
are	O
consistent	O
with	O
this	O
observation	O
.	O

Global	O
methylation	O
status	O
of	O
hypothalamic	O
genomic	O
DNA	O
was	O
determined	O
by	O
the	O
in	O
vitro	O
methyl	O
acceptance	O
assay	O
method	O
as	O
described	O
previously	O
.	O
18	O
,	O
19This	O
assay	O
involves3H	O
-	O
methyl	O
-	O
S	O
-	O
adenosylmethionine	O
(	O
New	O
England	O
Nuclear	O
,	O
Boston	O
,	O
MA	O
,	O
USA	O
)	O
as	O
a	O
methyl	O
donor	O
mediated	O
by	O
Sss1	O
DNA	O
methyltransferase	O
(	O
New	O
England	O
Biolabs	O
,	O
Pickering	O
,	O
ON	O
,	O
Canada	O
).	O

Consequently	O
,	O
a	O
range	O
of	O
mechanisms	O
for	O
the	O
demethylation	O
of	O
DNA	O
have	O
been	O
proposed	O
(	O
described	O
in	O
relation	O
to	O
mammalian	O
development	O
in	O
Dean2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
,	O
2016	O
).	O

Specific	O
pharmacological	O
agents	O
for	O
treatment	O
of	O
asthma	O
or	O
allergic	O
diseases	O
must	O
be	O
cautiously	O
selected	O
and	O
are	O
discussed	O
here	O
with	O
respect	O
to	O
safety	O
considerations	O
in	O
pregnancy	O
.	O

Therefore	O
,	O
the	O
down	O
-	O
regulation	O
of	O
cell	O
cycle	O
regulating	O
pathways	O
might	O
lead	O
to	O
a	O
lengthened	O
cell	O
cycle	O
in	O
LP	O
fetuses	O
and	O
offspring	O
[	O
27	O
]	O
and	O
cumulate	O
in	O
growth	O
retardation	O
in	O
LP	O
fetuses	O
.	O

The	O
eight	O
eligible	O
studies	O
were	O
graded	O
as	O
negative	O
,	O
neutral	O
or	O
positive	O
overall	O
based	O
on	O
NHMRC	O
guidelines	O
for	O
scientific	O
literature	O
reviews	O
[	O
16	O
].	O

In	O
the	O
mission	O
to	O
enhance	O
and	O
compound	O
the	O
benefit	O
of	O
services	O
delivered	O
under	O
ICDS	O
,	O
Government	O
of	O
India	O
has	O
developed	O
partnerships	O
with	O
the	O
international	O
agencies	O
like	O
United	O
Nations	O
International	O
Children	O
’	O
Emergency	O
Fund	O
(	O
for	O
providing	O
technical	O
guidance	O
in	O
developing	O
need	O
-	O
based	O
training	O
plans	O
;	O
assist	O
in	O
organizing	O
scientific	O
workshops	O
;	O
and	O
in	O
impact	O
assessment	O
on	O
early	O
childhood	O
nutrition	O
and	O
development	O
),	O
Cooperative	O
for	O
Assistance	O
and	O
Relief	O
Everywhere	O
(	O
contribution	O
in	O
the	O
areas	O
of	O
maternal	O
and	O
child	O
health	O
,	O
girl	O
primary	O
education	O
,	O
etc	O
.	O

Interestingly	O
,	O
the	O
decreased	O
gene	O
expression	O
of	O
Ppar	O
γ	O
has	O
been	O
linked	O
to	O
inflammatory	O
processes	O
associated	O
with	O
obesity	O
and	O
insulin	O
resistance	O
(	O
Odegaard	O
et	O
al	O
.,	O
2007	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
),	O
an	O
issue	O
that	O
enhances	O
the	O
importance	O
of	O
the	O
inflammatory	O
responses	O
in	O
the	O
developmental	O
programming	O
.	O

Of	O
this	O
source	O
population	O
,	O
96	O
000	O
women	O
were	O
randomly	O
selected	O
from	O
four	O
age	O
strata	O
(	O
30	O
-	O
34	O
,	O
35	O
-	O
39	O
,	O
40	O
-	O
44	O
and	O
45	O
-	O
49	O
years	O
)	O
and	O
were	O
invited	O
to	O
participate	O
in	O
the	O
Swedish	O
component	O
of	O
the	O
Scandinavian	O
Women	O
'	O
s	O
Lifestyle	O
and	O
Health	O
Cohort	O
[	O
19	O
,	O
20	O
].	O

Conversely	O
,	O
several	O
studies	O
in	O
both	O
rodents	O
and	O
humans	O
have	O
shown	O
that	O
BAT	O
activation	O
(	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
treatment	O
,	O
transplantation	O
and	O
others	O
)	O
improves	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
.	O

Other	O
studies	O
show	O
that	O
factors	O
associated	O
with	O
multivitamin	O
supplementation	O
during	O
pregnancy	O
are	O
schooling	O
level	O
[	O
15	O
,	O
40	O
]	O
and	O
age	O
[	O
28	O
].	O

This	O
includes	O
information	O
regarding	O
GDM	O
,	O
self	O
-	O
monitoring	O
of	O
blood	O
glucose	O
,	O
dietary	O
counseling	O
,	O
and	O
advice	O
regarding	O
healthy	O
lifestyle	O
measures	O
post	O
-	O
partum	O
.	O

Hypocalcemia	O
has	O
also	O
been	O
shown	O
to	O
occur	O
in	O
exclusively	O
breast	O
fed	O
babies	O
not	O
exposed	O
to	O
sunlight	O
and	O
in	O
infants	O
whose	O
mothers	O
are	O
deficient	O
in	O
vitamin	O
D	O
.[	O
1	O
]	O
Symptoms	O
of	O
hypocalcemia	O
in	O
children	O
include	O
lethargy	O
,	O
recurrent	O
respiratory	O
tract	O
infections	O
,	O
focal	O
clonic	O
seizures	O
,	O
jitteriness	O
,	O
carpopedal	O
spasm	O
and	O
rarely	O
stridor	O
due	O
to	O
laryngospasm	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

For	O
this	O
purpose	O
,	O
we	O
searched	O
the	O
current	O
literature	O
on	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
and	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
rodent	O
models	O
in	O
PubMed	O
using	O
the	O
terms	O
in	O
Supplementary	O
Table	O
1	O
;	O
defining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
as	O
environmental	O
factors	O
(	O
chemicals	O
,	O
radiation	O
and	O
lifestyle	O
factors	O
(	O
including	O
alcohol	O
,	O
nutrition	O
and	O
smoking	O
))	O
that	O
induce	O
adverse	O
effects	O
(	O
growth	O
retardation	O
,	O
fertility	O
problems	O
,	O
hormonal	O
changes	O
,	O
reproductive	O
and	O
/	O
or	O
other	O
organ	O
-	O
and	O
system	O
-	O
specific	O
abnormalities	O
(	O
including	O
immune	O
disorders	O
,	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
))	O
and	O
are	O
associated	O
with	O
epigenetic	O
mechanisms	O
(	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
,	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
and	O
other	O
epigenetic	O
machinery	O
(	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
)).	O

The	O
prevalence	O
of	O
postnatal	O
depression	O
in	O
some	O
Asian	O
countries	O
has	O
been	O
reported	O
between	O
22	O
and	O
46	O
.	O
9	O
%	O
[	O
7	O
,	O
8	O
].	O

Such	O
commonly	O
identified	O
,	O
prenatal	O
risk	O
factors	O
may	O
include	O
advanced	O
-	O
aged	O
parents	O
,	O
a	O
short	O
gestation	O
period	O
,	O
low	O
birth	O
weight	O
,	O
hyperbilirubinemia	O
,	O
and	O
breech	O
presentation	O
[	O
3	O
].	O

Responses	O
were	O
recorded	O
as	O
integers	O
.	O

Finally	O
,	O
lambda	O
stat	O
was	O
used	O
to	O
compare	O
correlation	O
coefficients	O
of	O
variables	O
in	O
the	O
two	O
groups	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

The	O
researchers	O
believe	O
the	O
antioxidant	O
properties	O
of	O
garlic	O
,	O
along	O
with	O
the	O
chelating	O
efficacy	O
exhibited	O
,	O
led	O
to	O
the	O
success	O
of	O
the	O
treatment	O
.	O

Some	O
clinical	O
trials	O
in	O
non	O
-	O
pregnant	O
people	O
showed	O
that	O
vitamin	O
D	O
was	O
effective	O
in	O
decreasing	O
depression	O
level	O
.	O

2010	O
;	O
Marsit	O
et	O
al	O
.	O

Food	O
consumption	O
frequency	O
of	O
food	O
rich	O
in	O
Vitamin	O
D	O
Participants	O
filled	O
dietary	O
records	O
for	O
7	O
–	O
232	O
days	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
7	O
days	O
.	O

While	O
the	O
findings	O
reveal	O
a	O
relatively	O
modest	O
impact	O
on	O
weight	O
gain	O
[	O
14	O
],	O
very	O
little	O
attention	O
has	O
been	O
directed	O
towards	O
the	O
ongoing	O
follow	O
-	O
up	O
of	O
women	O
and	O
infants	O
beyond	O
the	O
neonatal	O
period	O
to	O
assess	O
longer	O
term	O
outcomes	O
.	O

Those	O
who	O
did	O
not	O
complete	O
the	O
interview	O
were	O
recorded	O
as	O
having	O
refused	O
to	O
participate	O
and	O
were	O
taken	O
into	O
account	O
when	O
calculating	O
the	O
refusal	O
rate	O
,	O
but	O
excluded	O
from	O
the	O
final	O
analysis	O
.	O

Role	O
of	O
the	O
funding	O
source	O
The	O
sponsor	O
of	O
the	O
study	O
had	O
no	O
role	O
in	O
study	O
design	O
,	O
data	O
collection	O
,	O
data	O
analysis	O
,	O
data	O
interpretation	O
,	O
or	O
writing	O
of	O
the	O
report	O
.	O

The	O
porcine	O
expression	O
patterns	O
in	O
this	O
study	O
showed	O
a	O
decreased	O
mRNA	O
expression	O
of	O
genes	O
associated	O
with	O
the	O
control	O
of	O
mitosis	O
and	O
cell	O
cycle	O
checkpoint	O
regulation	O
at	O
stage	O
94	O
dpc	O
in	O
LP	O
fetuses	O
.	O

The	O
mother	O
is	O
given	O
medical	O
advice	O
and	O
referred	O
if	O
necessary	O
.	O

2011	O
;	O
Sood	O
et	O
al	O
.	O

However	O
,	O
according	O
to	O
literature	O
data	O
and	O
our	O
own	O
experience	O
pregnancy	O
after	O
thyroid	O
cancer	O
has	O
been	O
shown	O
to	O
have	O
no	O
significant	O
effect	O
on	O
morbidity	O
,	O
disease	O
-	O
free	O
period	O
or	O
survival	O
time	O
.	O

The	O
PAT	O
of	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
exhibited	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
the	O
β	O
-	O
oxidation	O
enzymes	O
Cpt1b	O
and	O
Acox1	O
,	O
the	O
mitochondrial	O
respiratory	O
chain	O
subunit	O
Cox4i1	O
and	O
the	O
lipid	O
storage	O
-	O
stimulating	O
transcription	O
factor	O
Ppar	O
γ	O
.	O

The	O
placenta	O
expresses	O
all	O
the	O
necessary	O
components	O
to	O
convert	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
and	O
thus	O
utilise	O
active	O
vitamin	O
D	O
either	O
locally	O
or	O
in	O
a	O
paracrine	O
manner	O
[	O
45	O
,	O
47	O
].	O

the	O
same	O
epigenetic	O
change	O
(	O
s	O
)	O
reported	O
in	O
multiple	O
independent	O
studies	O
or	O
multiple	O
epigenetic	O
changes	O
that	O
contribute	O
to	O
the	O
same	O
biological	O
pathway	O
),	O
and	O
,	O
therefore	O
,	O
are	O
included	O
in	O
Supplementary	O
Table	O
3	O
.	O

Conclusions	O
and	O
public	O
health	O
implications	O
We	O
conclude	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
.	O

Sunscreen	O
lotions	O
prevent	O
UV	O
radiation	O
from	O
reaching	O
the	O
skin	O
and	O
might	O
therefore	O
reduce	O
the	O
skin	O
’	O
s	O
vitamin	O
D	O
production	O
[	O
56	O
].	O

Discussion	O
This	O
is	O
one	O
of	O
the	O
few	O
studies	O
to	O
prospectively	O
and	O
simultaneously	O
examine	O
the	O
impact	O
of	O
dietary	O
,	O
physical	O
activity	O
,	O
and	O
psychosocial	O
parameters	O
during	O
pregnancy	O
on	O
the	O
offspring	O
weight	O
status	O
of	O
overweight	O
/	O
obese	O
and	O
normal	O
weight	O
mothers	O
.	O

5	O
.	O

Firstly	O
,	O
children	O
develop	O
in	O
‘	O
spurts	O
’	O
rather	O
than	O
in	O
a	O
continuous	O
fashion	O
,	O
which	O
means	O
they	O
may	O
slip	O
in	O
and	O
out	O
of	O
the	O
‘	O
normal	O
’	O
reference	O
ranges	O
,	O
particularly	O
in	O
the	O
earlier	O
years	O
[	O
27	O
,	O
28	O
].	O

Interactions	O
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
34	O
.	O
005	O
,	O
P	O
<	O
0	O
.	O
01	O
],	O
and	O
diet	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
4	O
.	O
58	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
were	O
found	O
.	O

Iron	O
supplements	O
can	O
be	O
given	O
by	O
mouth	O
and	O
parenteral	O
route	O
as	O
intramuscular	O
and	O
intravenous	O
injections	O
;	O
in	O
addition	O
,	O
it	O
can	O
be	O
administered	O
as	O
blood	O
transfusion	O
and	O
recombinant	O
erythropoietin	O
with	O
iron	O
.	O

The	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
was	O
10	O
.	O
5	O
%,	O
compared	O
to	O
3	O
.	O
7	O
%	O
for	O
insulin	O
and	O
25	O
%	O
for	O
glyburide	O
(	O
p	O
=	O
0	O
.	O
07	O
).	O

This	O
supplement	O
should	O
include	O
400	O
μ	O
g	O
of	O
folic	O
acid	O
or	O
lower	O
doses	O
,	O
if	O
this	O
amount	O
is	O
not	O
available	O
[	O
7	O
].	O

Therefore	O
,	O
a	O
nonparametric	O
test	O
was	O
used	O
for	O
25	O
-	O
hydroxyvitamin	O
D	O
data	O
.	O

(	O
2015	O
)‡	O
Susiarjo	O
et	O
al	O
.	O

However	O
,	O
women	O
with	O
a	O
high	O
level	O
of	O
education	O
were	O
less	O
satisfied	O
with	O
the	O
reception	O
as	O
compared	O
to	O
those	O
with	O
a	O
low	O
educational	O
level	O
.	O

The	O
NCCLS	O
is	O
a	O
population	O
-	O
based	O
case	O
–	O
control	O
study	O
of	O
risk	O
factors	O
for	O
child	O
leukemia	O
,	O
including	O
maternal	O
diet	O
.	O

The	O
prevalence	O
of	O
vitamin	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
is	O
high	O
in	O
many	O
European	O
countries	O
[	O
36	O
]–[	O
43	O
]	O
and	O
some	O
studies	O
suggest	O
that	O
pregnant	O
women	O
in	O
Europe	O
are	O
also	O
at	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
29	O
],[	O
30	O
].	O

The	O
up	O
-	O
to	O
-	O
date	O
annotation	O
of	O
Affymetrix	O
probe	O
-	O
sets	O
to	O
EnsEMBL	O
Sscofa	O
9	O
(	O
20	O
,	O
439	O
of	O
23	O
,	O
935	O
annotated	O
probe	O
-	O
sets	O
)	O
was	O
used	O
[	O
18	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
No	O
.	O

Although	O
we	O
are	O
the	O
first	O
to	O
show	O
that	O
the	O
brain	O
at	O
maturity	O
responds	O
to	O
vitamins	O
,	O
our	O
results	O
are	O
substantiated	O
by	O
a	O
report	O
of	O
hypothalamic	O
changes	O
in	O
the	O
food	O
intake	O
regulatory	O
genes	O
due	O
to	O
the	O
interaction	O
of	O
maternal	O
and	O
post	O
-	O
weaning	O
diets	O
high	O
in	O
saturated	O
fats	O
in	O
male	O
offspring	O
.	O
29	O
Surprisingly	O
,	O
a	O
ten	O
-	O
fold	O
addition	O
of	O
folate	O
alone	O
to	O
the	O
RV	O
diet	O
modified	O
some	O
of	O
the	O
effects	O
of	O
the	O
maternal	O
HV	O
diet	O
on	O
the	O
offspring	O
,	O
suggesting	O
a	O
possible	O
primary	O
role	O
for	O
this	O
methyl	O
group	O
vitamin	O
.	O

They	O
were	O
impatient	O
because	O
they	O
claimed	O
they	O
had	O
other	O
preoccupations	O
.	O

Another	O
signaling	O
pathway	O
identified	O
to	O
be	O
regulated	O
in	O
a	O
diet	O
-	O
dependent	O
manner	O
is	O
the	O
'	O
VEGF	O
(	O
vascular	O
endothelial	O
growth	O
factor	O
)	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
known	O
from	O
gene	O
deletion	O
studies	O
to	O
be	O
essential	O
in	O
developmental	O
processes	O
[	O
36	O
,	O
37	O
].	O

Conclusions	O
In	O
conclusion	O
,	O
once	O
standardised	O
against	O
month	O
of	O
sampling	O
,	O
we	O
demonstrate	O
a	O
protective	O
effect	O
of	O
high	O
vitamin	O
D	O
with	O
GDM	O
.	O

In	O
the	O
third	O
trimester	O
,	O
surgery	O
may	O
induce	O
premature	O
labour	O
.	O

Results	O
T1	O
25OHD	O
was	O
negatively	O
associated	O
with	O
pregnancy	O
loss	O
and	O
1	O
nmol	O
/	O
L	O
increase	O
in	O
25OHD	O
was	O
associated	O
with	O
1	O
%	O
lower	O
odds	O
of	O
pregnancy	O
loss	O
(	O
OR	O
0	O
.	O
99	O
,	O
p	O
=	O
0	O
.	O
046	O
).	O

Several	O
studies	O
have	O
suggested	O
the	O
association	O
between	O
perinatal	O
factors	O
and	O
the	O
onset	O
of	O
autism	O
.	O

Our	O
recent	O
study	O
indicated	O
that	O
a	O
lower	O
ambient	O
temperature	O
decreased	O
growth	O
and	O
feed	O
efficiency	O
in	O
Korean	O
cattle	O
steers	O
[	O
78	O
].	O

Several	O
factors	O
,	O
including	O
MS	O
or	O
QG	O
,	O
feed	O
costs	O
,	O
and	O
carcass	O
prices	O
need	O
to	O
be	O
considered	O
to	O
determine	O
the	O
optimum	O
slaughter	O
weight	O
for	O
the	O
maximum	O
profit	O
.	O

When	O
juvenile	O
and	O
young	O
adult	O
pigs	O
(	O
period	O
III	O
)	O
are	O
compared	O
,	O
1	O
,	O
549	O
probe	O
-	O
sets	O
differed	O
significantly	O
(	O
697	O
188	O
dpn	O
≻	O
28	O
dpn	O
)	O
in	O
AP	O
offspring	O
.	O

Although	O
,	O
the	O
point	O
estimates	O
indicated	O
a	O
marginal	O
increased	O
risk	O
for	O
developing	O
any	O
pregnancy	O
complication	O
with	O
severe	O
(<	O
25	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
those	O
who	O
had	O
levels	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
(	O
aRR	O
:	O
1	O
.	O
10	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
).	O

The	O
associations	O
were	O
J	O
-	O
shaped	O
with	O
the	O
strongest	O
reduced	O
risk	O
for	O
an	O
intermediate	O
intake	O
of	O
fish	O
or	O
PUFA	O
.	O

Any	O
explanation	O
for	O
these	O
dimorphisms	O
should	O
be	O
supported	O
by	O
the	O
elevated	O
gene	O
expression	O
of	O
Cnr2	O
in	O
the	O
liver	O
and	O
PAT	O
of	O
the	O
RC	O
female	O
offspring	O
compared	O
to	O
those	O
of	O
the	O
RC	O
males	O
.	O

There	O
were	O
five	O
deaths	O
to	O
6	O
months	O
of	O
age	O
(	O
4	O
neonatal	O
deaths	O
as	O
reported	O
previously	O
[	O
22	O
],	O
and	O
the	O
death	O
of	O
one	O
infant	O
prior	O
to	O
6	O
months	O
of	O
age	O
attributable	O
to	O
sudden	O
infant	O
death	O
syndrome	O
).	O

Numerous	O
individual	O
nutrients	O
consumed	O
by	O
the	O
mother	O
during	O
pregnancy	O
have	O
been	O
suggested	O
as	O
being	O
preventive	O
for	O
development	O
of	O
atopic	O
diseases	O
in	O
the	O
child	O
;	O
these	O
include	O
apples	O
or	O
fish	O
,[	O
80	O
]	O
vitamin	O
D	O
,[	O
107	O
]	O
vitamin	O
E	O
,[	O
108	O
]	O
and	O
various	O
probiotics	O
,	O
the	O
latter	O
having	O
been	O
shown	O
to	O
be	O
effective	O
in	O
mouse	O
models	O
[	O
109	O
]	O
and	O
human	O
studies	O
[	O
110	O
].	O

Our	O
results	O
are	O
consistent	O
with	O
other	O
data	O
showing	O
that	O
early	O
nutrition	O
alters	O
the	O
central	O
appetite	O
regulatory	O
network	O
.	O
22Effects	O
of	O
the	O
maternal	O
diet	O
on	O
the	O
hypothalamic	O
expression	O
of	O
food	O
intake	O
regulatory	O
pathways	O
were	O
found	O
in	O
lambs	O
of	O
ewes	O
fed	O
a	O
diet	O
that	O
exceeded	O
their	O
energy	O
requirement	O
.	O

Calcitonin	O
is	O
the	O
most	O
clinically	O
useful	O
biochemical	O
marker	O
for	O
these	O
tumours	O
,	O
and	O
C	O
cell	O
hyperplasia	O
represents	O
a	O
pre	O
-	O
cancerous	O
stage	O
.	O

Comparable	O
results	O
were	O
documented	O
with	O
dietary	O
supplements	O
containing	O
iron	O
and	O
ironfortified	O
milk	O
[	O
30	O
,	O
31	O
].	O

A	O
total	O
of	O
2136	O
infants	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
and	O
included	O
in	O
the	O
analysis	O
(	O
96	O
.	O
6	O
%	O
of	O
the	O
randomised	O
sample	O
).	O

We	O
assessed	O
violation	O
of	O
the	O
proportionality	O
assumption	O
with	O
Schoenfeld	O
residuals	O
.	O

Gestational	O
Diabetes	O
Insipidus	O
Associated	O
with	O
HELLP	O
Syndrome	O
:	O
A	O
Case	O
Report	O
Abstract	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
,	O
but	O
well	O
recognized	O
,	O
complication	O
of	O
pregnancy	O
.	O

Little	O
is	O
known	O
about	O
specific	O
determinants	O
of	O
asthma	O
and	O
atopy	O
in	O
the	O
farm	O
setting	O
.	O

Interestingly	O
,	O
increased	O
risk	O
for	O
glioma	O
has	O
been	O
observed	O
in	O
patients	O
with	O
AIDS	O
-	O
related	O
immuno	O
-	O
suppression	O
[	O
122	O
–	O
124	O
],	O
but	O
not	O
in	O
those	O
with	O
iatrogenic	O
immuno	O
-	O
suppression	O
[	O
125	O
].	O

The	O
offspring	O
of	O
overweight	O
mothers	O
were	O
larger	O
at	O
birth	O
but	O
,	O
by	O
6	O
-	O
months	O
,	O
did	O
not	O
significantly	O
differ	O
from	O
those	O
of	O
normal	O
weight	O
mothers	O
.	O

In	O
order	O
to	O
identify	O
molecular	O
pathways	O
affected	O
by	O
the	O
gestational	O
diets	O
we	O
first	O
analysed	O
differential	O
expression	O
between	O
the	O
dietary	O
groups	O
within	O
each	O
stage	O
separately	O
.	O

Being	O
raised	O
on	O
a	O
farm	O
[	O
102	O
–	O
114	O
]	O
or	O
in	O
a	O
rural	O
area	O
[	O
115	O
]	O
has	O
been	O
shown	O
in	O
some	O
studies	O
to	O
protect	O
against	O
asthma	O
,	O
hay	O
fever	O
,	O
and	O
atopic	O
sensitization	O
.	O

Secondary	O
study	O
outcomes	O
included	O
a	O
range	O
of	O
infant	O
anthropometric	O
measures	O
,	O
neurodevelopment	O
,	O
general	O
health	O
,	O
and	O
infant	O
feeding	O
.	O

Our	O
analysis	O
was	O
by	O
intention	O
to	O
treat	O
.	O

There	O
is	O
strong	O
evidence	O
that	O
maternal	O
iron	O
deficiency	O
anaemia	O
increases	O
the	O
risk	O
of	O
adverse	O
perinatal	O
outcomes	O
.	O

As	O
the	O
main	O
endogenous	O
agonists	O
(	O
anandamide	O
and	O
2	O
-	O
arachidonoyl	O
glycerol	O
)	O
of	O
the	O
cannabinoid	O
receptors	O
CB1	O
and	O
CB2	O
are	O
derivatives	O
of	O
fatty	O
acids	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
the	O
lipid	O
profile	O
of	O
the	O
diet	O
could	O
modify	O
the	O
endocannabinoid	O
levels	O
(	O
Artmann	O
et	O
al	O
.,	O
2008	O
)	O
in	O
some	O
tissues	O
,	O
including	O
the	O
early	O
developing	O
brain	O
(	O
Berger	O
et	O
al	O
.,	O
2001	O
).	O

Moreover	O
,	O
dietary	O
factors	O
,	O
before	O
and	O
during	O
pregnancy	O
,	O
have	O
been	O
linked	O
to	O
increased	O
risk	O
for	O
GDM	O
.	O

A	O
total	O
of	O
169	O
participants	O
were	O
assigned	O
to	O
the	O
two	O
groups	O
of	O
placebo	O
and	O
vitamin	O
D	O
through	O
block	O
randomization	O
design	O
.	O

Weight	O
,	O
length	O
,	O
BMI	O
,	O
weight	O
-	O
for	O
-	O
length	O
,	O
and	O
head	O
circumference	O
measures	O
were	O
converted	O
to	O
z	O
-	O
scores	O
for	O
age	O
and	O
gender	O
,	O
using	O
WHO	O
standards	O
[	O
27	O
,	O
30	O
].	O

The	O
endocannabinoid	O
system	O
(	O
ECS	O
)	O
is	O
also	O
implicated	O
in	O
metabolic	O
and	O
behavioral	O
mechanisms	O
involved	O
in	O
fetal	O
programming	O
such	O
as	O
leptin	O
signaling	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
)	O
or	O
dopaminergic	O
system	O
(	O
Melis	O
et	O
al	O
.,	O
2004	O
).	O

Thus	O
,	O
there	O
are	O
reasons	O
to	O
believe	O
that	O
the	O
dimension	O
of	O
positive	O
symptoms	O
is	O
an	O
independent	O
dimension	O
.	O

We	O
identified	O
147	O
rodent	O
studies	O
within	O
PubMed	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
demonstrating	O
both	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
reduced	O
fertility	O
,	O
reproductive	O
,	O
developmental	O
or	O
other	O
organ	O
-	O
specific	O
abnormalities	O
,	O
or	O
adult	O
onset	O
diseases	O
(	O
cancer	O
,	O
diabetes	O
,	O
obesity	O
or	O
immune	O
disorders	O
))	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
histone	O
modification	O
,	O
DNA	O
methylation	O
,	O
epigenetic	O
machinery	O
or	O
miRNAs	O
)	O
following	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
chemicals	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
,	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
lactation	O
,	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
).	O

If	O
there	O
are	O
more	O
than	O
5	O
%	O
errors	O
,	O
respective	O
data	O
are	O
re	O
-	O
captured	O
.	O

Data	O
collection	O
is	O
projected	O
to	O
be	O
complete	O
by	O
mid	O
-	O
2008	O
.	O

Measurement	O
of	O
metabolites	O
,	O
hepatic	O
enzymes	O
,	O
and	O
leptin	O
in	O
plasma	O
The	O
following	O
plasma	O
metabolites	O
and	O
enzymes	O
were	O
measured	O
:	O
basal	O
glucose	O
,	O
triglycerides	O
,	O
total	O
cholesterol	O
,	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
),	O
urea	O
,	O
bilirubin	O
,	O
alkaline	O
phosphatase	O
(	O
ALKP	O
),	O
and	O
the	O
hepatic	O
enzymes	O
alanine	O
aminotransferase	O
(	O
ALT	O
),	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
and	O
gamma	O
-	O
glutamyl	O
transpeptidase	O
(	O
γGT	O
).	O

In	O
the	O
case	O
of	O
preterm	O
delivery	O
,	O
vitamin	O
D	O
status	O
measured	O
closer	O
to	O
the	O
delivery	O
date	O
was	O
more	O
significantly	O
associated	O
with	O
preterm	O
delivery	O
than	O
earlier	O
measures	O
[	O
26	O
].	O

The	O
measles	O
immunisation	O
in	O
South	O
Africa	O
forms	O
part	O
of	O
the	O
National	O
Expanded	O
Programme	O
for	O
Immunisation	O
and	O
permission	O
to	O
administer	O
it	O
at	O
the	O
study	O
site	O
has	O
been	O
granted	O
by	O
the	O
Department	O
of	O
Health	O
of	O
Gauteng	O
Province	O
and	O
the	O
City	O
of	O
Johannesburg	O
.	O

The	O
association	O
between	O
“	O
standardised	O
”	O
25	O
(	O
OH	O
)	O
D	O
with	O
pregnancy	O
complications	O
is	O
presented	O
in	O
Table	O
2	O
.	O

The	O
range	O
between	O
therapeutic	O
and	O
toxic	O
doses	O
is	O
narrow	O
,	O
and	O
vitamin	O
D	O
toxicity	O
,	O
when	O
it	O
occurs	O
,	O
is	O
a	O
serious	O
problem	O
.	O

Combined	O
with	O
other	O
experimental	O
findings	O
,	O
the	O
current	O
study	O
lends	O
further	O
credibility	O
to	O
the	O
notion	O
that	O
developmental	O
vitamin	O
D	O
deficiency	O
impacts	O
adversely	O
on	O
normal	O
brain	O
development	O
[	O
30	O
].	O

Although	O
previously	O
suggested	O
that	O
pregnant	O
women	O
with	O
risks	O
avoid	O
peanuts	O
,	O
a	O
subsequent	O
study	O
found	O
no	O
evidence	O
of	O
prenatal	O
sensitization	O
from	O
maternal	O
consumption	O
of	O
peanuts	O
[	O
100	O
].	O

Owing	O
to	O
the	O
lack	O
of	O
other	O
available	O
data	O
,	O
we	O
used	O
the	O
annual	O
number	O
of	O
live	O
births	O
in	O
Iaşi	O
county	O
reported	O
on	O
01	O
July	O
2009	O
(	O
n	O
=	O
9	O
,	O
499	O
)	O
to	O
define	O
the	O
size	O
of	O
the	O
reference	O
group	O
[	O
23	O
].	O

The	O
majority	O
of	O
women	O
(	O
80	O
.	O
8	O
%)	O
were	O
married	O
.	O

The	O
average	O
daily	O
Vitamin	O
D	O
intake	O
dose	O
in	O
the	O
rest	O
eighty	O
-	O
four	O
participants	O
was	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

The	O
relative	O
quantification	O
was	O
calculated	O
using	O
the	O
ΔΔCt	O
method	O
and	O
normalized	O
to	O
the	O
control	O
group	O
.	O

Also	O
,	O
there	O
were	O
positive	O
nonsignificant	O
relationships	O
between	O
adherence	O
to	O
western	O
[	O
OR	O
1	O
.	O
31	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
68	O
-	O
2	O
.	O
51	O
),	O
P	O
=	O
0	O
.	O
28	O
]	O
and	O
healthy	O
[	O
OR	O
1	O
.	O
02	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
39	O
-	O
2	O
.	O
63	O
),	O
P	O
=	O
0	O
.	O
40	O
]	O
dietary	O
pattern	O
of	O
mothers	O
with	O
having	O
short	O
height	O
infant	O
in	O
the	O
final	O
adjusted	O
model	O
.	O

Exposure	O
assessment	O
Data	O
on	O
maternal	O
diet	O
in	O
pregnancy	O
were	O
collected	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
at	O
32	O
weeks	O
gestation	O
,	O
covering	O
all	O
the	O
main	O
foods	O
consumed	O
in	O
Britain	O
[	O
13	O
].	O

Micelle	O
formation	O
profoundly	O
increases	O
the	O
fraction	O
of	O
lipid	O
molecules	O
accessible	O
to	O
the	O
action	O
of	O
intestinal	O
lipase	O
,	O
aiding	O
fat	O
digestion	O
in	O
the	O
intestine	O
.	O

Two	O
lines	O
of	O
evidence	O
support	O
the	O
PAR	O
hypothesis	O
.	O

A	O
group	O
in	O
Norway	O
assessed	O
the	O
association	O
between	O
interpregnancy	O
lengths	O
and	O
ASD	O
and	O
found	O
that	O
interpregnancy	O
intervals	O
for	O
less	O
than	O
9	O
months	O
and	O
interpregnancy	O
between	O
9	O
and	O
11	O
months	O
carried	O
an	O
increased	O
risk	O
for	O
ASD	O
[	O
11	O
].	O

Further	O
questions	O
arise	O
with	O
respect	O
to	O
the	O
previous	O
treatment	O
trial	O
in	O
the	O
same	O
region	O
of	O
Kabul	O
,	O
which	O
showed	O
that	O
a	O
single	O
high	O
-	O
dose	O
supplementation	O
with	O
100	O
000	O
IU	O
vitamin	O
D3given	O
orally	O
to	O
young	O
children	O
,	O
along	O
with	O
antibiotic	O
treatment	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
reduced	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
.	O
3The	O
inconsistent	O
results	O
could	O
be	O
related	O
to	O
the	O
evidence	O
that	O
stimulation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
macrophages	O
and	O
monocytes	O
by	O
bacterial	O
antigens	O
is	O
important	O
in	O
up	O
-	O
regulation	O
of	O
CYP27B1	O
and	O
the	O
vitamin	O
D	O
receptor	O
,	O
5which	O
are	O
crucial	O
in	O
production	O
of	O
cathelicidins	O
in	O
vitamin	O
-	O
D	O
-	O
depleted	O
individuals	O
.	O

The	O
infant	O
is	O
weighed	O
on	O
a	O
calibrated	O
scale	O
with	O
minimum	O
of	O
clothing	O
,	O
namely	O
only	O
a	O
vest	O
,	O
and	O
without	O
a	O
nappy	O
;	O
and	O
recorded	O
to	O
the	O
nearest	O
5	O
g	O
.	O
Recumbent	O
length	O
of	O
the	O
infants	O
is	O
taken	O
by	O
means	O
of	O
an	O
infantometer	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
.	O

Anaphylaxis	O
The	O
exact	O
prevalence	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
unknown	O
,	O
but	O
it	O
is	O
extremely	O
uncommon	O
[	O
30	O
].	O

Gestational	O
age	O
was	O
calculated	O
based	O
on	O
the	O
first	O
day	O
of	O
the	O
last	O
menstruation	O
(	O
LMP	O
),	O
or	O
the	O
first	O
trimester	O
ultrasound	O
(	O
if	O
uncertain	O
about	O
LMP	O
).	O

In	O
a	O
study	O
of	O
neonatal	O
rats	O
,	O
Zerrate	O
et	O
al	O
.	O

In	O
these	O
studies	O
,	O
the	O
normally	O
weaned	O
steers	O
remained	O
on	O
pasture	O
during	O
nursing	O
and	O
weaning	O
at	O
231	O
d	O
(	O
study	O
1	O
)	O
and	O
213	O
d	O
of	O
age	O
(	O
study	O
2	O
),	O
respectively	O
,	O
and	O
they	O
were	O
then	O
placed	O
on	O
a	O
finishing	O
diet	O
.	O

T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
(	O
equal	O
to	O
40	O
ng	O
/	O
ml	O
)	O
was	O
associated	O
with	O
lower	O
odds	O
of	O
SGA	O
(	O
OR	O
0	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
and	O
LBW	O
(	O
OR	O
0	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
046	O
),	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
(	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
or	O
12	O
ng	O
/	O
ml	O
).	O

Besides	O
,	O
activated	O
lymphocytes	O
can	O
cross	O
the	O
blood	O
–	O
brain	O
barrier	O
and	O
secrete	O
cytokines	O
in	O
the	O
brain	O
[	O
72	O
].	O

In	O
the	O
literature	O
,	O
2	O
out	O
of	O
23	O
children	O
fathered	O
by	O
men	O
on	O
methotrexate	O
were	O
found	O
to	O
have	O
congenital	O
abnormalities	O
.	O

All	O
the	O
mothers	O
completed	O
a	O
questionnaire	O
pertaining	O
to	O
their	O
diet	O
in	O
the	O
12	O
months	O
prior	O
to	O
pregnancy	O
.	O

BAT	O
,	O
the	O
principal	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
i	O
.	O
e	O
.,	O
heat	O
production	O
that	O
does	O
not	O
involve	O
skeletal	O
muscle	O
contraction	O
),	O
is	O
present	O
in	O
most	O
mammals	O
and	O
its	O
maturation	O
in	O
the	O
perinatal	O
period	O
varies	O
between	O
species	O
,	O
according	O
to	O
their	O
developmental	O
status	O
at	O
birth	O
(	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

When	O
the	O
data	O
were	O
stratified	O
by	O
gender	O
in	O
post	O
-	O
hoc	O
analyses	O
,	O
only	O
the	O
male	O
population	O
continued	O
to	O
demonstrate	O
this	O
correlation	O
(	O
ρ	O
=	O
0	O
.	O
292	O
,	O
p	O
=	O
0	O
.	O
014	O
),	O
while	O
females	O
did	O
not	O
(	O
ρ	O
=	O
0	O
.	O
103	O
,	O
p	O
=	O
0	O
.	O
425	O
).	O

Studies	O
exposing	O
pregnant	O
rats	O
and	O
mice	O
to	O
valproate	O
demonstrated	O
increased	O
autistic	O
-	O
like	O
behaviors	O
in	O
the	O
offspring	O
.	O

Radunz	O
et	O
al	O
[	O
156	O
]	O
tested	O
the	O
effects	O
of	O
three	O
maternal	O
late	O
-	O
gestational	O
dietary	O
energy	O
sources	O
(	O
grass	O
hay	O
,	O
corn	O
,	O
and	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
)	O
on	O
progeny	O
postnatal	O
growth	O
and	O
beef	O
MS	O
in	O
an	O
Angus	O
cross	O
-	O
breed	O
.	O

Therefore	O
,	O
these	O
potential	O
limitations	O
should	O
be	O
considered	O
in	O
the	O
interpretation	O
of	O
our	O
results	O
.	O

Phosphatase	O
and	O
tensin	O
homolog	O
deleted	O
on	O
chromosome	O
ten	O
(	O
PTEN	O
),	O
a	O
well	O
-	O
known	O
tumor	O
suppressor	O
is	O
a	O
phosphatase	O
that	O
specifically	O
catalyzes	O
the	O
dephosphorylation	O
of	O
phosphatidylinositol	O
-	O
3	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
(	O
PIP3	O
),	O
in	O
phosphatidylinositol	O
-	O
4	O
,	O
5	O
-	O
diphosphate	O
PIP2	O
(	O
Cantley	O
and	O
Neel	O
,	O
1999	O
).	O

4	O
.	O

This	O
family	O
,	O
which	O
can	O
oxidize	O
5mC	O
to	O
5	O
-	O
hydroxymethylcytosine	O
(	O
5hmC	O
)	O
and	O
further	O
to	O
5	O
-	O
formylcytosine	O
(	O
5fC	O
)	O
and	O
5	O
-	O
carboxycytosine	O
(	O
5caC	O
)	O
(	O
Tahiliani	O
et	O
al	O
.	O
2009	O
;	O
Ito	O
et	O
al	O
.	O
2011	O
),	O
has	O
fueled	O
research	O
into	O
indirect	O
active	O
DNA	O
demethylation	O
pathways	O
.	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
may	O
interfere	O
with	O
many	O
functions	O
beyond	O
calcium	O
metabolism	O
,	O
such	O
as	O
foetal	O
"	O
imprinting	O
"	O
that	O
may	O
affect	O
neurodevelopment	O
,	O
immune	O
function	O
and	O
chronic	O
disease	O
susceptibility	O
later	O
in	O
life	O
,	O
as	O
well	O
as	O
soon	O
after	O
birth2425	O
.	O

A	O
basal	O
-	O
bolus	O
regimen	O
of	O
insulin	O
gives	O
the	O
most	O
effective	O
glucose	O
control	O
,	O
and	O
produces	O
better	O
fetal	O
outcomes	O
than	O
a	O
twice	O
daily	O
regime	O
.	O
34Prandial	O
fast	O
-	O
acting	O
insulin	O
is	O
administered	O
to	O
control	O
post	O
-	O
prandial	O
hyperglycemia	O
,	O
and	O
bedtime	O
basal	O
insulin	O
is	O
given	O
if	O
there	O
is	O
fasting	O
hyperglycemia	O
.	O

Advantage	O
of	O
this	O
questionnaire	O
is	O
that	O
it	O
focuses	O
on	O
psychological	O
signs	O
of	O
depression	O
rather	O
than	O
physical	O
signs	O
[	O
36	O
].	O

Experimental	O
Section	O
2	O
.	O
1	O
.	O

[	O
3	O
]	O
A	O
fatal	O
case	O
of	O
biphasic	O
wheezing	O
in	O
an	O
infant	O
attributed	O
to	O
hypocalcemia	O
has	O
been	O
described	O
in	O
literature	O
.	O

While	O
such	O
complex	B
networks	O
exist	O
to	O
maintain	O
cellular	O
homeostasis	O
,	O
they	O
are	O
open	O
to	O
environmental	O
perturbation	O
(	O
Figure	O
1	O
).	O

Gross	O
anatomical	O
abnormalities	O
were	O
greater	O
in	O
mice	O
fathered	O
by	O
FD	O
mice	O
(	O
27	O
%	O
vs	O
.	O
3	O
%)	O
which	O
included	O
craniofacial	O
,	O
hydrocephalus	O
,	O
limb	O
,	O
and	O
muscle	O
/	O
skeletal	O
defects	O
.	O

In	O
this	O
context	O
,	O
the	O
sheep	O
appears	O
to	O
be	O
a	O
very	O
good	O
model	O
,	O
because	O
as	O
for	O
humans	O
,	O
the	O
major	O
source	O
of	O
BAT	O
in	O
the	O
fetus	O
is	O
around	O
central	O
organs	O
and	O
is	O
replaced	O
by	O
WAT	O
after	O
birth	O
,	O
whereas	O
in	O
rodents	O
,	O
the	O
primary	O
BAT	O
depot	O
is	O
interscapular	O
and	O
it	O
remains	O
throughout	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

It	O
is	O
important	O
to	O
note	O
that	O
not	O
all	O
environmentally	O
induced	O
adverse	O
phenotypes	O
have	O
been	O
associated	O
with	O
epigenetic	O
changes	O
.	O

Thus	O
,	O
it	O
may	O
be	O
that	O
,	O
in	O
some	O
cases	O
,	O
depression	O
itself	O
or	O
other	O
concomitant	O
factors	O
have	O
a	O
combined	O
effect	O
that	O
is	O
not	O
necessarily	O
due	O
to	O
the	O
use	O
of	O
SSRIs	O
.	O

PubMed	O
Central	O
:	O

In	O
general	O
,	O
Stanford	O
type	O
A	O
dissections	O
involve	O
the	O
ascending	O
aorta	O
and	O
are	O
managed	O
surgically	O
while	O
type	O
B	O
dissections	O
involved	O
the	O
descending	O
aorta	O
and	O
are	O
managed	O
medically	O
.	O

Accordingly	O
,	O
in	O
human	O
blood	O
samples	O
,	O
Th2	O
cytokines	O
responsible	O
for	O
a	O
predisposition	O
toward	O
allergy	O
were	O
elevated	O
in	O
the	O
neonates	O
only	O
of	O
mothers	O
who	O
had	O
smoked	O
during	O
pregnancy	O
[	O
71	O
].	O

Results	O
The	O
two	O
groups	O
were	O
similar	O
in	O
relation	O
to	O
baseline	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

The	O
TSH	O
concentration	O
generally	O
lies	O
within	O
the	O
normal	O
range	O
after	O
the	O
16th	O
to	O
18th	O
week11171920	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
age	O
,	O
gestational	O
week	O
or	O
pre	O
-	O
pregnancy	O
BMI	O
between	O
participants	O
in	O
intervention	O
group	O
and	O
control	O
group	O
.	O

The	O
latter	O
is	O
possibly	O
due	O
to	O
the	O
fact	O
that	O
women	O
using	O
sunscreen	O
lotion	O
are	O
more	O
often	O
exposed	O
to	O
the	O
sun	O
.	O

We	O
analysed	O
the	O
repeat	O
episodes	O
accounting	O
for	O
clustering	O
within	O
individuals	O
.	O

PubMed	O
Central	O
:	O

Inclusion	O
of	O
older	O
children	O
and	O
young	O
adults	O
would	O
allow	O
cathelicidin	O
to	O
be	O
followed	O
throughout	O
a	O
longer	O
period	O
of	O
childhood	O
development	O
and	O
further	O
describe	O
how	O
cathelicidin	O
and	O
innate	O
immune	O
function	O
develop	O
over	O
time	O
.	O

Moreover	O
,	O
40	O
subjects	O
with	O
samples	O
from	O
two	O
subsequent	O
years	O
showed	O
a	O
highly	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
increase	O
in	O
cathelicidin	O
concentration	O
from	O
visit	O
one	O
to	O
visit	O
two	O
.	O

MATERIALS	O
AND	O
METHODS	O
Animals	O
and	O
Diets	O
First	O
-	O
time	O
pregnant	O
Wistar	O
rats	O
(	O
day	O
2	O
–	O
3	O
of	O
pregnancy	O
)	O
was	O
purchased	O
from	O
Charles	O
River	O
(	O
Montreal	O
,	O
QC	O
,	O
Canada	O
).	O

The	O
data	O
were	O
analyzed	O
using	O
the	O
SPSS	O
statistical	O
software	O
(	O
v	O
.	O
16	O
).	O

This	O
review	O
focuses	O
on	O
neurodevelopmental	O
outcomes	O
for	O
the	O
foetus	O
as	O
much	O
of	O
the	O
published	O
research	O
into	O
fish	O
consumption	O
during	O
pregnancy	O
has	O
focused	O
on	O
methyl	O
-	O
mercury	O
,	O
LC	O
n	O
-	O
3PUFAs	O
and	O
iodine	O
,	O
all	O
known	O
to	O
impact	O
foetal	O
neurodevelopment	O
[	O
13	O
,	O
14	O
].	O

Baseline	O
characteristics	O
between	O
the	O
low	O
and	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
compared	O
using	O
a	O
two	O
-	O
sided	O
t	O
-	O
test	O
for	O
equal	O
means	O
for	O
continuous	O
,	O
normally	O
distributed	O
variables	O
and	O
and	O
χ2	O
-	O
test	O
for	O
categorical	O
variables	O
.	O

Factors	O
affecting	O
BAT	O
function	O
and	O
energy	O
metabolism	O
improve	O
overall	O
metabolism	O
In	O
rodents	O
,	O
brown	O
adipocytes	O
are	O
found	O
in	O
discrete	O
areas	O
,	O
such	O
as	O
interscapular	O
,	O
cervical	O
,	O
peri	O
-	O
aortic	O
,	O
peri	O
-	O
renal	O
,	O
intercostal	O
and	O
mediastinal	O
depots	O
(	O
Cinti	O
,	O
2001	O
),	O
which	O
are	O
referred	O
to	O
as	O
“	O
classical	O
”	O
BAT	O
depots	O
.	O

We	O
collected	O
venous	O
blood	O
samples	O
from	O
randomly	O
selected	O
blocks	O
of	O
children	O
on	O
the	O
basis	O
of	O
the	O
assumption	O
that	O
each	O
block	O
had	O
an	O
equal	O
number	O
of	O
children	O
from	O
the	O
vitamin	O
D3and	O
placebo	O
groups	O
.	O

Newborn	O
and	O
infant	O
children	O
have	O
greater	O
contact	O
with	O
these	O
contaminants	O
since	O
they	O
lie	O
,	O
crawl	O
and	O
play	O
near	O
the	O
ground	O
and	O
frequently	O
place	O
their	O
hands	O
,	O
objects	O
or	O
food	O
in	O
their	O
mouths	O
[	O
29	O
,	O
33	O
,	O
34	O
].	O

During	O
the	O
final	O
stage	O
,	O
from	O
18	O
months	O
to	O
slaughter	O
(	O
28	O
to	O
30	O
months	O
of	O
age	O
),	O
the	O
concentrate	O
is	O
84	O
.	O
2	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
,	O
and	O
the	O
rest	O
is	O
roughage	O
(	O
rice	O
straw	O
).	O

The	O
potential	O
for	O
contamination	O
by	O
heavy	O
metals	O
,	O
as	O
well	O
as	O
risk	O
of	O
listeriosis	O
requires	O
careful	O
consideration	O
of	O
the	O
shaping	O
of	O
dietary	O
messages	O
related	O
to	O
fish	O
intake	O
during	O
pregnancy	O
.	O

Stress	O
increases	O
circulating	O
concentrations	O
of	O
cortisol	O
,	O
a	O
typical	O
stress	O
marker	O
[	O
99	O
].	O

The	O
subjects	O
with	O
the	O
three	O
highest	O
cathelicidin	O
concentration	O
values	O
had	O
characteristics	O
including	O
25	O
(	O
OH	O
)	O
D	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
age	O
,	O
which	O
were	O
comparable	O
to	O
the	O
corresponding	O
variable	O
represented	O
in	O
the	O
entire	O
cohort	O
.	O

This	O
is	O
especially	O
important	O
for	O
pregnant	O
asthmatic	O
patients	O
,	O
in	O
whom	O
smoking	O
-	O
related	O
morbidity	O
is	O
independent	O
of	O
--	O
and	O
adds	O
to	O
--	O
the	O
morbidity	O
resulting	O
from	O
asthma	O
[	O
96	O
].	O

In	O
addition	O
,	O
10	O
%	O
of	O
the	O
questionnaires	O
were	O
doubled	O
-	O
checked	O
by	O
a	O
co	O
-	O
investigator	O
,	O
different	O
from	O
the	O
original	O
data	O
entry	O
person	O
.	O

Introduction	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
,	O
and	O
it	O
is	O
related	O
to	O
excess	O
vasopressinase	O
activity	O
.	O

Nucleotide	O
polymorphism	O
of	O
the	O
β	O
2	O
adrenergic	O
receptor	O
gene	O
has	O
also	O
been	O
implicated	O
as	O
risk	O
factors	O
for	O
autism	O
,	O
namely	O
,	O
Gly	O
16	O
and	O
Glu	O
27	O
[	O
24	O
,	O
25	O
].	O

In	O
addition	O
to	O
the	O
uncertainty	O
concerning	O
the	O
optimal	O
vitamin	O
D	O
intakes	O
preventing	O
vitamin	O
D	O
deficiency	O
,	O
there	O
exists	O
also	O
a	O
lack	O
of	O
recommendations	O
to	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

The	O
role	O
of	O
paternal	O
nutrition	O
on	O
epigenetically	O
linked	O
heritable	O
diseases	O
such	O
as	O
cardiovascular	O
and	O
obesity	O
have	O
been	O
suggested	O
in	O
epidemiological	O
studies	O
[	O
10	O
].	O

It	O
has	O
long	O
been	O
proposed	O
that	O
the	O
mother	O
should	O
avoid	O
such	O
foods	O
containing	O
potential	O
allergens	O
during	O
pregnancy	O
and	O
lactation	O
to	O
prevent	O
food	O
sensitization	O
in	O
the	O
child	O
.	O

The	O
same	O
applies	O
to	O
in	O
vivo	O
tests	O
such	O
as	O
food	O
challenge	O
tests	O
and	O
patch	O
tests	O
.	O

Red	O
and	O
processed	O
meat	O
intake	O
is	O
considered	O
less	O
healthful	O
,	O
and	O
consumption	O
below	O
the	O
median	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

Blood	O
glucose	O
levels	O
are	O
usually	O
monitored	O
in	O
the	O
fasting	O
state	O
and	O
1	O
–	O
2	O
hours	O
after	O
meals	O
.	O

These	O
two	O
enzymes	O
are	O
induced	O
in	O
adipose	O
tissues	O
of	O
ruminants	O
by	O
increasing	O
energy	O
intake	O
[	O
89	O
].	O

An	O
increase	O
in	O
this	O
hormone	O
can	O
lead	O
to	O
brain	O
dysfunctions	O
[	O
70	O
,	O
71	O
].	O

(	O
2013	O
)*	O
Phthalates	O
:	O
Dibutylphthalate	O
(	O
DBP	O
)	O
RatOral	O
(	O
gavage	O
)	O
(	O
500	O
mg	O
/	O
kg	O
/	O
d	O
)	O
In	O
uteroIn	O
utero	O
to	O
early	O
adulthood	O
F1male	O
offspring	O
↓	O
testicular	O
testosterone	O
and	O
Leydig	O
stem	O
cellsHistone	O
modificationKilcoyne	O
et	O
al	O
.	O

These	O
models	O
were	O
adjusted	O
for	O
BMI	O
,	O
season	O
of	O
conception	O
,	O
education	O
level	O
,	O
origin	O
and	O
gestational	O
age	O
at	O
registration	O
to	O
antenatal	O
care	O
(	O
based	O
on	O
last	O
menstrual	O
period	O
).	O

Moreover	O
,	O
the	O
outcomes	O
of	O
the	O
present	O
study	O
enhance	O
the	O
importance	O
of	O
the	O
periconceptional	O
period	O
as	O
well	O
as	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
the	O
early	O
life	O
programming	O
,	O
due	O
to	O
the	O
fact	O
that	O
the	O
maternal	O
undernutrition	O
was	O
implemented	O
before	O
mating	O
and	O
offspring	O
were	O
raised	O
in	O
an	O
ad	O
libitum	O
standard	O
feeding	O
.	O

We	O
compared	O
a	O
number	O
of	O
characteristics	O
for	O
participants	O
who	O
completed	O
the	O
questionnaire	O
,	O
both	O
in	O
the	O
parent	O
study	O
and	O
the	O
follow	O
-	O
up	O
study	O
,	O
with	O
those	O
who	O
only	O
answered	O
the	O
questionnaire	O
in	O
the	O
parent	O
study	O
.	O

We	O
found	O
no	O
significant	O
prenatal	O
predictors	O
of	O
change	O
in	O
WFA	O
z	O
-	O
scores	O
between	O
birth	O
and	O
6	O
months	O
.	O

The	O
acceptance	O
capacity	O
of	O
methyl	O
groups	O
in	O
the	O
whole	O
genome	O
is	O
known	O
to	O
be	O
inversely	O
related	O
to	O
the	O
exogenous3H	O
-	O
methyl	O
incorporation	O
.	O

It	O
should	O
also	O
be	O
noted	O
that	O
,	O
despite	O
ongoing	O
research	O
efforts	O
,	O
relatively	O
little	O
has	O
yet	O
been	O
divulged	O
regarding	O
delivery	O
-	O
room	O
attributes	O
that	O
may	O
be	O
directly	O
or	O
indirectly	O
associated	O
with	O
the	O
incidence	O
of	O
autism	O
.	O

Besides	O
the	O
role	O
of	O
genetic	O
predisposition	O
,	O
some	O
factors	O
have	O
been	O
identified	O
that	O
may	O
either	O
contribute	O
to	O
sensitization	O
of	O
the	O
mother	O
and	O
to	O
the	O
subsequent	O
transfer	O
of	O
a	O
predisposition	O
for	O
allergy	O
to	O
the	O
offspring	O
,	O
or	O
that	O
directly	O
induce	O
sensitization	O
in	O
offspring	O
that	O
manifests	O
shortly	O
after	O
birth	O
or	O
at	O
a	O
young	O
age	O
.	O

However	O
,	O
dietary	O
protein	O
levels	O
do	O
not	O
affect	O
IMF	O
deposition	O
in	O
Angus	O
or	O
Shorthorn	O
steers	O
(	O
reviewed	O
in	O
Bindon	O
[	O
115	O
]).	O

A	O
review	O
of	O
the	O
literature	O
revealed	O
a	O
paucity	O
of	O
published	O
cases	O
describing	O
the	O
successful	O
,	O
emergent	O
repair	O
of	O
acute	O
type	O
A	O
aortic	O
dissections	O
in	O
third	O
-	O
trimester	O
gravid	O
patients	O
.	O

Also	O
the	O
present	O
diet	O
substances	O
causes	O
complication	O
.	O

2	O
.	O

2008	O
)	O
by	O
rating	O
the	O
quality	O
of	O
individual	O
studies	O
and	O
carrying	O
out	O
a	O
sensitivity	O
analysis	O
by	O
excluding	O
studies	O
for	O
which	O
the	O
quality	O
score	O
was	O
below	O
a	O
chosen	O
value	O
.	O

MTC	O
is	O
somewhat	O
more	O
aggressive	O
than	O
papillary	O
or	O
follicular	O
carcinoma	O
.	O

Individuals	O
with	O
a	O
BMI	O
above	O
30	O
kg	O
/	O
m2are	O
classified	O
as	O
obese	O
;	O
those	O
with	O
a	O
BMI	O
between	O
25	O
and	O
30	O
kg	O
/	O
m2are	O
considered	O
to	O
be	O
overweight	O
.	O

Of	O
all	O
women	O
included	O
,	O
15	O
%	O
smoked	O
during	O
pregnancy	O
and	O
12	O
%	O
reported	O
having	O
drunk	O
alcohol	O
during	O
pregnancy	O
(	O
Table	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Characteristics	O
of	O
the	O
pregnant	O
women	O
included	O
in	O
the	O
study	O
(	O
n	O
=	O
1311	O
)	O
(	O
Belgian	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
,	O
2010	O
–	O
2011	O
).	O
CharacteristicNMean	O
age28	O
.	O
5	O
±	O
5	O
.	O
11305Mean	O
BMI	O
*(	O
kg	O
/	O
m2	O
)	O
24	O
.	O
4	O
±	O
5	O
.	O
11290	O
%	O
Underweight5	O
.	O
6673	O
%	O
Healthy	O
weight59	O
.	O
20763	O
%	O
Overweight22	O
.	O
09285	O
%	O
Obese13	O
.	O
10169	O
Ethnicity	O
%	O
White	O
/	O
Caucasian73	O
.	O
61965	O
%	O
Asiatic2	O
.	O
5233	O
%	O
African	O
(	O
Black	O
)	O
4	O
.	O
8864	O
%	O
North	O
African13	O
.	O
42176	O
%	O
Hispanic0	O
.	O
9212	O
%	O
Not	O
known4	O
.	O
6561	O
Education	O
level	O
%	O
Secondary	O
education	O
or	O
lower54	O
.	O
54715	O
%	O
Higher	O
education27	O
.	O
23357	O
%	O
University	O
or	O
higher14	O
.	O
87195	O
%	O
Other	O
education0	O
.	O
233	O
%	O
No	O
diploma0	O
.	O
699	O
%	O
Not	O
known2	O
.	O
4432	O
Smoking	O
%	O
Yes16	O
.	O
78220	O
%	O
Of	O
which	O
during	O
past	O
4	O
wks15	O
.	O
41202	O
%	O
No82	O
.	O
911087	O
%	O
Not	O
known0	O
.	O
314	O
Drinking	O
alcohol	O
%	O
Yes20	O
.	O
37267	O
%	O
Of	O
which	O
during	O
past	O
4	O
wks11	O
.	O
51151	O
%	O
No78	O
.	O
491029	O
%	O
Not	O
known1	O
.	O
1415	O
First	O
trimester	O
BMI	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
.	O

As	O
few	O
food	O
items	O
contain	O
or	O
are	O
fortified	O
with	O
vitamin	O
D	O
(	O
such	O
as	O
liver	O
,	O
fatty	O
fish	O
,	O
eggs	O
,	O
milk	O
and	O
dairy	O
products	O
,	O
soy	O
milk	O
,	O
butter	O
,	O
margarines	O
),	O
the	O
skin	O
synthesis	O
of	O
vitamin	O
D	O
induced	O
by	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
is	O
the	O
main	O
determinant	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
[	O
23	O
].	O

Except	O
for	O
a	O
small	O
percentage	O
of	O
cases	O
,	O
the	O
tumors	O
continue	O
to	O
show	O
high	O
morbidity	O
and	O
mortality	O
.	O

However	O
,	O
such	O
a	O
relation	O
has	O
not	O
yet	O
been	O
confirmed	O
.	O

Both	O
hyperplasia	O
and	O
hypertrophy	O
are	O
involved	O
in	O
IMF	O
deposition	O
(	O
Figure	O
1	O
).	O

[	O
17	O
]	O
Rojroongwasonkul	O
et	O
al	O
.	O

Thus	O
,	O
the	O
incorporation	O
of	O
epigenetics	O
within	O
chemical	O
regulation	O
could	O
ultimately	O
reduce	O
animal	O
usage	O
and	O
the	O
time	O
and	O
cost	O
of	O
chemical	O
research	O
and	O
development	O
,	O
while	O
simultaneously	O
improving	O
the	O
protection	O
of	O
public	O
health	O
worldwide	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
use	O
of	O
supplements	O
and	O
socio	O
-	O
demographic	O
factors	O
,	O
pre	O
-	O
natal	O
care	O
and	O
nutritional	O
knowledge	O
Folic	O
acidIronVitamins	O
YES	O
YES	O
YES	O
N	O
%	O
pn	O
%	O
pn	O
%	O
p	O
Urban	O
environment13863	O
.	O
6	O
<	O
0	O
.	O
001	O
17178	O
.	O
80	O
.	O
1417178	O
.	O
8	O
<	O
0	O
.	O
001	O
Rural	O
environment5436	O
.	O
410155	O
.	O
210155	O
.	O
2Education	O
(	O
number	O
of	O
years	O
)	O
≤	O
8115	O
.	O
7	O
<	O
0	O
.	O
001	O
4524	O
.	O
9	O
<	O
0	O
.	O
001	O
4315	O
.	O
8	O
<	O
0	O
.	O
001	O
9	O
-	O
128242	O
.	O
77541	O
.	O
411040	O
.	O
4	O
>	O
129951	O
.	O
6	O
6133	O
.	O
7	O
11943	O
.	O
8	O
Age	O
(	O
years	O
old	O
)	O
<	O
1800	O
<	O
0	O
.	O
001	O
942	O
.	O
9	O
0	O
.	O
043	O
942	O
.	O
9	O
0	O
.	O
011	O
≥	O
1819250	O
.	O
726369	O
.	O
426369	O
.	O
4Number	O
of	O
births	O
≤	O
217352	O
.	O
624273	O
.	O
624273	O
.	O
6	O
>	O
21926	O
.	O
83042	O
.	O
33042	O
.	O
3Wanted	O
pregnancy17949	O
.	O
9	O
0	O
.	O
017	O
25470	O
.	O
8	O
0	O
.	O
009	O
25470	O
.	O
8	O
<	O
0	O
.	O
001	O
Unwanted	O
pregnancy1230	O
.	O
01742	O
.	O
51742	O
.	O
5	O
Married17654	O
.	O
5	O
<	O
0	O
.	O
001	O
23572	O
.	O
8	O
0	O
.	O
01	O
23572	O
.	O
8	O
<	O
0	O
.	O
001	O
Single1620	O
.	O
83748	O
.	O
13748	O
.	O
1Pregnancy	O
registration	O
General	O
practitioner	O
Yes18949	O
.	O
1	O
0	O
.	O
027	O
26769	O
.	O
40	O
.	O

Special	O
hypoallergenic	O
formula	O
(	O
extensively	O
hydrolyzed	O
,	O
not	O
soy	O
-	O
based	O
)	O
should	O
be	O
used	O
only	O
if	O
the	O
child	O
is	O
diagnosed	O
with	O
atopy	O
.	O

Whether	O
brown	O
and	O
brite	O
adipocytes	O
display	O
some	O
degree	O
of	O
specialization	O
with	O
regard	O
to	O
these	O
different	O
functions	O
has	O
to	O
be	O
established	O
.	O

Thus	O
,	O
even	O
though	O
there	O
is	O
no	O
consensus	O
on	O
recommending	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
,	O
they	O
are	O
used	O
more	O
often	O
by	O
those	O
women	O
with	O
a	O
better	O
socio	O
-	O
economic	O
status	O
,	O
with	O
a	O
higher	O
level	O
of	O
education	O
and	O
who	O
attended	O
more	O
prenatal	O
consultations	O
.	O

GSEA	O
analysis	O
.	O

The	O
development	O
of	O
adipose	O
tissue	O
coincides	O
with	O
myogenesis	O
during	O
a	O
particular	O
time	O
in	O
fetal	O
development	O
[	O
18	O
].	O

